<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Heliyon</journal-id><journal-id journal-id-type="iso-abbrev">Heliyon</journal-id><journal-id journal-id-type="pmc-domain-id">2992</journal-id><journal-id journal-id-type="pmc-domain">heliyon</journal-id><journal-title-group><journal-title>Heliyon</journal-title></journal-title-group><issn pub-type="epub">2405-8440</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7729279</article-id><article-id pub-id-type="pmcid-ver">PMC7729279.2</article-id><article-id pub-id-type="pmcaid">7729279</article-id><article-id pub-id-type="pmcaiid">7736724</article-id><article-id pub-id-type="pmid">33324769</article-id><article-id pub-id-type="doi">10.1016/j.heliyon.2020.e05706</article-id><article-id pub-id-type="pii">S2405-8440(20)32549-4</article-id><article-id pub-id-type="publisher-id">e05706</article-id><article-version article-version-type="pmc-version">2</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Recent updates on COVID-19: A holistic review</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name name-style="western"><surname>Jakhmola</surname><given-names initials="S">Shweta</given-names></name><xref rid="aff1" ref-type="aff">a</xref><xref rid="fn1" ref-type="fn">1</xref></contrib><contrib contrib-type="author" id="au2"><name name-style="western"><surname>Indari</surname><given-names initials="O">Omkar</given-names></name><xref rid="aff1" ref-type="aff">a</xref><xref rid="fn1" ref-type="fn">1</xref></contrib><contrib contrib-type="author" id="au3"><name name-style="western"><surname>Kashyap</surname><given-names initials="D">Dharmendra</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au4"><name name-style="western"><surname>Varshney</surname><given-names initials="N">Nidhi</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au5"><name name-style="western"><surname>Rani</surname><given-names initials="A">Annu</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au6"><name name-style="western"><surname>Sonkar</surname><given-names initials="C">Charu</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au7"><name name-style="western"><surname>Baral</surname><given-names initials="B">Budhadev</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au8"><name name-style="western"><surname>Chatterjee</surname><given-names initials="S">Sayantani</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au9"><name name-style="western"><surname>Das</surname><given-names initials="A">Ayan</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au10"><name name-style="western"><surname>Kumar</surname><given-names initials="R">Rajesh</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au11"><name name-style="western"><surname>Jha</surname><given-names initials="HC">Hem Chandra</given-names></name><email>hemcjha@iiti.ac.in</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="cor1" ref-type="corresp">&#8727;</xref></contrib><aff id="aff1"><label>a</label>Discipline of Biosciences and Biomedical Engineering, Indian Institute of Technology, Indore, India</aff><aff id="aff2"><label>b</label>Discipline of Physics, Indian Institute of Technology, Indore, India</aff></contrib-group><author-notes><corresp id="cor1"><label>&#8727;</label>Corresponding author. <email>hemcjha@iiti.ac.in</email></corresp><fn id="fn1"><label>1</label><p id="ntpara0010">Equal contributors.</p></fn></author-notes><pub-date pub-type="collection"><month>12</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>11</day><month>12</month><year>2020</year></pub-date><volume>6</volume><issue>12</issue><issue-id pub-id-type="pmc-issue-id">370010</issue-id><elocation-id>e05706</elocation-id><history><date date-type="received"><day>22</day><month>7</month><year>2020</year></date><date date-type="rev-recd"><day>21</day><month>9</month><year>2020</year></date><date date-type="accepted"><day>4</day><month>12</month><year>2020</year></date></history><pub-history><event event-type="pmc-release"><date><day>11</day><month>12</month><year>2020</year></date></event><event event-type="pmc-live"><date><day>11</day><month>12</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-08-03 20:25:36.563"><day>03</day><month>08</month><year>2024</year></date></event><event event-type="pmc-version" specific-use="live"><article-id pub-id-type="pmcaiid">7729279</article-id><article-id pub-id-type="doi">10.1016/j.heliyon.2020.e05706</article-id><article-version>1</article-version><pub-date><day>11</day><month>12</month><year>2020</year></pub-date></event><event event-type="pmc-version" specific-use="live"><article-id pub-id-type="pmcaiid">7736724</article-id><article-id pub-id-type="doi">10.1016/j.heliyon.2020.e05706</article-id><article-version>2</article-version><pub-date><day>11</day><month>12</month><year>2020</year></pub-date></event></pub-history><permissions><copyright-statement>&#169; 2020 The Authors</copyright-statement><copyright-year>2020</copyright-year><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract id="abs0010"><p>Coronaviruses are large positive-sense RNA viruses with spike-like peplomers on their surface. The <italic toggle="yes">Coronaviridae</italic> family's strains infect different animals and are popularly associated with several outbreaks, namely SARS and MERS epidemic. COVID-19 is one such recent outbreak caused by SARS-CoV-2 identified first in Wuhan, China. COVID-19 was declared a pandemic by WHO on 11<sup>th</sup> March 2020. Our review provides information covering various facets of the disease starting from its origin, transmission, mutations in the virus to pathophysiological changes in the host upon infection followed by diagnostics and possible therapeutics available to tackle the situation. We have highlighted the zoonotic origin of SARS-CoV-2, known to share 96.2% nucleotide similarity with bat coronavirus. Notably, several mutations in SARS-CoV-2 spike protein, nucleocapsid protein, PLpro, and ORF3a are reported across the globe. These mutations could alter the usual receptor binding function, fusion process with the host cell, virus replication, and the virus's assembly. Therefore, studying these mutations could help understand the virus's virulence properties and design suitable therapeutics. Moreover, the aggravated immune response to COVID-19 can be fatal. Hypertension, diabetes, and cardiovascular diseases are comorbidities substantially associated with SARS-CoV-2 infection. The review article discusses these aspects, stating the importance of various comorbidities in disease outcomes. Furthermore, medications' unavailability compels the clinicians to opt for atypical drugs like remdesivir, chloroquine, etc. The current diagnostics of COVID-19 include qRT-PCR, CT scan, serological tests, etc. We have described these aspects to expose the information to the scientific community and to accelerate the research.</p></abstract><abstract abstract-type="teaser" id="abs0015"><p>Microbiology; Virology; Viruses; Epidemiology; Vaccines; Health Disparity; Diagnostics; SARS-CoV-2; Mutations; Comorbidities; signalling; Diagnostics; Vaccination; spike protein.</p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>Microbiology</kwd><kwd>Virology</kwd><kwd>Viruses</kwd><kwd>Epidemiology</kwd><kwd>Vaccines</kwd><kwd>Health disparity</kwd><kwd>Diagnostics</kwd><kwd>SARS-CoV-2</kwd><kwd>Mutations</kwd><kwd>Comorbidities</kwd><kwd>Signalling</kwd><kwd>Vaccination</kwd><kwd>Spike protein</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><label>1</label><title>A brief introduction of coronaviruses and associated pandemics</title><p id="p0010">In Latin, coronavirus (CoV) refers to "halo" or "crown" viruses as these have spike-like projections on its surface [<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib2" ref-type="bibr">2</xref>]. The genome size of the virus ranges from 26 to 32 &#215; 10<sup>3</sup> bp and consists of multiple open reading frames (ORFs) (from 6 to 11). The first ORF constituting 67% of the whole virus genome is responsible for 16 non-structural proteins (nsps). The other necessary proteins are encoded by the remaining ORFs [<xref rid="bib3" ref-type="bibr">3</xref>]. The four main structural proteins of the virus include the spike surface glycoprotein (S), envelope (E), membrane (M), and nucleocapsid (N). The S protein establishes the essential host cell tropism [<xref rid="bib4" ref-type="bibr">4</xref>]. Further speaking of the first infectious CoV, the virus was isolated from birds with bronchitis in the 1930s [<xref rid="bib5" ref-type="bibr">5</xref>]. CoVs comprises four genera: Alpha, Beta, Gamma, and Delta CoV. The first two genera of CoVs are known to infect humans, while the latter two predominantly infect birds [<xref rid="bib6" ref-type="bibr">6</xref>]. In the 1960s, the first human coronavirus (HCoV) from the cultures of patients with a common cold was obtained [<xref rid="bib7" ref-type="bibr">7</xref>]. Apart from the newly recognized severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), six other HCoVs have been identified, namely HCoV-NL63 and HCoV-229E, which belong to the genus Alpha CoV [<xref rid="bib8" ref-type="bibr">8</xref>], HCoV-HKU1, HCoV-OC43, Middle East respiratory syndrome coronavirus (MERS-CoV), and SARS-CoV which are categorized as Beta CoVs [<xref rid="bib8" ref-type="bibr">8</xref>].</p><p id="p0015">CoVs are responsible for almost 30% of common colds, and often the individuals are infected with these viruses in their lifetime [<xref rid="bib9" ref-type="bibr">9</xref>]. CoV infections display a seasonal pattern with an increased number of cases during winter and early spring [<xref rid="bib10" ref-type="bibr">10</xref>]. Occasionally, the virus can infect other animals, apart from its natural host, and undergo mutations resulting in a more evolved virus capable of affecting a broader and distinct population. CoVs were mainly highlighted after the 2003 SARS pandemic followed by the MERS epidemic in 2012, and now the very recent SARS-CoV-2 outbreak [<xref rid="bib11" ref-type="bibr">11</xref>]. The 2002&#8211;2003 SARS pandemic affected almost 8,096 and claimed 774 lives of four continents before its containment [<xref rid="bib12" ref-type="bibr">12</xref>]. The SARS CoV resembled the bat CoV, its natural host [<xref rid="bib13" ref-type="bibr">13</xref>]. However, the virus was investigated to spread to humans by handling and consuming palm civets, raccoon dogs, and Chinese ferret badgers sold and slaughtered at the wet markets of China [<xref rid="bib13" ref-type="bibr">13</xref>]. The virus infected individuals with severe pulmonary syndrome and showed a mortality rate of 10% [<xref rid="bib14" ref-type="bibr">14</xref>]. Furthermore, the SARS-CoV S protein receptor-binding domain (RBD) binds to the host receptor angiotensin-converting enzyme2 (ACE2) [<xref rid="bib15" ref-type="bibr">15</xref>] with CD209L as a substituting receptor [<xref rid="bib16" ref-type="bibr">16</xref>]. After SARS-CoV, another highly pathogenic CoV outbreak was the MERS-CoV pandemic [<xref rid="bib17" ref-type="bibr">17</xref>] that mostly affected the Arabian Peninsula [<xref rid="bib18" ref-type="bibr">18</xref>]. MERS-CoV lasted for seven years, even after its spread in the confined areas. To date, almost 2500 cases of MERS have been confirmed with a mortality rate of ~35% [<xref rid="bib19" ref-type="bibr">19</xref>]. It is more closely associated with bat CoVs than that of other HCoVs [<xref rid="bib20" ref-type="bibr">20</xref>]. For entry, MERS-CoV uses dipeptidyl peptidase 4 (DPP4, also known as CD26) as a receptor [<xref rid="bib21" ref-type="bibr">21</xref>, <xref rid="bib22" ref-type="bibr">22</xref>]. To date, no vaccination or particular treatment is functional for MERS-CoV; however, a recent candidate DNA vaccine developed from MERS-CoV S protein subunit 1 (S1) is under study [<xref rid="bib23" ref-type="bibr">23</xref>]. MERS-CoV has shown recurrence in the human population by direct or indirect contact with infected primary reservoirs, which are the dromedary camels [<xref rid="bib24" ref-type="bibr">24</xref>].</p><p id="p0020">The severe pathogenic ability of SARS viruses to cross-species and undergo high mutation rates has resulted in the emergence of a new virus, i.e., SARS-CoV-2. The virus originated in the Wuhan province of China, and the disease, coronavirus disease-2019 (COVID-19), has become an emerging global health emergency since 11<sup>th</sup> March 2020 [<xref rid="bib25" ref-type="bibr">25</xref>]. The virus affected a considerable population within a short period indicating its rapid potential to spread. The virus's ability to infect humans was reported due to the evolution of RBD towards ACE2 receptors expressed on various human cells [<xref rid="bib21" ref-type="bibr">21</xref>]. The virus is known to reach and infect different organs like the brain, kidney, liver, gastrointestinal system, etc. thereby causing multiple organs failure [<xref rid="bib26" ref-type="bibr">26</xref>, <xref rid="bib27" ref-type="bibr">27</xref>, <xref rid="bib28" ref-type="bibr">28</xref>]. Symptoms of COVID-19 that resemble SARS and MERS include fever, cough, and shortness of breath [<xref rid="bib29" ref-type="bibr">29</xref>]. Furthermore, SARS-CoV usually infects the young population, and MERS-CoV affects people aged above 50 years. However, SARS-CoV-2 is mostly known to cause severe manifestations in middle-aged and older people [<xref rid="bib30" ref-type="bibr">30</xref>, <xref rid="bib31" ref-type="bibr">31</xref>]. Collectively, our review aims to provide information on SARS-CoV-2 evolution, associated comorbidities, and its influence on infected individuals at the molecular and pathophysiological levels. Briefly, we also highlight the probable vaccine candidates from varied organizations in different phases of clinical trials. In addition, a glimpse into the diagnostics, along with possible interventions adapted to date to contain the virus, is presented. The information about various facets of SARS-CoV-2 infection is scattered in numerous types of reports. A comprehensive presentation of updated information is therefore necessary. The information here will enable us to understand SARS-CoV-2 from different angles and aid in the research of COVID-19.</p></sec><sec id="sec2"><label>2</label><title>Zoonotic origin of SARS-CoV-2</title><p id="p0025">Tracing back the tracks of history and early epidemiological studies, it has become evident that HCoV infections have zoonotic origins [<xref rid="bib32" ref-type="bibr">32</xref>]. The intermediate host, to which the virus is recently introduced, can amicably serve as a zoonotic source with the capability to transfer the infection to humans at a full scale. The intermediate host provides the virus with the necessary conditions to amplify and replicate transiently [<xref rid="bib33" ref-type="bibr">33</xref>]. Besides, the virus can come to a dead-end situation if its sustenance is supported within the intermediate host or evolve itself according to the host, making it its natural reservoir host. What needs to be investigated regarding SARS-CoV-2 is if the virus acclimatizes to humans and can transmit without its intermediate host. Therefore, identifying the animal source can provide us with preventive human disease interventions. Phylogenetic studies have shown bats and rodents as the reservoir of most alpha- and beta-CoVs evident [<xref rid="bib34" ref-type="bibr">34</xref>]. For long, the CoVs are known to cross the barrier of species specificity and enter the human population like MERS-CoV, SARS-CoV, and SARS-CoV-2 [<xref rid="bib35" ref-type="bibr">35</xref>].</p><p id="p0030">Homology studies have demonstrated 96.2% nucleotide similarity between the SARS-CoV-2 and RaTG13, a bat CoV obtained from <italic toggle="yes">Rhinolophus Affinis</italic> [<xref rid="bib36" ref-type="bibr">36</xref>]. Based on similar reviews, another conclusion was drawn that bats cannot serve as intermediate reservoir hosts for SARS-CoV-2 until an almost identical CoV is acquired from bats. The spread of the virus has to be from some of the wild animals dealt at the Huanan seafood wholesale. The site accounts for the initial cases of COVID-19 and seems suitable for an animal to human transmission [<xref rid="bib37" ref-type="bibr">37</xref>]. Further, the metagenomic studies hint towards pangolins (<italic toggle="yes">Manis javanica</italic>) as a plausible intermediate host capable of harboring beta-CoVs related to SARS-CoV-2 [<xref rid="bib38" ref-type="bibr">38</xref>]. Jaimes <italic toggle="yes">et&#160;al.</italic> performed S protein-based phylogenetic analysis of pangolin-CoVs from Malayan pangolins brought into China from Guangxi and Guangdong Province, SARS-CoV-2, BatCoV-RaTG13, and other beta coronaviruses [<xref rid="bib39" ref-type="bibr">39</xref>]. Also, a detailed similarity analysis of different betacoronavirus involved 148 human SARS-CoV-2 sequences, six pangolin CoVs (PcoV_GX_P5L, P2V, P4L, P1E, P5E, and MP789), and two bat CoVs namely RaTG13 (from <italic toggle="yes">Rhinolophus affinis</italic>) and RmYN02 (from <italic toggle="yes">R.&#160;malayanus</italic>) [<xref rid="bib40" ref-type="bibr">40</xref>]. The CoV (MP789 CoV) derived from these small endangered mammals share nucleotide homology, up to 85&#8211;92%, with the SARS-CoV-2 [<xref rid="bib38" ref-type="bibr">38</xref>,<xref rid="bib40" ref-type="bibr">40</xref>]. Surprisingly, despite the higher sequence homology of SARS-CoV-2 with RaTG13 (96.3%), the SARS-CoV-2 RBD shares 97.4% amino acid sequence similarity with RBD of Guangdong pangolin CoV [<xref rid="bib38" ref-type="bibr">38</xref>].</p><p id="p0035">Supporting the link between the pangolins and SARS-CoV-2, others report the presence of similar viral fragments from diseased pangolins lung samples [<xref rid="bib41" ref-type="bibr">41</xref>]. Although no direct evidence exists that defines pangolins as the origin of SARS-CoV-2. Theories also suggest the chances of a highly occurring event in CoVs called recombination between the above two species in a third animal species [<xref rid="bib42" ref-type="bibr">42</xref>]. Several earlier examples demonstrate the ability of the CoVs to be able to transmit from domestic animals to humans; for instance, the HCoV-OC43 pandemic around 1890 was recorded after the virus jumped from domestic livestock to humans [<xref rid="bib43" ref-type="bibr">43</xref>]. Bats are apt agents for interspecies virus dispersal because of many reasons like their ability to be in close social densely packed colonies, longevity, and ability to fly, which in turn allows them to cover and spread the pathogen to wider areas [<xref rid="bib44" ref-type="bibr">44</xref>]. Usually, bats transmit the microorganisms through intermediate hosts, mostly when the intermediate host consumes the partially digested bat food, which serves as a potential source of infection [<xref rid="bib44" ref-type="bibr">44</xref>]. These placental mammals provide suitable body temperature, allowing replication of viruses sensitive to increased temperatures [<xref rid="bib45" ref-type="bibr">45</xref>]. Bats have long been known to serve as reservoirs of various microorganisms, especially RNA viruses, implicated in several human diseases. It is noteworthy to mention that more than 200 viruses are associated with bats, including SARS and MERS coronaviruses, as well as Ebola and Marburg viruses [<xref rid="bib45" ref-type="bibr">45</xref>].</p><p id="p0040">CoVs being RNA viruses, have an immense potential to introduce mutation during replicating its genome, with ~10<sup>&#8722;4</sup> average substitutions per site in a year [<xref rid="bib46" ref-type="bibr">46</xref>]. The mutation rates give the viruses the ability for interspecies co-evolution. Further, the virus family has a proofreading exoribonuclease, elimination of which can result in an even higher mutation rate [<xref rid="bib47" ref-type="bibr">47</xref>]. Nevertheless, the mutation rate is approximately a million times more in the CoVs rather than their hosts [<xref rid="bib48" ref-type="bibr">48</xref>]. However, the rate of variation in SARS-CoV-2 is relatively lower to SARS-CoV, therefore making it more adaptable to humans [<xref rid="bib49" ref-type="bibr">49</xref>]. The CoVs have an ample number of RNA fragments (ORFs), and the viruses often switch the templates during replication. Notably, it is known that new CoVs could generate homologous recombination of full length and subgenomic RNAs [<xref rid="bib50" ref-type="bibr">50</xref>]. An example of this is natural recombination between HCoV-HKU1 and HCoV-OC43 [<xref rid="bib51" ref-type="bibr">51</xref>].</p><p id="p0045">Additionally, the host plays a crucial role in the interspecies spread of the virus. In other words, a host may be suitable for infection by one virus, with just a difference of a few amino acids substitution in its protein. A cryo-electron microscopy study demonstrates that a difference of 30% in between the S protein of SARS-CoV-2 and SARS-CoV is responsible for 20 fold higher affinity of the SARS-CoV-2 S protein with ACE2 receptors expressed by the human cells [<xref rid="bib52" ref-type="bibr">52</xref>]. Therefore, these variations could be responsible for establishing a CoV in humans upon transmission from their natural reservoir host. Nonetheless, the HCoVs frequently possess factors that subvert the host restriction factors for successful interspecies transmission.</p></sec><sec id="sec3"><label>3</label><title>Mutations in SARS-CoV-2 proteins from various isolates around the world</title><p id="p0050">The potency of viruses to adapt to new hosts and niches is based on their ability to generate beneficial genomic diversity in short periods [<xref rid="bib53" ref-type="bibr">53</xref>]. Nucleotides substitutions have been determined as one of the critical mechanisms of viral development [<xref rid="bib54" ref-type="bibr">54</xref>]. These substitutions not only alter the genome of the virus but also get mirrored into the subsequent proteome. The changes in protein sequences can cause anomalies in their structure and function, giving the virus new tools to adapt and survive. As mentioned previously, the RNA viruses have a huge potential to mutate. Likewise, SARS-CoV-2, during its spread in the different populations in varied subcontinental areas, has undergone distinct mutations, whereas very few mutations have been observed at the geographical level [<xref rid="bib55" ref-type="bibr">55</xref>, <xref rid="bib56" ref-type="bibr">56</xref>, <xref rid="bib57" ref-type="bibr">57</xref>]. This further adds up to the challenges in fundamental research regarding SARS-CoV-2 as well as in vaccine and drug development (<xref rid="fig1" ref-type="fig">Figure&#160;1</xref>).<fig id="fig1" position="float" orientation="portrait"><label>Figure&#160;1</label><caption><p><bold>Overview of various aspects associated with SARS-CoV-2 infection: Origin, transmission, risk factors within a population, host response, diagnostics, and respective future directions.</bold> SARS-CoV-2 has a zoonotic origin. It might have travelled to humans from bat through an intermediate host like a pangolin. During further spread among the human population, it has undergone many mutations. Additionally, individuals with comorbidities may be susceptible to infection or disease severity. Viral entry inside the cell with subsequent molecular signaling and pathophysiological changes within the host is needed to be understood for better diagnosis and therapeutic targets. However, various diagnostics tools have made detection of infection easier. In the near future, the current pandemic demands more viral mutation studies, the development of better diagnostic tools, accelerated research for vaccine development, drug repurposing, and further amendments in the treatment of patients with comorbidities.</p></caption><alt-text id="alttext0010">Figure&#160;1</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr1.jpg"/></fig></p><p id="p0055">We have briefly reviewed several mutations reported in various SARS-CoV-2 proteins from different sub-continental areas. The open-reading frames (ORFs) in the SARS-CoV-2 genome are similar to those of all &#946;-coronaviruses [<xref rid="bib58" ref-type="bibr">58</xref>, <xref rid="bib59" ref-type="bibr">59</xref>, <xref rid="bib60" ref-type="bibr">60</xref>]. ORF1a/b encodes various essential accessory proteins like proteases, helicase, etc. The S, E, M, and the N proteins are encoded by their distinct ORFs. Some other ORFs like ORF3a, ORF6a, ORFF7a, and ORF8a, are involved in different putative functions such as inhibition of interferon-&#946; (IFN-&#946;), DNA synthesis, etc. as summarized in a report [<xref rid="bib61" ref-type="bibr">61</xref>]. Nonetheless, the function of ORF9b and ORF10a is yet to be explored [<xref rid="bib59" ref-type="bibr">59</xref>, <xref rid="bib61" ref-type="bibr">61</xref>]. In a report addressing mutations in different ORFs, the ORFs of E protein, M glycoprotein, ORF6, ORF7b, and ORF10 were found to be conserved while several mutations were observed in ORF1a, ORF1b, ORF3a, ORF7a, ORF8, as well as in N and S protein ORF [<xref rid="bib62" ref-type="bibr">62</xref>]. Another study on Indian isolates observed that the 5&#8242;terminal containing the genes for the ORF1ab, S, ORF3a, and E are more prone to mutations than 3&#8242;terminal, and are key drivers for virus diversity [<xref rid="bib56" ref-type="bibr">56</xref>].</p><p id="p0060">It is noteworthy that most of the worldwide reported mutations were from the S protein ORF [<xref rid="bib63" ref-type="bibr">63</xref>, <xref rid="bib64" ref-type="bibr">64</xref>, <xref rid="bib65" ref-type="bibr">65</xref>]. The S protein mutations alter the receptor binding affinity, interaction, and amalgamation of viral covering with host cell membranes, thereby amending virus-host interaction. One of S protein mutations reported was D614G, which lies at the S1/S2 subunit junction [<xref rid="bib63" ref-type="bibr">63</xref>]. The mutation is reported in the isolates from Chile, Egypt, Germany, India, and the USA (<xref rid="tbl1" ref-type="table">Table&#160;1</xref>). D614G mutation in S protein along with other mutations, result in significantly more infectious virus particles and provide fitness advantages [<xref rid="bib57" ref-type="bibr">57</xref>, <xref rid="bib66" ref-type="bibr">66</xref>]. Moreover, pseudoviruses with alone D614G mutations have shown increased infectious titers compared to the non-mutated forms [<xref rid="bib67" ref-type="bibr">67</xref>, <xref rid="bib68" ref-type="bibr">68</xref>]. Other observed S protein mutations include R407I, A930V, and G1124V from Indian isolates and Q57H and V367 from French isolates [<xref rid="bib63" ref-type="bibr">63</xref>, <xref rid="bib64" ref-type="bibr">64</xref>, <xref rid="bib65" ref-type="bibr">65</xref>]. These mutations could alter the infectivity, host-dependent modifications, replication cycle, evolutionary adaptation, species recognition, host receptor affinity, and pathophysiology of the disease [<xref rid="bib55" ref-type="bibr">55</xref>, <xref rid="bib65" ref-type="bibr">65</xref>, <xref rid="bib66" ref-type="bibr">66</xref>, <xref rid="bib67" ref-type="bibr">67</xref>]. L84S, G392D, and G251V were also reported from the USA, German and Brazilian isolates, respectively [<xref rid="bib63" ref-type="bibr">63</xref>]. Additionally, some of the mutations such as A475V, L452R, V483A, and F490L in RBD of S protein make SARS-CoV-2 resistant against neutralizing antibodies and are less infectious [<xref rid="bib66" ref-type="bibr">66</xref>]. RBD mutation enhances the virus's binding affinity with the ACE2 receptor; hence, it promotes the replication and infectivity of the virus [<xref rid="bib56" ref-type="bibr">56</xref>].<table-wrap position="float" id="tbl1" orientation="portrait"><label>Table&#160;1</label><caption><p>Comprehensive view of various mutations in SARS-CoV-2 proteins (S protein, N protein, PLpro and ORF3a) among different country-wise isolates.</p></caption><alt-text id="alttext0020">Table&#160;1</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" colspan="1">Countries</th><th colspan="15" rowspan="1">Mutations<hr/></th></tr><tr><th colspan="9" rowspan="1">S protein<hr/></th><th colspan="3" rowspan="1">N protein<hr/></th><th colspan="1" rowspan="1">RdRp<hr/></th><th colspan="1" rowspan="1">PLPro<hr/></th><th colspan="1" rowspan="1">ORF3a<hr/></th></tr><tr><th colspan="1" rowspan="1">Q<break/>57<break/>H</th><th colspan="1" rowspan="1">L<break/>84<break/>S</th><th colspan="1" rowspan="1">G<break/>251<break/>V</th><th colspan="1" rowspan="1">V<break/>367<break/>F</th><th colspan="1" rowspan="1">G<break/>392<break/>D</th><th colspan="1" rowspan="1">R<break/>407<break/>I</th><th colspan="1" rowspan="1">D<break/>614<break/>G</th><th colspan="1" rowspan="1">A<break/>930<break/>V</th><th colspan="1" rowspan="1">G<break/>1124<break/>V</th><th colspan="1" rowspan="1">S<break/>194<break/>L</th><th colspan="1" rowspan="1">R<break/>203<break/>K</th><th colspan="1" rowspan="1">G<break/>204<break/>R</th><th colspan="1" rowspan="1">P<break/>323<break/>L</th><th colspan="1" rowspan="1">A<break/>225<break/>V</th><th colspan="1" rowspan="1">G<break/>5214<break/>S</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Brazil</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Chile</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Egypt</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">+</td></tr><tr><td colspan="1" rowspan="1">France</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Germany</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">India</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">USA</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">REF</td><td colspan="1" rowspan="1">a)</td><td colspan="1" rowspan="1">a)</td><td colspan="1" rowspan="1">a)</td><td colspan="1" rowspan="1">b)</td><td colspan="1" rowspan="1">a)</td><td colspan="1" rowspan="1">c)</td><td colspan="1" rowspan="1">a)</td><td colspan="1" rowspan="1">c)</td><td colspan="1" rowspan="1">d)</td><td colspan="1" rowspan="1">b)</td><td colspan="1" rowspan="1">e)</td><td colspan="1" rowspan="1">f)</td><td colspan="1" rowspan="1">e)</td><td colspan="1" rowspan="1">e)</td><td colspan="1" rowspan="1">g)</td></tr></tbody></table><table-wrap-foot><fn><p>[References: a) [<xref rid="bib63" ref-type="bibr">63</xref>]; b) [<xref rid="bib64" ref-type="bibr">64</xref>]; c) [<xref rid="bib76" ref-type="bibr">76</xref>]; d) [<xref rid="bib69" ref-type="bibr">69</xref>] e) [<xref rid="bib70" ref-type="bibr">70</xref>]; f) [<xref rid="bib71" ref-type="bibr">71</xref>]; g) [<xref rid="bib75" ref-type="bibr">75</xref>]].</p></fn></table-wrap-foot></table-wrap></p><p id="p0065">N protein is yet another critical protein playing structural as well as non-structural roles [<xref rid="bib68" ref-type="bibr">68</xref>]. This protein also has strong immunogenicity [<xref rid="bib68" ref-type="bibr">68</xref>]. Two reported mutations, R203K and G204R, have been found in isolates from Chile and India, which trigger the viral capsid formation [<xref rid="bib69" ref-type="bibr">69</xref>, <xref rid="bib70" ref-type="bibr">70</xref>, <xref rid="bib71" ref-type="bibr">71</xref>]. In addition, S197L mutation in N protein is reported in isolates from Chile and the USA [<xref rid="bib64" ref-type="bibr">64</xref>]. These mutations could modulate the interaction, the protein functionality, and the structural integrity for better organization in viral assembly [<xref rid="bib69" ref-type="bibr">69</xref>, <xref rid="bib72" ref-type="bibr">72</xref>]. Furthermore, the viral RNA dependent RNA polymerase (RdRp) plays a vital viral genome replication task. P323L mutation is reported in the isolates from Chile and India [<xref rid="bib70" ref-type="bibr">70</xref>]. This mutation's significance needs to be investigated and could provide insights into the SARS-CoV-2 evolution and the role of this enzyme in the current mutation rate. Mutations are also reported in the papain-like protease (PLpro), an enzyme that performs the cleavage of replicase polyprotein at conserved sites. This step is necessary for the development of functional replication assembly [<xref rid="bib73" ref-type="bibr">73</xref>]. The A225V mutation in this protein was found in isolates from Chile [<xref rid="bib74" ref-type="bibr">74</xref>]. Additionally, ORF3a is an accessory protein of SARS-CoV-2 and is known to induce pro-apoptotic activity [<xref rid="bib74" ref-type="bibr">74</xref>]. The G5214S mutation is observed in ORF3a of the isolates from Egypt [<xref rid="bib75" ref-type="bibr">75</xref>]. However, the contribution of each of these mutations in terms of SARS-CoV-2 evolution, virulence, and transmission needs to be investigated further.</p></sec><sec id="sec4"><label>4</label><title>Comorbidities and its alliance with SARS-CoV-2</title><p id="p0070">Emanating data speculates elevated association and fierce mortality rate in COVID-19 patients with comorbidities [<xref rid="bib77" ref-type="bibr">77</xref>]. We have briefed about some of the COVID-19 associated comorbidities.</p><sec id="sec4.1"><label>4.1</label><title>Diabetes and hypertension: an inevitable risk factor for COVID-19</title><p id="p0075">The involvement of hypertension and diabetes in COVID-19 patients is not surprising, given the elevating myriad of both of these chronic diseases globally [<xref rid="bib78" ref-type="bibr">78</xref>, <xref rid="bib79" ref-type="bibr">79</xref>, <xref rid="bib80" ref-type="bibr">80</xref>, <xref rid="bib81" ref-type="bibr">81</xref>, <xref rid="bib82" ref-type="bibr">82</xref>, <xref rid="bib83" ref-type="bibr">83</xref>]. Diabetes and hypertension are interrelated; reports suggest that hypertension is twice as common in diabetic patients as in non-diabetics [<xref rid="bib84" ref-type="bibr">84</xref>, <xref rid="bib85" ref-type="bibr">85</xref>]. This overlap generally causes ischemic cerebrovascular disease, retinopathy, diabetic nephropathy, and sexual dysfunction [<xref rid="bib80" ref-type="bibr">80</xref>]. Diabetes alone can lead to severe cardiovascular diseases and an increase in vascular smooth muscle cells [<xref rid="bib85" ref-type="bibr">85</xref>]. Various meta-analyses and other independent studies have revealed hypertension and diabetes to be among the most prevalent comorbidities associated with COVID-19 [<xref rid="bib86" ref-type="bibr">86</xref>,<xref rid="bib87" ref-type="bibr">87</xref>,<xref rid="bib88" ref-type="bibr">88</xref>,<xref rid="bib89" ref-type="bibr">89</xref>]. Recently we have analyzed the data of hospitalized and deceased COVID-19 patients from various countries with comorbidities like diabetes, hypertension, heart diseases, immunocompromised and neurological diseases. The report suggests that comorbidities particularly, diabetes, hypertension, and heart diseases, are widely related to deaths in COVID-19 patients [<xref rid="bib77" ref-type="bibr">77</xref>]. Reports indicate that out of the total COVID-19 patients with at least one comorbidity, 28&#8211;30% had hypertension, and 12&#8211;19% had diabetes [<xref rid="bib90" ref-type="bibr">90</xref>, <xref rid="bib91" ref-type="bibr">91</xref>]. Moreover, diabetic COVID-19 patients exhibit an increased risk of thrombotic complications [<xref rid="bib92" ref-type="bibr">92</xref>]. Reports suggest the association of type 2 and type 1 diabetes with COVID-19 [<xref rid="bib93" ref-type="bibr">93</xref>]. SARS-CoV-2 infection can trigger severe metabolic complications in individuals with pre-diabetic conditions and influence diabetic ketoacidosis and hyperosmolarity. Also, it could lead to the onset of diabetes [<xref rid="bib93" ref-type="bibr">93</xref>, <xref rid="bib94" ref-type="bibr">94</xref>].</p><p id="p0080">Insulin resistance in diabetic patients leads to sodium retention, stimulation of the sympathetic nervous system, and the renin-angiotensin system [<xref rid="bib95" ref-type="bibr">95</xref>, <xref rid="bib96" ref-type="bibr">96</xref>]. However, as the ACE2 has a protective role in blood pressure, its deficiency causes hypertension [<xref rid="bib97" ref-type="bibr">97</xref>, <xref rid="bib98" ref-type="bibr">98</xref>, <xref rid="bib99" ref-type="bibr">99</xref>]. Diabetes and hypertension patients are prescribed with ACE inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) [<xref rid="bib100" ref-type="bibr">100</xref>]. Upon use of ACEIs or ARBs, to compensate ACE inhibition, ACE2 overexpression is facilitated, hence increasing patients' vulnerability [<xref rid="bib101" ref-type="bibr">101</xref>, <xref rid="bib102" ref-type="bibr">102</xref>]. ACE2 can also be elevated by thiazolidinediones and ibuprofen [<xref rid="bib100" ref-type="bibr">100</xref>]. Few studies recommend that due to the finite availability of serine protease TMPRSS2, increased ACE2 expression does not result in more viral entry. TMPRSS2 inhibitor camostat mesylate has been demonstrated to obstruct SARS-CoV-2 entry [<xref rid="bib88" ref-type="bibr">88</xref>, <xref rid="bib103" ref-type="bibr">103</xref>].</p></sec><sec id="sec4.2"><label>4.2</label><title>Cardiovascular diseases: a scary association with SARS-CoV-2 infection</title><p id="p0085">Cardiac conditions like arrhythmia, cardiomyopathy, and coronary heart disease are significant cardiovascular comorbidities seen in severe COVID-19 cases [<xref rid="bib104" ref-type="bibr">104</xref>]. Earlier reports have demonstrated the presence of the virus in heart autopsy samples. In the case of heart tissue, SARS-CoV-2 receptors are highly expressed [<xref rid="bib105" ref-type="bibr">105</xref>]. Moreover, in mice, the virus led to ACE2 dependent myocardial infections [<xref rid="bib106" ref-type="bibr">106</xref>]. The SARS-CoV and SARS-CoV-2 show similarities in their S protein, more specifically in the RBD domain. Hence it has been hypothesized that SARS-CoV-2 could infect cardiac tissue and aid in the severity of the disease [<xref rid="bib107" ref-type="bibr">107</xref>]. Another potent HCoV, MERS-CoV, has also been associated with acute myocarditis and heart failure [<xref rid="bib108" ref-type="bibr">108</xref>]. SARS-CoV-2 shares similar pathogenicity as MERS-CoV; therefore, SARS-CoV-2 can increase the disease complexity in the patients. Furthermore, SARS-CoV-2 infection injures the myocardium, which is determined by an increase in levels of myocardial biomarkers like creatine kinase (CK), creatine kinase MB isoenzyme (CK-MB), and lactate dehydrogenase (LDH) [<xref rid="bib107" ref-type="bibr">107</xref>, <xref rid="bib109" ref-type="bibr">109</xref>, <xref rid="bib110" ref-type="bibr">110</xref>]. The specific biomarker with high-sensitivity is cardiac troponin I (hs-cTnI). However, the biomarkers do not always alter in the same pattern [<xref rid="bib110" ref-type="bibr">110</xref>]. According to a study among 187 COVID-19 patients, 27.8% exhibited myocardial injury, demonstrated by elevation of troponin (TnT) levels. The study suggested patients with underlying cardiovascular diseases and escalation of TnT levels had the highest mortality (69.44%) [<xref rid="bib111" ref-type="bibr">111</xref>]. Plasma TnT levels were positively correlated with plasma high-sensitivity C-reactive protein levels, showing possible myocardial injury association with inflammatory pathogenesis during the disease progression [<xref rid="bib111" ref-type="bibr">111</xref>].</p><p id="p0090">Importantly, severe COVID-19 patients with cardiovascular problems have difficulty in gas exchange and might lead to hypoxemia [<xref rid="bib112" ref-type="bibr">112</xref>]. Thus, the virus infection triggers an exaggerated immune response by releasing interleukin-2 (IL-2), IL-6, IL-10, granulocyte colony-stimulating factor (GCSF), interferon-&#947; (IFN-&#947;), monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1-alpha (MIP-1-&#945;), and tumor necrosis factor-&#945; (TNF-&#945;) mediators. It leads to cytokine storms and contributes to myocardial tissue inflammation, ultimately leading to heart dysfunction [<xref rid="bib113" ref-type="bibr">113</xref>]. The excessive release of pro-inflammatory cytokines further triggers a reduction in coronary blood flow, decreases in oxygen supply, destabilization of coronary plaque, and micro-thrombogenesis [<xref rid="bib114" ref-type="bibr">114</xref>]. Also it has been known that ACEIs/ARBs upregulated ACE2 which can make cardiac tissue more susceptible to SARS-CoV-2 infection [<xref rid="bib115" ref-type="bibr">115</xref>]. It leads to an increase in severity in cardiovascular patients.</p></sec><sec id="sec4.3"><label>4.3</label><title>Does SARS-CoV-2 infections in immunosuppressive conditions worsen the outcome?</title><p id="p0095">An immunocompromised state, co-pathogen, and host factors are correlated with increased risk for respiratory diseases [<xref rid="bib116" ref-type="bibr">116</xref>]. The widespread COVID-19 has put forward a stringent situation to work on the treatment of critically ill patients [<xref rid="bib117" ref-type="bibr">117</xref>]. According to a study, the chance of acquiring HCoV-infection in immunocompromised patients compared to healthy controls was twice as likely [<xref rid="bib118" ref-type="bibr">118</xref>]. However, a report of SARS-CoV infection in AIDS patients suggests mild SARS infection because highly active antiretroviral therapy (HAART) might have benefited in fighting viral factors [<xref rid="bib119" ref-type="bibr">119</xref>]. In such cases, the symptoms of SARS-CoV infection in the AIDS patient may not be noticed, and hence the patient may serve as a carrier in spreading the virus. Additionally, an animal model study performed on Syrian golden hamsters regarding immunocompromised state and SARS-CoV infection, little clinical illness, and no mortality were observed after virus infection [<xref rid="bib120" ref-type="bibr">120</xref>].</p><p id="p0100">According to an Italian report on patients with chronic arthritis treated with disease-modifying antirheumatic drugs (DMARDs), the patients do not seem to be at increased risk of respiratory or life-threatening complications from SARS-CoV-2 compared to the general population [<xref rid="bib121" ref-type="bibr">121</xref>]. Few reports suggest that the most recently approved antirheumatic drugs prove to be strong allies in the fight against COVID-19 as they can precisely target the critical steps of the immune response that became dysregulated during the disorder. Due to this fact, the SARS-related lung damage can be caused more by an exaggerated immune response than the virus itself [<xref rid="bib122" ref-type="bibr">122</xref>].</p><p id="p0105">Respiratory infections may be present in solid organ transplant (SOT) patients that are under continual immunosuppression. After the treatment with a minimized immunosuppressant dose, these patients recovered successfully [<xref rid="bib123" ref-type="bibr">123</xref>, <xref rid="bib124" ref-type="bibr">124</xref>]. A recent study from Italy correlated the occurrence of SARS-CoV-2 in patients undergoing doctoral investigation of SOT, cirrhosis, autoimmune liver disease, chemotherapy for hepatoblastoma [<xref rid="bib125" ref-type="bibr">125</xref>]. Even after being positive for SARS-CoV-2, the patients did not develop acute lung pathology of SARS. A study from Spain regarding COVID-19 in kidney transplant patients and another from China related to heart transplant patients suggest that there could be an atypical presentation of symptoms (fever, diarrhea, fatigue) instead of typical SARS symptoms [<xref rid="bib126" ref-type="bibr">126</xref>, <xref rid="bib127" ref-type="bibr">127</xref>]. These reports indicate the importance of careful monitoring and vigilant follow up of the patients with SOT during the COVID-19 outbreak [<xref rid="bib128" ref-type="bibr">128</xref>].</p><p id="p0110">Immunocompromised individuals have a similar threat of COVID-19 as that of others. Whereas, the outcome variations can depends upon an individual's immune status. A vigilant follow up for any symptoms is needed as there could be atypical symptoms representation. The immunosuppressive drug regime has to be adjusted as per the case based on the patient's clinical condition, age, gender, and previous history.</p></sec></sec><sec id="sec5"><label>5</label><title>Lungs pathophysiology: the drive of SARS-CoV-2 inside the body</title><p id="p0115">SARS-CoV-2 fabricates the complexities of the respiratory tract [<xref rid="bib129" ref-type="bibr">129</xref>]. SARS-CoV-2 could transmit among people through respiratory droplets and contact routes [<xref rid="bib130" ref-type="bibr">130</xref>]. Droplet transmission occurs when a person comes in close contact (~1 m) with an infected patient. During this, a healthy individual's mouth, nose, and eyes get exposed to potentially infective respiratory droplets [<xref rid="bib131" ref-type="bibr">131</xref>]. Infection feasibility [<xref rid="bib132" ref-type="bibr">132</xref>] also gets transmitted through fomites in the close environment of an infected person [<xref rid="bib133" ref-type="bibr">133</xref>, <xref rid="bib134" ref-type="bibr">134</xref>]. The virus further attacks an individual's exposed part's epithelial lining, gaining entry in the host tissue. Once in the cell, it hijacks the cellular machinery producing multiple copies. Further, it could reach the lungs through the respiratory tract [<xref rid="bib134" ref-type="bibr">134</xref>]. Additionally, in the lungs, the virus triggers morphological as well as biochemical alterations.</p><p id="p0120">Post SARS-CoV-2 infection, the histopathological changes in different body organs, including lungs, kidneys, gastrointestinal tract, liver, heart, skin, and brain, are observed [<xref rid="bib135" ref-type="bibr">135</xref>]. The lung biopsy examination of COVID-19 patients shows dispersed alveolar damage, patches of hemorrhagic necrosis, alveolitis with atrophy, intra-alveolar fibrinous exudate, loose interstitial fibrosis [<xref rid="bib135" ref-type="bibr">135</xref>, <xref rid="bib136" ref-type="bibr">136</xref>]. There is diffuse alveolar damage (DAD), vascular congestion with occasional inflammatory cells, damaged pneumocytes with focal sloughing and formation of syncytial giant cells, etc. Additional findings include intra-alveolar hemorrhages, type II pneumocyte hyperplasia, fibrinoid necrosis of the small vasculature, and abundant intra-alveolar neutrophil infiltration to bronchopneumonia [<xref rid="bib135" ref-type="bibr">135</xref>]. Most of the histopathological findings are similar to those described in SARS-CoV and MERS-CoV.</p><p id="p0125">The radiological findings include bilateral and peripheral ground glass-like opacification in COVID-19, also observed in MERS-CoV infection [<xref rid="bib137" ref-type="bibr">137</xref>, <xref rid="bib138" ref-type="bibr">138</xref>]. As the SARS-CoV-2 disease progresses, ground-glass opacification decreases, and consolidation with mixed patterns and subsequent resolution of air space changes is observed [<xref rid="bib137" ref-type="bibr">137</xref>]. In contrast, intra-alveolar plugs have been observed in both SARS-CoV and SARS-CoV-2 infections, whereas multinucleated pneumocytes disperse alveolar damage, tissue plug formation demonstrated in SARS-CoV infection [<xref rid="bib138" ref-type="bibr">138</xref>, <xref rid="bib139" ref-type="bibr">139</xref>]. Hence, the radiological findings have few limitations like the formation of multinuclear pneumocytes are not only found in the case of SARS infection, but also seen in the case of other viral diseases like <italic toggle="yes">Paramyxoviridae</italic> family viruses, measles, mumps, RSV, parainfluenza viruses, and metapneumovirus, etc. [<xref rid="bib140" ref-type="bibr">140</xref>].</p><p id="p0130">The damage of lung tissues in COVID-19 patients might be an outcome of inflammatory responses like cytokines/chemokine storm [<xref rid="bib26" ref-type="bibr">26</xref>, <xref rid="bib141" ref-type="bibr">141</xref>]. The pro-inflammatory mediator's level increases over anti-inflammatory, which results in changes in the biochemical territory of lung tissues [<xref rid="bib142" ref-type="bibr">142</xref>]. The SARS-CoV-2 infection possibly stimulates the release of interleukin-1&#946; (IL-1&#946;), IFN-&#947;, interferon-inducible protein-10 (IP-10), and MCP1 (a pro-inflammatory cytokine) by triggering activation of T-helper-1 (Th1) cell responses [<xref rid="bib141" ref-type="bibr">141</xref>]. In the case of SARS-CoV patients, lung damage gets deteriorated with an increasing amount of IL-1&#946;, IL-6, IL-12, IFN-&#947;, IP-10, and MCP1 whereas, in MERS-CoV infection, IFN-&#947;, TNF-&#945;, IL-15, and IL-17 set off inflammation in the lungs [<xref rid="bib49" ref-type="bibr">49</xref>, <xref rid="bib143" ref-type="bibr">143</xref>]. The interferon-&#945;/&#946; (IFN-&#945;/&#946;), chemokine (C&#8211;C motif) ligand 5 (CCL5) genes also get activated in these viral infections [<xref rid="bib144" ref-type="bibr">144</xref>]. Additionally, a few factors which deteriorate the respiratory system, like asthma, smoking where lungs already have prior exposure to inflammatory reactions, might be more susceptible to SARS-CoV-2 infection [<xref rid="bib145" ref-type="bibr">145</xref>]. In asthma, the lungs' epithelial lining triggers an antiviral response that relies on the prompt induction of cytokines, mostly type I/III- interferons (IFNs), and the type-2 cytokines like IL-13, IL-4, IL-5, IL-9, etc. These cytokines ultimately weaken the epithelium barrier and commence pro-inflammatory reactions [<xref rid="bib121" ref-type="bibr">121</xref>, <xref rid="bib144" ref-type="bibr">144</xref>, <xref rid="bib145" ref-type="bibr">145</xref>]. Interestingly, few reports have observed that smoking upregulates the ACE2 level in airways epithelium [<xref rid="bib146" ref-type="bibr">146</xref>, <xref rid="bib147" ref-type="bibr">147</xref>]. Smoking not only accelerates phosphorylation of microtubule-associated protein kinase (MAPK) while also the production of specific cytokines, such as type I and III IFNs, IL-1&#946;, IL-18, TNF-&#945;, IL-6, IL-8, and the "alarmin" IL-33, which lead to the inflammation in lungs [<xref rid="bib148" ref-type="bibr">148</xref>, <xref rid="bib149" ref-type="bibr">149</xref>]. Apart from ACE2, SARS-CoV-2 takes entry inside the cells by using receptors like CD147 and targets key signaling molecules like nuclear factor kappa light chain enhancer of activated B cells (NK-kB), interferon regulatory factors (IRFs), IRF-3, and IRF-7, which ultimately create pathophysiological conditions in the lungs [<xref rid="bib150" ref-type="bibr">150</xref>]. Further, we have discussed these factors in greater detail in the molecular signaling part.</p></sec><sec id="sec6"><label>6</label><title>Molecular signaling involved in the development of pathophysiology of SARS-CoV-2 infection</title><p id="p0135">SARS-CoV-2 S protein is primed by cellular serine protease TMPRSS2 and invades host cells using ACE2 receptors (<xref rid="fig2" ref-type="fig">Figure&#160;2</xref>) [<xref rid="bib103" ref-type="bibr">103</xref>]. S proteins are a trimeric class of proteins with two subunits, namely S1 and S2. S1 facilitates the attachment, and S2 is responsible for the fusion of viral protein to the host receptor [<xref rid="bib151" ref-type="bibr">151</xref>]. S1 and S2 together have 22 N-glycosylation sites (presence of 14&#8211;16 glycans) and four O-glycosylation sites, and these sites are primarily responsible for host priming, antibody recognition, steric hindrance, innate and adaptive responses [<xref rid="bib152" ref-type="bibr">152</xref>]. S1 subunit contains two domains N-terminal domain (NTD) and the C-terminal domain, the RBD. RBD contains highly sialylated glycans at N234 and N282, which determine viral attachment with ACE2 host receptors [<xref rid="bib153" ref-type="bibr">153</xref>]. O-glycans are suggested to form a mucin-like domain known to shield the virus from immune invasion [<xref rid="bib154" ref-type="bibr">154</xref>].<fig id="fig2" position="float" orientation="portrait"><label>Figure&#160;2</label><caption><p><bold>Illustration of molecular signaling involved in SARS-CoV-2 infection.</bold> SARS-CoV-2 spike protein is detected via ACE2 with the help of TMPRSS2 protease and initiates phagocytosis into the cell. TLRs, RLRs, and cGAS detect viral RNA in the endosomal and cytosolic compartments. TLR7/8 activates type 1 Interferon genes (IFN &#945;/&#946;) via IRF3 and IRF7 dimerization. The RLRs cytosolic receptors detect dsRNA, which is converted from ssRNA by the action of RNA dependent RNA polymerase (RdRp) after hijacking the host ribosomal machinery. Further, RLRs trigger NF-&#954;B as well as IRF3-IRF7 dimer formation after binding of the CARDs domain of RLR to MAVS in mitochondria. The cGAS-STING also detects the dsRNA followed by induction of IRF3-IRF7 dimer formation, which increases IFN&#945;/&#946; gene expression. This IFN&#945;/&#946; activates the cytokines via the JAK-STAT pathway in an autocrine and paracrine manner. Additionally, the same IRFs and NF-&#954;B pathway get activated by the herpes viruses as well as bacteria like <italic toggle="yes">E.&#160;coli, P.aeruginosa</italic>, and <italic toggle="yes">Clostridium sp</italic>.</p></caption><alt-text id="alttext0015">Figure&#160;2</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr2.jpg"/></fig></p><p id="p0140">The pattern recognition family (PRR), which recognizes RNA, includes Toll-like receptors like the TLR 3, 7, and 8. TLR3 discriminately recognizes viruses with double-stranded RNA (dsRNA), either genome or virus replication intermediates, whereas TLR7 and 8 recognize ssRNA [<xref rid="bib155" ref-type="bibr">155</xref>]. The cytosolic receptors for viral RNA recognition include cyclic GMP-AMP Synthase-Stimulator of interferon genes (cGAS-STING) and family of RIG-I (retinoic acid-inducible gene I)-like receptors (RLRs) and melanoma differentiation factor 5 (MDA5). The RLRs have caspase activation and recruitment domain (CARDs) and inhibitory helicase domain (<xref rid="fig2" ref-type="fig">Figure&#160;2</xref>) [<xref rid="bib156" ref-type="bibr">156</xref>]. After attaching RIG-I to the 5&#8242; PPP end of RNA, the inhibitory helicase domain of CARDs gets removed, and it propagates to the interior of dsRNA after hydrolyzing an ATP molecule [<xref rid="bib155" ref-type="bibr">155</xref>].</p><p id="p0145">RIG-I is further activated via polyubiquitination and triggers RIG-I receptor tetramerization. RIG-1 then binds with mitochondrial antiviral signaling protein (MAVS) to set off activation of interferon regulatory factors (IRF) and NF-&#954;B (<xref rid="fig2" ref-type="fig">Figure&#160;2</xref>) [<xref rid="bib155" ref-type="bibr">155</xref>]. NF-&#954;B not only targets regulatory genes of inflammatory cytokines and cell survival, proliferation, and several cell surface proteins [<xref rid="bib155" ref-type="bibr">155</xref>]. Further, the Janus Kinase-signal transducer and activator of transcription protein (JAK-STAT) pathway is activated by IFN-&#945;/&#946; [<xref rid="bib157" ref-type="bibr">157</xref>]. Activation of the JAK-STAT pathway contributes to inflammation by secreting interferon-stimulated genes (ISG), 2&#8242;-5&#8242;-oligoadenylate synthetase (OAS), and IRF-7 [<xref rid="bib157" ref-type="bibr">157</xref>,<xref rid="bib158" ref-type="bibr">158</xref>].</p><p id="p0150">Moreover, TLR7/8 detects ssRNA in the endosome and recruits a few factors like TRAF, ultimately activating interferon genes (<xref rid="fig2" ref-type="fig">Figure&#160;2</xref>) [<xref rid="bib155" ref-type="bibr">155</xref>]. Even the DNA viruses, like human papillomavirus (HPV), Epstein-Barr Virus (EBV), Kaposi's sarcoma-associated herpesvirus (KSHV), and Merkel cell polyomavirus induce TLR9 detected type I interferon (IFN) secretion [<xref rid="bib159" ref-type="bibr">159</xref>]. These viruses also activate several PRR families like RLRs, cGAS-STING, and PYHIN protein culminating in the NF-&#954;B pathway like SARS CoV [<xref rid="bib160" ref-type="bibr">160</xref>, <xref rid="bib161" ref-type="bibr">161</xref>]. Additionally, several bacteria like <italic toggle="yes">Pseudomonas aeruginosa (P. aeruginosa)</italic>, <italic toggle="yes">Escherichia coli</italic> (<italic toggle="yes">E.&#160;coli)</italic> (gram-negative), and <italic toggle="yes">Clostridium sp.</italic> (gram-positive), are detected by TLR4 and TLR1/2/6 respectively [<xref rid="bib162" ref-type="bibr">162</xref>, <xref rid="bib163" ref-type="bibr">163</xref>]. Also, these bacteria activate the same inflammatory cytokines/chemokines pathways [<xref rid="bib164" ref-type="bibr">164</xref>]. Hence, SARS-CoV-2 possibly triggers inflammation in the lungs via NF-&#954;B and IRFs, while these factors also get activated in several other bacterial and viral infections.</p></sec><sec id="sec7"><label>7</label><title>Possible and in-use diagnostics to detect SARS-CoV-2 infection: an urgent requirement</title><p id="p0155">The first stepping stone to combat is to find effective diagnosis methods. We have provided an overview of various diagnostic techniques that are useful in the case of SARS-CoV-2 detection.</p><sec id="sec7.1"><label>7.1</label><title>Molecular biology-based methods</title><p id="p0160">Currently, quantitative reverse transcriptase PCR (qRT-PCR) is favored over conventional reverse transcriptase PCR (RT-PCR) for the detection of CoV as it is a way more sensitive technique (<xref rid="tbl2" ref-type="table">Table&#160;2</xref>) [<xref rid="bib165" ref-type="bibr">165</xref>]. Additionally, an advanced variant of PCR, the digital droplet PCR (ddPCR), has an edge over qRT-PCR. The ddPCR division of reaction mixture into tens of thousands of nanodroplets improves detection dynamics and accuracy [<xref rid="bib166" ref-type="bibr">166</xref>].<table-wrap position="float" id="tbl2" orientation="portrait"><label>Table&#160;2</label><caption><p>Overview of various diagnostic techniques for detection of SARS-CoV-2 infection.</p></caption><alt-text id="alttext0025">Table&#160;2</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Diagnostic Tests</th><th colspan="1" rowspan="1">Sample</th><th colspan="1" rowspan="1">Target</th><th colspan="1" rowspan="1">Advantages</th><th colspan="1" rowspan="1">Limitations</th><th colspan="1" rowspan="1">Ref.</th></tr></thead><tbody><tr><td colspan="6" rowspan="1"><bold>Molecular methods</bold><hr/></td></tr><tr><td colspan="1" rowspan="1">Real time-reverse transcriptase PCR</td><td colspan="1" rowspan="1">Throat swab</td><td colspan="1" rowspan="1">Viral genetic material</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0010"><list-item id="u0010"><label>&#8226;</label><p id="p0250">LoD&#8727;: 3.6&#8211;3.9 copies /reaction</p></list-item><list-item id="u0015"><label>&#8226;</label><p id="p0255">Detection probability: 95%.</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0015"><list-item id="u0020"><label>&#8226;</label><p id="p0260">Requires bulky instrumentation and expensive prerequisites</p></list-item><list-item id="u0025"><label>&#8226;</label><p id="p0265">Approximate assay reaction time: 120 min</p></list-item><list-item id="u0030"><label>&#8226;</label><p id="p0270">Sample-to-result time: almost 4 h</p></list-item></list></td><td colspan="1" rowspan="1">[<xref rid="bib165" ref-type="bibr">165</xref>]<break/>[<xref rid="bib177" ref-type="bibr">177</xref>]</td></tr><tr><td colspan="1" rowspan="1">Digital droplet PCR</td><td colspan="1" rowspan="1">Throat swab</td><td colspan="1" rowspan="1">Viral genetic material</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0020"><list-item id="u0035"><label>&#8226;</label><p id="p0275">Detection range: 10 to 5 x 10<sup>4</sup> copies/reaction</p></list-item><list-item id="u0040"><label>&#8226;</label><p id="p0280">Sensitivity: 94%</p></list-item><list-item id="u0045"><label>&#8226;</label><p id="p0285">LoD&#8727;: 10 copies/test</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0025"><list-item id="u0050"><label>&#8226;</label><p id="p0290">Expensive</p></list-item><list-item id="u0055"><label>&#8226;</label><p id="p0295">Need experts to perform the test</p></list-item></list></td><td colspan="1" rowspan="1">[<xref rid="bib166" ref-type="bibr">166</xref>]</td></tr><tr><td colspan="1" rowspan="1">CRISPR-Cas12 based method<hr/></td><td colspan="1" rowspan="1">Nasal and oro-pharyngeal swab<hr/></td><td colspan="1" rowspan="1">Viral genetic material<hr/></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0030"><list-item id="u0060"><label>&#8226;</label><p id="p0300">Analytical LoD: 10 copies/ul input</p></list-item><list-item id="u0065"><label>&#8226;</label><p id="p0305">Portable</p></list-item><list-item id="u0070"><label>&#8226;</label><p id="p0310">Approximate sample-to-result assay time: 45 min.</p></list-item></list><hr/></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0035"><list-item id="u0075"><label>&#8226;</label><p id="p0315">Qualitative output</p></list-item><list-item id="u0080"><label>&#8226;</label><p id="p0320">Expensive</p></list-item><list-item id="u0085"><label>&#8226;</label><p id="p0325">Need expert to perform</p></list-item></list><hr/></td><td colspan="1" rowspan="1">[<xref rid="bib167" ref-type="bibr">167</xref>]<hr/></td></tr><tr><td colspan="6" rowspan="1"><bold>Serological test</bold><hr/></td></tr><tr><td colspan="1" rowspan="1">ELISA</td><td colspan="1" rowspan="1">Blood</td><td colspan="1" rowspan="1">Virus specific Antibody</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0040"><list-item id="u0090"><label>&#8226;</label><p id="p0330">Sensitivity: 74.3&#8211;77.1%</p></list-item><list-item id="u0095"><label>&#8226;</label><p id="p0335">Accuracy: 97.3%</p></list-item><list-item id="u0100"><label>&#8226;</label><p id="p0340">Can identify multiple pathogens at a single time</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0045"><list-item id="u0105"><label>&#8226;</label><p id="p0345">Primary disease diagnosis is not possible as 30&#8211;50% of positive rate observed at 0&#8211;10 d.p.o&#8727;&#8727;</p></list-item><list-item id="u0110"><label>&#8226;</label><p id="p0350">Invasive</p></list-item></list></td><td colspan="1" rowspan="1">. [<xref rid="bib178" ref-type="bibr">178</xref>]</td></tr><tr><td colspan="1" rowspan="1">IgM-IgG combined detection<hr/></td><td colspan="1" rowspan="1">Blood<hr/></td><td colspan="1" rowspan="1">Virus specific antibody<hr/></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0050"><list-item id="u0115"><label>&#8226;</label><p id="p0355">Sensitivity: 88.6%</p></list-item><list-item id="u0120"><label>&#8226;</label><p id="p0360">Specificity: 90.63%</p></list-item><list-item id="u0125"><label>&#8226;</label><p id="p0365">Minimize the chances of false positive test</p></list-item></list><hr/></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0055"><list-item id="u0130"><label>&#8226;</label><p id="p0370">Time consuming</p></list-item><list-item id="u0135"><label>&#8226;</label><p id="p0375">Labour intensive</p></list-item><list-item id="u0140"><label>&#8226;</label><p id="p0380">Invasive method</p></list-item></list><hr/></td><td colspan="1" rowspan="1">[<xref rid="bib107" ref-type="bibr">107</xref>]<hr/></td></tr><tr><td colspan="6" rowspan="1"><bold>Radiological tests</bold><hr/></td></tr><tr><td colspan="1" rowspan="1">Chest CT</td><td colspan="1" rowspan="1">Lung scan</td><td colspan="1" rowspan="1">Lungs morphological and patho-physiological changes</td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0060"><list-item id="u0145"><label>&#8226;</label><p id="p0385">Non-invasive</p></list-item><list-item id="u0150"><label>&#8226;</label><p id="p0390">Less labour-intensive process</p></list-item><list-item id="u0155"><label>&#8226;</label><p id="p0395">Identification of ground-glass opacification and consolidation with interlobular septum thickening as well as paving pattern</p></list-item></list></td><td colspan="1" rowspan="1"><list list-type="simple" id="ulist0065"><list-item id="u0160"><label>&#8226;</label><p id="p0400">Not-specific the infection type</p></list-item><list-item id="u0165"><label>&#8226;</label><p id="p0405">Huge and non-portable machines required for examination.</p></list-item><list-item id="u0170"><label>&#8226;</label><p id="p0410">Involves exposure to radiations</p></list-item><list-item id="u0175"><label>&#8226;</label><p id="p0415">Need experts to decipher the scans</p></list-item></list></td><td colspan="1" rowspan="1">[<xref rid="bib179" ref-type="bibr">179</xref>]<break/>[<xref rid="bib180" ref-type="bibr">180</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>(&#8727;LoD = Limit of detection, &#8727;&#8727;d.p.o = days post infection).</p></fn></table-wrap-foot></table-wrap></p><p id="p0165">Also, clustered regularly interspaced short palindromic repeats (CRISPR) based detection methods can be used for the detection of SARS-CoV-2. Here, simultaneous, reverse transcription with isothermal loop-mediated amplification is carried out, followed by cas-12 screening for RNA extracted from patient samples [<xref rid="bib167" ref-type="bibr">167</xref>]. Furthermore, CRISPR-based specific high-sensitivity enzymatic reporter unlocking (SHERLOCK) method, combined with isothermal loop-mediated amplification [<xref rid="bib168" ref-type="bibr">168</xref>], can be a promising SARS-CoV-2 detection technique [<xref rid="bib169" ref-type="bibr">169</xref>]. It includes cas-12/cas-13 mediated detection via fluorescence and colorimetric readouts (<xref rid="tbl2" ref-type="table">Table&#160;2</xref>) [<xref rid="bib170" ref-type="bibr">170</xref>]. However, CRISPR based SHERLOCK technology developed for the detection of SARS-CoV-2 remains to be verified and tested using clinical samples.</p></sec><sec id="sec7.2"><label>7.2</label><title>Serological test</title><p id="p0170">Also, with rapid IgG/IgM detection through immunoassay, Enzyme-linked immunosorbent assay (ELISA) can be used as a detection method of SARS-CoV-2 infection (<xref rid="tbl2" ref-type="table">Table&#160;2</xref>) [<xref rid="bib107" ref-type="bibr">107</xref>, <xref rid="bib171" ref-type="bibr">171</xref>, <xref rid="bib172" ref-type="bibr">172</xref>]. The nucleocapsid and spike protein-based ELISA can be used for SARS-CoV-2 detection [<xref rid="bib40" ref-type="bibr">40</xref>].</p></sec><sec id="sec7.3"><label>7.3</label><title>Chest computed axial tomography (CT) and clinical methods</title><p id="p0175">Being a non-invasive, time saving, and less labor-intensive process, chest CT is the most favored diagnostic method [<xref rid="bib173" ref-type="bibr">173</xref>]. Also, liver function tests could indicate SARS-CoV-2 infection as altered liver function is observed in COVID-19 patients [<xref rid="bib174" ref-type="bibr">174</xref>]. This includes changed levels of different liver enzymes, a predominance of monocytes in sputum, high level of activated prothrombin, bilirubin, troponin, decrease in pro-albumin, and albumin [<xref rid="bib175" ref-type="bibr">175</xref>, <xref rid="bib176" ref-type="bibr">176</xref>]. By balancing the pros and cons of the methods, more economical and optimal options can be obtained.</p></sec></sec><sec id="sec8"><label>8</label><title>Drugs and vaccines for SARS-CoV-2</title><p id="p0180">Researchers and pharma industries are working relentlessly for the development of new drugs and vaccines against SARS-CoV-2. Further, considering the urgency and time taken to develop new drugs or vaccines, different regulatory bodies have relaxed the norms for development and trials [<xref rid="bib181" ref-type="bibr">181</xref>]. WHO has also launched a "Solidarity" clinical trial for COVID-19 treatments, to reduce the time taken by randomized clinical trials by 80% [<xref rid="bib182" ref-type="bibr">182</xref>].</p><p id="p0185">Moreover, several studies are going on for repurposing of the existing drugs against COVID-19, including the Solidarity trial, which involves antiviral drugs like Remdesivir, Lopinavir, Ritonavir, anti-malarial drugs like Chloroquine and Hydroxychloroquine and drugs used in the treatment of multiple sclerosis, i.e., IFN&#946;-1a [<xref rid="bib183" ref-type="bibr">183</xref>]. Furthermore, medications like Baricitinib [<xref rid="bib184" ref-type="bibr">184</xref>], Galidesivir [<xref rid="bib185" ref-type="bibr">185</xref>, <xref rid="bib186" ref-type="bibr">186</xref>], Ribavirin [<xref rid="bib187" ref-type="bibr">187</xref>, <xref rid="bib188" ref-type="bibr">188</xref>], Azithromycin, a common antibiotic [<xref rid="bib189" ref-type="bibr">189</xref>] are some of the drugs which are repurposed for the COVID-19 treatment. With some studies supporting the effectiveness of these drugs and some disagreeing with it, these drugs need to be used cautiously and subjected to detailed research.</p><p id="p0190">Preventing a disease is always better than treating it. Different companies and research groups have already taken the initiative to develop vaccines against COVID-19. Moreover, they are in various development phases, from preclinical stages to clinical trials; some of the promising vaccines already in the clinical phase are listed in <xref rid="tbl3" ref-type="table">Table&#160;3</xref>. Further, about 150 vaccine candidates are in different stages of pre-clinical phase [<xref rid="bib190" ref-type="bibr">190</xref>].<table-wrap position="float" id="tbl3" orientation="portrait"><label>Table&#160;3</label><caption><p>Vaccine candidates from different organizations, which are in various phases of clinical trials.</p></caption><alt-text id="alttext0030">Table&#160;3</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Type</th><th colspan="1" rowspan="1">Organization</th><th colspan="1" rowspan="1">Constituents</th><th colspan="1" rowspan="1">Phase of develop-ment</th></tr></thead><tbody><tr><td rowspan="6" colspan="1">Whole Virus Vaccines</td><td colspan="1" rowspan="1">Wuhan Institute of Biological Products/Sinopharm</td><td colspan="1" rowspan="1">Inactivated SARS-CoV-2</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Beijing Institute of Biological Products/Sinopharm</td><td colspan="1" rowspan="1">Inactivated SARS-CoV-2</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Sinovac</td><td colspan="1" rowspan="1">Inactivated SARS-CoV-2 + alum</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Institute of Medical Biology, Chinese Academy of Medical Sciences</td><td colspan="1" rowspan="1">Inactivated SARS-CoV-2</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Research Institute for Biological Safety Problems, Rep of Kazakhstan</td><td colspan="1" rowspan="1">Inactivated SARS-CoV-2</td><td colspan="1" rowspan="1">1/2</td></tr><tr><td colspan="1" rowspan="1">Bharat Biotech</td><td colspan="1" rowspan="1">Whole virion inactivated</td><td colspan="1" rowspan="1">1/2</td></tr><tr><td rowspan="10" colspan="1">Nucleic acid vaccines</td><td colspan="1" rowspan="1">BioNTech/Fosun Pharma/Pfizer</td><td colspan="1" rowspan="1">3 LNP-mRNAs</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Inovio Pharmaceuticals/International Vaccine Institute</td><td colspan="1" rowspan="1">DNA plasmid vaccine with electroporation</td><td colspan="1" rowspan="1">1/2</td></tr><tr><td colspan="1" rowspan="1">Moderna/NIAID</td><td colspan="1" rowspan="1">LNP encapsulated mRNA</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Genexine Consortium</td><td colspan="1" rowspan="1">DNA Vaccine (GX-19)</td><td colspan="1" rowspan="1">1/2</td></tr><tr><td colspan="1" rowspan="1">Cadila Healthcare Limited</td><td colspan="1" rowspan="1">DNA plasmid vaccine</td><td colspan="1" rowspan="1">1/2</td></tr><tr><td colspan="1" rowspan="1">Osaka University/AnGes/Takara Bio</td><td colspan="1" rowspan="1">DNA plasmid vaccine + Adjuvant</td><td colspan="1" rowspan="1">1/2</td></tr><tr><td colspan="1" rowspan="1">Imperial College London</td><td colspan="1" rowspan="1">LNP-nCoVsaRNA</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Curevac</td><td colspan="1" rowspan="1">mRNA</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">People's Liberation Army (PLA) Academy of Military Sciences/Walvax Biotech</td><td colspan="1" rowspan="1">mRNA</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Arcturus/Duke-NUS</td><td colspan="1" rowspan="1">mRNA</td><td colspan="1" rowspan="1">1/2</td></tr><tr><td rowspan="6" colspan="1">Non-replicating viral vector</td><td colspan="1" rowspan="1">University of Oxford/AstraZeneca</td><td colspan="1" rowspan="1">ChAdOx1-S</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">CanSino Biological Inc./Beijing Institute of Biotechnology</td><td colspan="1" rowspan="1">Adenovirus Type 5 Vector</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Gamaleya Research Institute</td><td colspan="1" rowspan="1">Adeno-based</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Janssen Pharmaceutical Companies</td><td colspan="1" rowspan="1">Ad26COVS1</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">ReiThera/LEUKOCARE/Univercells</td><td colspan="1" rowspan="1">Replication defective Simian<break/>Adenovirus (GRAd) encoding S</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China</td><td colspan="1" rowspan="1">Ad5-nCoV</td><td colspan="1" rowspan="1">1</td></tr><tr><td rowspan="2" colspan="1">Replicating viral vector</td><td colspan="1" rowspan="1">Institute Pasteur/Themis/Univ. of Pittsburg CVR/Merck Sharp &amp; Dohme</td><td colspan="1" rowspan="1">Measles-vector based</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Beijing Wantai Biological Pharmacy/Xiamen University</td><td colspan="1" rowspan="1">Intranasal flu-based-RBD</td><td colspan="1" rowspan="1">1</td></tr><tr><td rowspan="13" colspan="1">Protein Subunit</td><td colspan="1" rowspan="1">Novavax</td><td colspan="1" rowspan="1">Full length recombinant SARS CoV-2 glycoprotein nanoparticle vaccine adjuvanted with Matrix M</td><td colspan="1" rowspan="1">2b</td></tr><tr><td colspan="1" rowspan="1">Clover Biopharmaceuticals Inc./GSK/Dynavax</td><td colspan="1" rowspan="1">Native like Trimeric subunit Spike Protein vaccine</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Anhui Zhifei Longcom Biopharmaceutical/Institute of Microbiology, Chinese Academy of Sciences</td><td colspan="1" rowspan="1">Adjuvanted recombinant protein (RBD Dimer)</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Vaxine Pty Ltd/Medytox</td><td colspan="1" rowspan="1">Recombinant S protein with Advax&#8482; adjuvant</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">University of Queensland/CSL/Seqirus</td><td colspan="1" rowspan="1">Molecular clamp stabilized Spike protein with MF59 adjuvant</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Medigen Vaccine Biologics<break/>Corporation/NIAID/Dynavax</td><td colspan="1" rowspan="1">S&#8211;2P protein + CpG 1018</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Instituto Finlay de Vacunas, Cuba</td><td colspan="1" rowspan="1">RBD + Adjuvant</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">FBRI SRC VB VECTOR, Rospotrebnadzor, Koltsovo</td><td colspan="1" rowspan="1">Peptide</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">West China Hospital, Sichuan University</td><td colspan="1" rowspan="1">RBD (baculovirus production expressed in Sf9 cells)</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">University Hospital Tuebingen</td><td colspan="1" rowspan="1">SARS-CoV-2 HLA-DR peptides</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">COVAXX</td><td colspan="1" rowspan="1">S1-RBD-protein</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Sanofi Pasteur/GSK</td><td colspan="1" rowspan="1">S protein (baculovirus production)</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Kentucky Bioprocessing, Inc</td><td colspan="1" rowspan="1">RBD based</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">VLP</td><td colspan="1" rowspan="1">Medicago Inc./Universit&#233; Laval</td><td colspan="1" rowspan="1">Plant-derived VLP</td><td colspan="1" rowspan="1">1</td></tr></tbody></table><table-wrap-foot><fn><p>(Adapted from- WHO Draft landscape of COVID-19 candidate vaccines &#8211; 22<sup>nd</sup> Sept 2020, with modifications).</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec9"><label>9</label><title>Future directions in COVID-19 research</title><p id="p0195">The previous epidemics like plague, smallpox, cholera, ebola, SARS, and many others have extended the horizon of human knowledge on pathogenic infectious diseases and compelled us to acquire new weapons for fighting and eradicate these. The current COVID-19 pandemic needs to be addressed rapidly but with patience. Moreover, in the fight against this deadly disease, past experiences and acquired knowledge about SARS-CoV-2 to date will help shape the future of diagnosis, treatment, and prevention. Diagnosis or prognosis is the gateway to fighting any disease; the degree of success largely depends on the correct and on-time diagnosis. Various molecular, biophysical, immunological, and biochemical diagnostic methods are used for the detection of the SARS-CoV-2 infection [<xref rid="bib170" ref-type="bibr">170</xref>, <xref rid="bib191" ref-type="bibr">191</xref>]. Moreover, qRT-PCR is the most trusted and immune or antibody-based detection is useful for large scale screening [<xref rid="bib165" ref-type="bibr">165</xref>]. Additionally, a CT scan is more effective in predicting disease severity [<xref rid="bib173" ref-type="bibr">173</xref>].</p><p id="p0200">One of the crucial aspects to be taken care of during the treatment of COVID-19 is the associated comorbidities. As people suffering from heart diseases, hypertension, and diabetes may be negatively impacted by ACEIs and ARB inhibitors for COVID-19 treatment. Furthermore, drugs like chloroquine, hydroxychloroquine, remdesivir, and tocilizumab recommended for SARS-CoV-2 infection, can cause irregularities in the arteries, kidney, liver, and nervous system [<xref rid="bib192" ref-type="bibr">192</xref>]. Hence people, who have one or more comorbidities or have immunosuppressed conditions should be treated with caution, else can cause more fatality [<xref rid="bib193" ref-type="bibr">193</xref>].</p><p id="p0205">In the current situation, drug repurposing is one of the safest options to be considered and implemented to treat the pandemic. Moreover, as these drugs are short term majors, new drugs and vaccines need to be developed for avoiding future consequences. However, the standard development process should be followed with different vaccines as a better alternative or as a backup if the current one is entirely or partially ineffective. For the time being, as an alternative to vaccines or nonspecific drugs, plasma infusion therapy can be used as in other diseases [<xref rid="bib194" ref-type="bibr">194</xref>]. Also, in this respect, plants can serve as sources of various antiviral substances like plant lectins, which are proven to be effective against Human Immunodeficiency Virus [<xref rid="bib195" ref-type="bibr">195</xref>]. Various <italic toggle="yes">in-silico</italic> studies have suggested that plants' active compounds such as withaferin A, withanolide D, quercetin, epigallocatechin gallate (EGCG), and hypericin have the potential to inhibit the transmission of SARS-CoV-2 infection [<xref rid="bib196" ref-type="bibr">196</xref>, <xref rid="bib197" ref-type="bibr">197</xref>]. The effect of withanone on TMPRSS2 expression in MCF7 cells is examined and found to remarkably downregulated TMPRSS2 mRNA in treated cells. This predicts the dual action of withanone to block SARS-CoV-2 entry into the host cells [<xref rid="bib192" ref-type="bibr">192</xref>]. Interestingly, EGCG is under phase-2 clinical trial for COVID-19 disease [<xref rid="bib198" ref-type="bibr">198</xref>].</p><p id="p0210">Also, as these viruses have a zoonotic origin, consumption of meat from close relative animals should be avoided. The government should take measures to prevent selling multiple meat varieties together to minimize the chances of cross-species virus transmission. Additionally, the viruses that can be virulent and causes such an epidemic needs to be studied in detail to avoid this kind of devastating situation in the future.</p></sec><sec id="sec10"><label>10</label><title>Conclusion and limitations</title><p id="p0215">SARS-CoV-2 has an immense potential to infect millions across the globe. The virus can undergo mutations in several of its proteins, like the S protein, N protein, PLpro, and ORF3a, making it more or less suitable or virulent to humans. Additionally, many computational and phylogenetic analyses have been done to explain the mutation in these proteins and their relativity to various human pathogenic viruses. This, in turn, could shed light on the virus's ability to bind to host surfaces, manipulate host cell functions, etc. However, <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> experimental studies establishing these facts remain to be conducted. Numerous clinical reports suggest the association of various comorbidities like diabetes, hypertension, cardiovascular diseases, and related immunocompromised situations to COVID-19. However, no particular treatment against COVID-19 is available, keeping in view the patient's comorbid condition. Certain pathophysiological changes in the lungs and the alterations at the cellular and molecular level post-SARS-CoV-2 infection are also reported. A clear distinction of these pathologies exclusive to COVID-19 does not exist; most of these pathologies are similar to those induced by viruses like SARS or MERS. Furthermore, experimental analysis corroborating the speculations and findings of virus-mediated host cell responses initiated by signaling molecules, like NF-&#954;B, IRFs remains a subject of investigation. Finally, a continuous upgrade in the diagnostic system is necessary for better diagnosis and prognosis of the disease to reduce the rate of mortality. Rigorous research regarding SARS-CoV-2 induced COVID-19 is an urgent need of the hour. Conclusively, addressing the above limitations requires prior information on various aspects of COVID-19, covered in our review article. Our review will help the scientific community by providing necessary information about different aspects of the current pandemic on a single platter.</p></sec><sec id="sec11"><title>Declarations</title><sec id="sec11.1"><title>Author contribution statement</title><p id="p0220">All authors listed have significantly contributed to the development and the writing of this article.</p></sec><sec id="sec11.2"><title>Funding statement</title><p id="p0225">This work was supported by <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100001332</institution-id><institution>Council for Scientific and Industrial Research</institution></institution-wrap></funding-source> grant no 37(1693)/17/EMR-II, <funding-source id="gs2">Department of Science and Technology as Ramanujan fellowship</funding-source> grant no. SB/S2/RJN-132/20/5. We are thankful to The Ministry of Human Resource, Department of Biotechnology, University Grants Commission, and DST-inspire for fellowship to Shweta Jakhmola, Omkar Indari, Budhadev Baral and Nidhi Varshney respectively and CSIR for a scholarship to Charu Sonkar, Dharmendra Kashyap, and Annu Rani in the form of research stipend.</p></sec><sec sec-type="data-availability" id="sec11.3"><title>Data availability statement</title><p id="p0230">Data included in article.</p></sec><sec id="sec11.4"><title>Competing interest statement</title><p id="p0235">The authors declare no conflict of interest.</p></sec><sec id="sec11.5"><title>Additional information</title><p id="p0240">No additional information is available for this paper.</p></sec></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="book" id="sref1"><person-group person-group-type="author"><name name-style="western"><surname>Siddell</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wege</surname><given-names>H.</given-names></name><name name-style="western"><surname>ter Meulen</surname><given-names>V.</given-names></name></person-group><chapter-title>The structure and replication of coronaviruses</chapter-title><source>Current Topics in Microbiology and Immunology</source><year>1982</year><publisher-name>Springer</publisher-name><publisher-loc>Berlin, Heidelberg</publisher-loc><fpage>131</fpage><lpage>163</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-3-642-68528-6_4</pub-id><pub-id pub-id-type="pmid">7047085</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name name-style="western"><surname>Tyrrell</surname><given-names>D.A.J.</given-names></name><name name-style="western"><surname>Almeida</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Berry</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Cunningham</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Hamre</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hofstad</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Mallucci</surname><given-names>L.</given-names></name><name name-style="western"><surname>McIntosh</surname><given-names>K.</given-names></name></person-group><article-title>Coronaviruses</article-title><source>Nature</source><volume>220</volume><year>1968</year><fpage>650</fpage></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>F.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Z.-L.</given-names></name></person-group><article-title>Origin and evolution of pathogenic coronaviruses</article-title><source>Nat. Rev. Microbiol.</source><volume>17</volume><year>2018</year><fpage>181</fpage><lpage>192</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41579-018-0118-9</pub-id><pub-id pub-id-type="pmcid">PMC7097006</pub-id><pub-id pub-id-type="pmid">30531947</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name name-style="western"><surname>Hulswit</surname><given-names>R.J.G.</given-names></name><name name-style="western"><surname>de Haan</surname><given-names>C.A.M.</given-names></name><name name-style="western"><surname>Bosch</surname><given-names>B.-J.</given-names></name></person-group><article-title>Coronavirus spike protein and tropism changes</article-title><source>Adv. Virus Res.</source><volume>96</volume><year>2016</year><fpage>29</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">27712627</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/bs.aivir.2016.08.004</pub-id><pub-id pub-id-type="pmcid">PMC7112277</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name name-style="western"><surname>Cavanagh</surname><given-names>D.</given-names></name></person-group><article-title>Coronaviruses in poultry and other birds</article-title><source>Avian Pathol.</source><volume>34</volume><year>2005</year><fpage>439</fpage><lpage>448</lpage><pub-id pub-id-type="pmid">16537157</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/03079450500367682</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name name-style="western"><surname>Mi&#322;ek</surname><given-names>J.</given-names></name><name name-style="western"><surname>Blicharz-Doma&#324;ska</surname><given-names>K.</given-names></name></person-group><article-title>Coronaviruses in avian species - review with focus on epidemiology and diagnosis in wild birds</article-title><source>J.&#160;Vet. Res.</source><volume>62</volume><year>2018</year><fpage>249</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">30584600</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2478/jvetres-2018-0035</pub-id><pub-id pub-id-type="pmcid">PMC6296008</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name name-style="western"><surname>Tyrrell</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Bynoe</surname><given-names>M.L.</given-names></name></person-group><article-title>Cultivation of viruses from a high proportion of patients with colds</article-title><source>Lancet</source><volume>1</volume><year>1966</year><fpage>76</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">4158999</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0140-6736(66)92364-6</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name name-style="western"><surname>de Groot</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Baker</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Baric</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Drosten</surname><given-names>C.</given-names></name><name name-style="western"><surname>Enjuanes</surname><given-names>L.</given-names></name><name name-style="western"><surname>Fouchier</surname><given-names>R.A.M.</given-names></name><name name-style="western"><surname>Galiano</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gorbalenya</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Memish</surname><given-names>Z.A.</given-names></name><name name-style="western"><surname>Perlman</surname><given-names>S.</given-names></name><name name-style="western"><surname>Poon</surname><given-names>L.L.M.</given-names></name><name name-style="western"><surname>Snijder</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Stephens</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Woo</surname><given-names>P.C.Y.</given-names></name><name name-style="western"><surname>Zaki</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Zambon</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ziebuhr</surname><given-names>J.</given-names></name></person-group><article-title>Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group</article-title><source>J.&#160;Virol.</source><volume>87</volume><year>2013</year><fpage>7790</fpage><lpage>7792</lpage><pub-id pub-id-type="pmid">23678167</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JVI.01244-13</pub-id><pub-id pub-id-type="pmcid">PMC3700179</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name name-style="western"><surname>Mesel-Lemoine</surname><given-names>M.</given-names></name><name name-style="western"><surname>Millet</surname><given-names>J.</given-names></name><name name-style="western"><surname>Vidalain</surname><given-names>P.-O.</given-names></name><name name-style="western"><surname>Law</surname><given-names>H.</given-names></name><name name-style="western"><surname>Vabret</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lorin</surname><given-names>V.</given-names></name><name name-style="western"><surname>Escriou</surname><given-names>N.</given-names></name><name name-style="western"><surname>Albert</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Nal</surname><given-names>B.</given-names></name><name name-style="western"><surname>Tangy</surname><given-names>F.</given-names></name></person-group><article-title>A&#160;human coronavirus responsible for the common cold massively kills dendritic cells but not monocytes</article-title><source>J.&#160;Virol.</source><volume>86</volume><year>2012</year><fpage>7577</fpage><lpage>7587</lpage><pub-id pub-id-type="pmid">22553325</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JVI.00269-12</pub-id><pub-id pub-id-type="pmcid">PMC3416289</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name name-style="western"><surname>Aldridge</surname><given-names>R.W.</given-names></name><name name-style="western"><surname>Lewer</surname><given-names>D.</given-names></name><name name-style="western"><surname>Beale</surname><given-names>S.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Zambon</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hayward</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Fragaszy</surname><given-names>E.</given-names></name><collab>1Flu Watch Group</collab></person-group><article-title>Seasonality and immunity to laboratory-confirmed seasonal coronaviruses (HCoV-NL63, HCoV-OC43, and HCoV-229E): results from the Flu Watch cohort study</article-title><source>Wellcome Open Res.</source><volume>5</volume><year>2020</year><fpage>52</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.12688/wellcomeopenres.15812.1</pub-id><pub-id pub-id-type="pmcid">PMC7786426</pub-id><pub-id pub-id-type="pmid">33447664</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>G.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>W.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>A.C.K.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Bi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>G.F.</given-names></name></person-group><article-title>Epidemiology, genetic recombination, and pathogenesis of coronaviruses</article-title><source>Trends Microbiol.</source><volume>24</volume><year>2016</year><fpage>490</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">27012512</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tim.2016.03.003</pub-id><pub-id pub-id-type="pmcid">PMC7125511</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="book" id="sref12"><person-group person-group-type="author"><name name-style="western"><surname>SARS</surname></name></person-group><chapter-title>Frequently Asked Questions</chapter-title><year>2019</year><publisher-name>CDC</publisher-name><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cdc.gov/sars/about/faq.html" id="intref0010">https://www.cdc.gov/sars/about/faq.html</ext-link><comment>(accessed April 21, 2020)</comment></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Navas-Martin</surname><given-names>S.</given-names></name></person-group><article-title>Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus</article-title><source>Microbiol. Mol. Biol. Rev.</source><volume>69</volume><year>2005</year><fpage>635</fpage><lpage>664</lpage><pub-id pub-id-type="pmid">16339739</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/MMBR.69.4.635-664.2005</pub-id><pub-id pub-id-type="pmcid">PMC1306801</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>V.C.C.</given-names></name><name name-style="western"><surname>Lau</surname><given-names>S.K.P.</given-names></name><name name-style="western"><surname>Woo</surname><given-names>P.C.Y.</given-names></name><name name-style="western"><surname>Yuen</surname><given-names>K.Y.</given-names></name></person-group><article-title>Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection</article-title><source>Clin. Microbiol. Rev.</source><volume>20</volume><year>2007</year><fpage>660</fpage><lpage>694</lpage><pub-id pub-id-type="pmid">17934078</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CMR.00023-07</pub-id><pub-id pub-id-type="pmcid">PMC2176051</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>G.</given-names></name><name name-style="western"><surname>Wilken</surname><given-names>M.</given-names></name><name name-style="western"><surname>Geraghty</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>F.</given-names></name></person-group><article-title>Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus</article-title><source>J.&#160;Biol. Chem.</source><volume>287</volume><year>2012</year><fpage>8904</fpage><lpage>8911</lpage><pub-id pub-id-type="pmid">22291007</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M111.325803</pub-id><pub-id pub-id-type="pmcid">PMC3308800</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name name-style="western"><surname>Jeffers</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Tusell</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Gillim-Ross</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hemmila</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Achenbach</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Babcock</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>W.D.</given-names></name><name name-style="western"><surname>Thackray</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Young</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Mason</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Ambrosino</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Wentworth</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>DeMartini</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>K.V.</given-names></name></person-group><article-title>CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>101</volume><year>2004</year><fpage>15748</fpage><lpage>15753</lpage><pub-id pub-id-type="pmid">15496474</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0403812101</pub-id><pub-id pub-id-type="pmcid">PMC524836</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name name-style="western"><surname>Zaki</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>van Boheemen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bestebroer</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Osterhaus</surname><given-names>A.D.M.E.</given-names></name><name name-style="western"><surname>Fouchier</surname><given-names>R.A.M.</given-names></name></person-group><article-title>Isolation of a novel coronavirus from a man with pneumonia in Saudi arabia</article-title><source>N.&#160;Engl. J. Med.</source><volume>367</volume><year>2012</year><fpage>1814</fpage><lpage>1820</lpage><pub-id pub-id-type="pmid">23075143</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1211721</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name name-style="western"><surname>Ramadan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Shaib</surname><given-names>H.</given-names></name></person-group><article-title>Middle East respiratory syndrome coronavirus (MERS-CoV): a review</article-title><source>Germs</source><volume>9</volume><year>2019</year><fpage>35</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">31119115</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18683/germs.2019.1155</pub-id><pub-id pub-id-type="pmcid">PMC6446491</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="book" id="sref19"><source>WHO MERS Summary Report</source><year>July 2019</year><comment>Available online:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://apps.who.int/iris/bitstream/handle/10665/326126/WHO-MERS-RA-19.1-eng.pdf?ua=1" id="interref0010">https://apps.who.int/iris/bitstream/handle/10665/326126/WHO-MERS-RA-19.1-eng.pdf?ua=1</ext-link></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name name-style="western"><surname>Banerjee</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kulcsar</surname><given-names>K.</given-names></name><name name-style="western"><surname>Misra</surname><given-names>V.</given-names></name><name name-style="western"><surname>Frieman</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mossman</surname><given-names>K.</given-names></name></person-group><article-title>Bats and coronaviruses</article-title><source>Viruses</source><volume>11</volume><year>2019</year><fpage>41</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/v11010041</pub-id><pub-id pub-id-type="pmcid">PMC6356540</pub-id><pub-id pub-id-type="pmid">30634396</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name name-style="western"><surname>Raj</surname><given-names>V.S.</given-names></name><name name-style="western"><surname>Mou</surname><given-names>H.</given-names></name><name name-style="western"><surname>Smits</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Dekkers</surname><given-names>D.H.W.</given-names></name><name name-style="western"><surname>M&#252;ller</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Dijkman</surname><given-names>R.</given-names></name><name name-style="western"><surname>Muth</surname><given-names>D.</given-names></name><name name-style="western"><surname>Demmers</surname><given-names>J.A.A.</given-names></name><name name-style="western"><surname>Zaki</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fouchier</surname><given-names>R.A.M.</given-names></name><name name-style="western"><surname>Thiel</surname><given-names>V.</given-names></name><name name-style="western"><surname>Drosten</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rottier</surname><given-names>P.J.M.</given-names></name><name name-style="western"><surname>Osterhaus</surname><given-names>A.D.M.E.</given-names></name><name name-style="western"><surname>Bosch</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Haagmans</surname><given-names>B.L.</given-names></name></person-group><article-title>Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC</article-title><source>Nature</source><volume>495</volume><year>2013</year><fpage>251</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">23486063</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature12005</pub-id><pub-id pub-id-type="pmcid">PMC7095326</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>P.-I.</given-names></name><name name-style="western"><surname>Hsueh</surname><given-names>P.-R.</given-names></name></person-group><article-title>Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV</article-title><source>J.&#160;Microbiol. Immunol. Infect.</source><volume>53</volume><year>2020</year><fpage>365</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">32035811</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jmii.2020.02.001</pub-id><pub-id pub-id-type="pmcid">PMC7102579</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="book" id="sref23"><person-group person-group-type="author"><name name-style="western"><surname>Excler</surname><given-names>J.-L.</given-names></name><name name-style="western"><surname>Delvecchio</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Wiley</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>I.-K.</given-names></name><name name-style="western"><surname>Modjarrad</surname><given-names>K.</given-names></name><name name-style="western"><surname>Boujelal</surname><given-names>M.</given-names></name><name name-style="western"><surname>Moorthy</surname><given-names>V.S.</given-names></name><name name-style="western"><surname>Hersi</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.H.</given-names></name></person-group><chapter-title>Toward Developing a Preventive MERS-CoV Vaccine&#8212;Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14&#8211;15, 2015 - Volume 22, Number 8&#8212;August 2016 - Emerging Infectious Diseases Journal - CDC</chapter-title><year>2020</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.3201/eid2208.160229</pub-id><pub-id pub-id-type="pmcid">PMC4982192</pub-id><pub-id pub-id-type="pmid">27439020</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name name-style="western"><surname>Conzade</surname><given-names>R.</given-names></name><name name-style="western"><surname>Grant</surname><given-names>R.</given-names></name><name name-style="western"><surname>Malik</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Elkholy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Elhakim</surname><given-names>M.</given-names></name><name name-style="western"><surname>Samhouri</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ben Embarek</surname><given-names>P.K.</given-names></name><name name-style="western"><surname>Van Kerkhove</surname><given-names>M.D.</given-names></name></person-group><article-title>Reported direct and indirect contact with dromedary camels among laboratory-confirmed MERS-CoV cases</article-title><source>Viruses</source><volume>10</volume><year>2018</year><fpage>425</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/v10080425</pub-id><pub-id pub-id-type="pmcid">PMC6115845</pub-id><pub-id pub-id-type="pmid">30104551</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="book" id="sref25"><source>WHO Announces COVID-19 Outbreak a Pandemic</source><year>2020</year><comment>Available online:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/3/who-announces-covid-19-outbreak-a-pandemic" id="intref0020">http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/3/who-announces-covid-19-outbreak-a-pandemic</ext-link></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name name-style="western"><surname>Jakhmola</surname><given-names>S.</given-names></name><name name-style="western"><surname>Indari</surname><given-names>O.</given-names></name><name name-style="western"><surname>Chatterjee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jha</surname><given-names>H.C.</given-names></name></person-group><article-title>SARS-CoV-2 an underestimated pathogen of the nervous system</article-title><source>SN Compreh. Clin. Med.</source><year>2020</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s42399-020-00522-7</pub-id><pub-id pub-id-type="pmcid">PMC7520376</pub-id><pub-id pub-id-type="pmid">33015550</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name name-style="western"><surname>Schaefer</surname><given-names>I.-M.</given-names></name><name name-style="western"><surname>Padera</surname><given-names>R.F.</given-names></name><name name-style="western"><surname>Solomon</surname><given-names>I.H.</given-names></name><name name-style="western"><surname>Kanjilal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hammer</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Hornick</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Sholl</surname><given-names>L.M.</given-names></name></person-group><article-title>In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19</article-title><source>Mod. Pathol.</source><year>2020</year><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">32561849</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41379-020-0595-z</pub-id><pub-id pub-id-type="pmcid">PMC7304376</pub-id></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name name-style="western"><surname>Mao</surname><given-names>R.</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>He</surname><given-names>J.-S.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>J.-Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.-H.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L.-R.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Iacucci</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ng</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M.-H.</given-names></name></person-group><article-title>Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis</article-title><source>Lancet Gastroenterol. Hepatol.</source><volume>5</volume><year>2020</year><fpage>667</fpage><lpage>678</lpage><pub-id pub-id-type="pmid">32405603</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2468-1253(20)30126-6</pub-id><pub-id pub-id-type="pmcid">PMC7217643</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>Z.-W.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yuen</surname><given-names>K.-S.</given-names></name><name name-style="western"><surname>Fung</surname><given-names>S.-Y.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>C.-P.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>D.-Y.</given-names></name></person-group><article-title>Zoonotic origins of human coronaviruses</article-title><source>Int. J. Biol. Sci.</source><volume>16</volume><year>2020</year><fpage>1686</fpage><lpage>1697</lpage><pub-id pub-id-type="pmid">32226286</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/ijbs.45472</pub-id><pub-id pub-id-type="pmcid">PMC7098031</pub-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>T.-C.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>Y.-T.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.T.-S.</given-names></name><name name-style="western"><surname>Geng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>N.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>W.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>E.</given-names></name><name name-style="western"><surname>King</surname><given-names>C.-C.</given-names></name></person-group><article-title>Comparative epidemiology of human infections with Middle East respiratory syndrome and severe acute respiratory syndrome coronaviruses among healthcare personnel</article-title><source>PloS One</source><volume>11</volume><year>2016</year><object-id pub-id-type="publisher-id">e0149988</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0149988</pub-id><pub-id pub-id-type="pmcid">PMC4773072</pub-id><pub-id pub-id-type="pmid">26930074</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="book" id="sref31"><person-group person-group-type="author"><collab>CDC</collab></person-group><chapter-title>Coronavirus Disease 2019 (COVID-19)</chapter-title><year>2020</year><comment>Available online:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/groups-at-higher-risk.html" id="intref0025">https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/groups-at-higher-risk.html</ext-link></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ge</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.-F.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Z.</given-names></name></person-group><article-title>Bat origin of human coronaviruses</article-title><source>Virol. J.</source><volume>12</volume><year>2015</year><fpage>221</fpage><pub-id pub-id-type="pmid">26689940</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12985-015-0422-1</pub-id><pub-id pub-id-type="pmcid">PMC4687304</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zai</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Nie</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Foley</surname><given-names>B.T.</given-names></name><name name-style="western"><surname>Chaillon</surname><given-names>A.</given-names></name></person-group><article-title>Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2</article-title><source>J.&#160;Med. Virol.</source><volume>92</volume><year>2020</year><fpage>602</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">32104911</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmv.25731</pub-id><pub-id pub-id-type="pmcid">PMC7228310</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ge</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.-F.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Z.</given-names></name></person-group><article-title>Bat origin of human coronaviruses</article-title><source>Virol. J.</source><volume>12</volume><year>2015</year><fpage>221</fpage><pub-id pub-id-type="pmid">26689940</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12985-015-0422-1</pub-id><pub-id pub-id-type="pmcid">PMC4687304</pub-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>G.F.</given-names></name></person-group><article-title>Bat-to-human: spike features determining &#8220;host jump&#8221; of coronaviruses SARS-CoV, MERS-CoV, and beyond</article-title><source>Trends Microbiol.</source><volume>23</volume><year>2015</year><fpage>468</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">26206723</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tim.2015.06.003</pub-id><pub-id pub-id-type="pmcid">PMC7125587</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>P.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X.-L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.-G.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Si</surname><given-names>H.-R.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>B.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>C.-L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H.-D.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>H.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>R.-D.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M.-Q.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>X.-R.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>X.-S.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Q.-J.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>F.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L.-L.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zhan</surname><given-names>F.-X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.-Y.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>G.-F.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Z.-L.</given-names></name></person-group><article-title>A&#160;pneumonia outbreak associated with a new coronavirus of probable bat origin</article-title><source>Nature</source><volume>579</volume><year>2020</year><fpage>270</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">32015507</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-020-2012-7</pub-id><pub-id pub-id-type="pmcid">PMC7095418</pub-id></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="book" id="sref37"><person-group person-group-type="author"><collab>Wuhan City Health Committee (WCHC)</collab></person-group><chapter-title>Wuhan Municipal Health and Health Commission's Briefing on the Current Pneumonia Epidemic Situation in Our City</chapter-title><year>2019</year><comment>[updated 31 December 2019, 14 January 2020]. Available online:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989" id="intref0030">http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989</ext-link><comment>(accessed on May 11, 2020)</comment></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name></person-group><article-title>Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak</article-title><source>Curr. Biol.</source><volume>30</volume><year>2020</year><fpage>1346</fpage><lpage>1351.e2</lpage><pub-id pub-id-type="pmid">32197085</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cub.2020.03.022</pub-id><pub-id pub-id-type="pmcid">PMC7156161</pub-id></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name name-style="western"><surname>Jaimes</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Andr&#233;</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Chappie</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Millet</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Whittaker</surname><given-names>G.R.</given-names></name></person-group><article-title>Phylogenetic analysis and structural modeling of SARS-CoV-2 spike protein reveals an evolutionary distinct and proteolytically sensitive activation loop</article-title><source>J.&#160;Mol. Biol.</source><volume>432</volume><year>2020</year><fpage>3309</fpage><lpage>3325</lpage><pub-id pub-id-type="pmid">32320687</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jmb.2020.04.009</pub-id><pub-id pub-id-type="pmcid">PMC7166309</pub-id></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name name-style="western"><surname>Flores-Alanis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sandner-Miranda</surname><given-names>L.</given-names></name><name name-style="western"><surname>Delgado</surname><given-names>G.</given-names></name><name name-style="western"><surname>Cravioto</surname><given-names>A.</given-names></name><name name-style="western"><surname>Morales-Espinosa</surname><given-names>R.</given-names></name></person-group><article-title>The receptor binding domain of SARS-CoV-2 spike protein is the result of an ancestral recombination between the bat-CoV RaTG13 and the pangolin-CoV MP789</article-title><source>BMC Res. Notes</source><volume>13</volume><year>2020</year><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">32854762</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13104-020-05242-8</pub-id><pub-id pub-id-type="pmcid">PMC7450963</pub-id></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>P.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.-P.</given-names></name></person-group><article-title>Viral metagenomics revealed sendai virus and coronavirus infection of malayan pangolins (Manis javanica)</article-title><source>Viruses</source><volume>11</volume><year>2019</year><fpage>979</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/v11110979</pub-id><pub-id pub-id-type="pmcid">PMC6893680</pub-id><pub-id pub-id-type="pmid">31652964</pub-id></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name name-style="western"><surname>Graham</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Baric</surname><given-names>R.S.</given-names></name></person-group><article-title>Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission</article-title><source>J.&#160;Virol.</source><volume>84</volume><year>2010</year><fpage>3134</fpage><lpage>3146</lpage><pub-id pub-id-type="pmid">19906932</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JVI.01394-09</pub-id><pub-id pub-id-type="pmcid">PMC2838128</pub-id></element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name name-style="western"><surname>Vijgen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Keyaerts</surname><given-names>E.</given-names></name><name name-style="western"><surname>Mo&#235;s</surname><given-names>E.</given-names></name><name name-style="western"><surname>Thoelen</surname><given-names>I.</given-names></name><name name-style="western"><surname>Wollants</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lemey</surname><given-names>P.</given-names></name><name name-style="western"><surname>Vandamme</surname><given-names>A.-M.</given-names></name><name name-style="western"><surname>Van Ranst</surname><given-names>M.</given-names></name></person-group><article-title>Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event</article-title><source>J.&#160;Virol.</source><volume>79</volume><year>2005</year><fpage>1595</fpage><lpage>1604</lpage><pub-id pub-id-type="pmid">15650185</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JVI.79.3.1595-1604.2005</pub-id><pub-id pub-id-type="pmcid">PMC544107</pub-id></element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name name-style="western"><surname>Moratelli</surname><given-names>R.</given-names></name><name name-style="western"><surname>Calisher</surname><given-names>C.H.</given-names></name></person-group><article-title>Bats and zoonotic viruses: can we confidently link bats with emerging deadly viruses?</article-title><source>Mem. Inst. Oswaldo Cruz</source><volume>110</volume><year>2015</year><fpage>1</fpage><lpage>22</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/0074-02760150048</pub-id><pub-id pub-id-type="pmcid">PMC4371215</pub-id><pub-id pub-id-type="pmid">25742261</pub-id></element-citation></ref><ref id="bib45"><label>45</label><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name name-style="western"><surname>Allocati</surname><given-names>N.</given-names></name><name name-style="western"><surname>Petrucci</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Di Giovanni</surname><given-names>P.</given-names></name><name name-style="western"><surname>Masulli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Di Ilio</surname><given-names>C.</given-names></name><name name-style="western"><surname>De Laurenzi</surname><given-names>V.</given-names></name></person-group><article-title>Bat&#8211;man disease transmission: zoonotic pathogens from wildlife reservoirs to human populations</article-title><source>Cell Death Disc.</source><volume>2</volume><year>2016</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/cddiscovery.2016.48</pub-id><pub-id pub-id-type="pmcid">PMC4979447</pub-id><pub-id pub-id-type="pmid">27551536</pub-id></element-citation></ref><ref id="bib46"><label>46</label><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name name-style="western"><surname>S&#225;nchez</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Gebauer</surname><given-names>F.</given-names></name><name name-style="western"><surname>Su&#241;&#233;</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mendez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dopazo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Enjuanes</surname><given-names>L.</given-names></name></person-group><article-title>Genetic evolution and tropism of transmissible gastroenteritis coronaviruses</article-title><source>Virology</source><volume>190</volume><year>1992</year><fpage>92</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">1326823</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0042-6822(92)91195-Z</pub-id><pub-id pub-id-type="pmcid">PMC7131265</pub-id></element-citation></ref><ref id="bib47"><label>47</label><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name name-style="western"><surname>Menachery</surname><given-names>V.D.</given-names></name><name name-style="western"><surname>Graham</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Baric</surname><given-names>R.S.</given-names></name></person-group><article-title>Jumping species-a mechanism for coronavirus persistence and survival</article-title><source>Curr. Opin. Virol.</source><volume>23</volume><year>2017</year><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">28214731</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.coviro.2017.01.002</pub-id><pub-id pub-id-type="pmcid">PMC5474123</pub-id></element-citation></ref><ref id="bib48"><label>48</label><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name name-style="western"><surname>Duffy</surname><given-names>S.</given-names></name></person-group><article-title>Why are RNA virus mutation rates so damn high?</article-title><source>PLoS Biol.</source><volume>16</volume><year>2018</year><object-id pub-id-type="publisher-id">e3000003</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pbio.3000003</pub-id><pub-id pub-id-type="pmcid">PMC6107253</pub-id><pub-id pub-id-type="pmid">30102691</pub-id></element-citation></ref><ref id="bib49"><label>49</label><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>G.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>B.</given-names></name></person-group><article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">31986264</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(20)30183-5</pub-id><pub-id pub-id-type="pmcid">PMC7159299</pub-id></element-citation></ref><ref id="bib50"><label>50</label><element-citation publication-type="book" id="sref50"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>M.M.C.</given-names></name><name name-style="western"><surname>Cavanagh</surname><given-names>D.</given-names></name></person-group><chapter-title>The Molecular Biology of Coronaviruses</chapter-title><year>1997</year><publisher-name>Elsevier</publisher-name><fpage>1</fpage><lpage>100</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0065-3527(08)60286-9</pub-id><pub-id pub-id-type="pmcid">PMC7130985</pub-id><pub-id pub-id-type="pmid">9233431</pub-id></element-citation></ref><ref id="bib51"><label>51</label><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name name-style="western"><surname>Lau</surname><given-names>S.K.P.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tsang</surname><given-names>A.K.L.</given-names></name><name name-style="western"><surname>Yip</surname><given-names>C.C.Y.</given-names></name><name name-style="western"><surname>Tse</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>So</surname><given-names>L.-Y.</given-names></name><name name-style="western"><surname>Lau</surname><given-names>Y.-L.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>K.-H.</given-names></name><name name-style="western"><surname>Woo</surname><given-names>P.C.Y.</given-names></name><name name-style="western"><surname>Yuen</surname><given-names>K.-Y.</given-names></name></person-group><article-title>Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination</article-title><source>J.&#160;Virol.</source><volume>85</volume><year>2011</year><fpage>11325</fpage><lpage>11337</lpage><pub-id pub-id-type="pmid">21849456</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JVI.05512-11</pub-id><pub-id pub-id-type="pmcid">PMC3194943</pub-id></element-citation></ref><ref id="bib52"><label>52</label><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name name-style="western"><surname>Wrapp</surname><given-names>D.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Corbett</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Goldsmith</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Hsieh</surname><given-names>C.-L.</given-names></name><name name-style="western"><surname>Abiona</surname><given-names>O.</given-names></name><name name-style="western"><surname>Graham</surname><given-names>B.S.</given-names></name><name name-style="western"><surname>McLellan</surname><given-names>J.S.</given-names></name></person-group><article-title>Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation</article-title><source>Science</source><volume>367</volume><year>2020</year><fpage>1260</fpage><lpage>1263</lpage><pub-id pub-id-type="pmid">32075877</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.abb2507</pub-id><pub-id pub-id-type="pmcid">PMC7164637</pub-id></element-citation></ref><ref id="bib53"><label>53</label><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name name-style="western"><surname>Sanju&#225;n</surname><given-names>R.</given-names></name><name name-style="western"><surname>Domingo-Calap</surname><given-names>P.</given-names></name></person-group><article-title>Mechanisms of viral mutation</article-title><source>Cell. Mol. Life Sci.</source><volume>73</volume><year>2016</year><fpage>4433</fpage><lpage>4448</lpage><pub-id pub-id-type="pmid">27392606</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00018-016-2299-6</pub-id><pub-id pub-id-type="pmcid">PMC5075021</pub-id></element-citation></ref><ref id="bib54"><label>54</label><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name name-style="western"><surname>Lauring</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Andino</surname><given-names>R.</given-names></name></person-group><article-title>Quasispecies theory and the behavior of RNA viruses</article-title><source>PLoS Pathog.</source><volume>6</volume><year>2010</year><object-id pub-id-type="publisher-id">e1001005</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.ppat.1001005</pub-id><pub-id pub-id-type="pmcid">PMC2908548</pub-id><pub-id pub-id-type="pmid">20661479</pub-id></element-citation></ref><ref id="bib55"><label>55</label><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name name-style="western"><surname>Bajaj</surname><given-names>A.</given-names></name><name name-style="western"><surname>Purohit</surname><given-names>H.J.</given-names></name></person-group><article-title>Understanding SARS-CoV-2: genetic diversity, transmission and cure in human</article-title><source>Indian J. Microbiol.</source><volume>60</volume><year>2020</year><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">32317810</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12088-020-00869-4</pub-id><pub-id pub-id-type="pmcid">PMC7169643</pub-id></element-citation></ref><ref id="bib56"><label>56</label><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name name-style="western"><surname>Sheikh</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>J.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>H.</given-names></name><name name-style="western"><surname>Jamal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Khubaib</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kohli</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dobrindt</surname><given-names>U.</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Ehtesham</surname><given-names>N.Z.</given-names></name><name name-style="western"><surname>Hasnain</surname><given-names>S.E.</given-names></name></person-group><article-title>Emerging genetic diversity among clinical isolates of SARS-CoV-2: lessons for today</article-title><source>Infect. Genet. Evol.</source><volume>84</volume><year>2020</year><fpage>104330</fpage><pub-id pub-id-type="pmid">32335334</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.meegid.2020.104330</pub-id><pub-id pub-id-type="pmcid">PMC7180377</pub-id></element-citation></ref><ref id="bib57"><label>57</label><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name name-style="western"><surname>Korber</surname><given-names>B.</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>W.M.</given-names></name><name name-style="western"><surname>Gnanakaran</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>H.</given-names></name><name name-style="western"><surname>Theiler</surname><given-names>J.</given-names></name><name name-style="western"><surname>Abfalterer</surname><given-names>W.</given-names></name><name name-style="western"><surname>Hengartner</surname><given-names>N.</given-names></name><name name-style="western"><surname>Giorgi</surname><given-names>E.E.</given-names></name><name name-style="western"><surname>Bhattacharya</surname><given-names>T.</given-names></name><name name-style="western"><surname>Foley</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hastie</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Parker</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Partridge</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Evans</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>de Silva</surname><given-names>T.I.</given-names></name></person-group><article-title>Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus</article-title><source>Cell</source><volume>182</volume><year>2020</year><fpage>812</fpage><lpage>827.e19</lpage><pub-id pub-id-type="pmid">32697968</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2020.06.043</pub-id><pub-id pub-id-type="pmcid">PMC7332439</pub-id></element-citation></ref><ref id="bib58"><label>58</label><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>J.F.-W.</given-names></name><name name-style="western"><surname>Kok</surname><given-names>K.-H.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>H.</given-names></name><name name-style="western"><surname>To</surname><given-names>K.K.-W.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yuen</surname><given-names>K.-Y.</given-names></name></person-group><article-title>Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan</article-title><source>Emerg. Microb. Infect.</source><volume>9</volume><year>2020</year><fpage>221</fpage><lpage>236</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/22221751.2020.1719902</pub-id><pub-id pub-id-type="pmcid">PMC7067204</pub-id><pub-id pub-id-type="pmid">31987001</pub-id></element-citation></ref><ref id="bib59"><label>59</label><element-citation publication-type="journal" id="sref59"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.-M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Song</surname><given-names>Z.-G.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Tao</surname><given-names>Z.-W.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>J.-H.</given-names></name><name name-style="western"><surname>Pei</surname><given-names>Y.-Y.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>M.-L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.-L.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>F.-H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q.-M.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>J.-J.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.-Z.</given-names></name></person-group><article-title>A&#160;new coronavirus associated with human respiratory disease in China</article-title><source>Nature</source><volume>579</volume><year>2020</year><fpage>265</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">32015508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-020-2008-3</pub-id><pub-id pub-id-type="pmcid">PMC7094943</pub-id></element-citation></ref><ref id="bib60"><label>60</label><element-citation publication-type="journal" id="sref60"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Chaubey</surname><given-names>G.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Suravajhala</surname><given-names>P.</given-names></name></person-group><article-title>Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis</article-title><source>Am. J. Physiol. Cell Physiol.</source><volume>319</volume><year>2020</year><fpage>C258</fpage><lpage>C267</lpage><pub-id pub-id-type="pmid">32510973</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpcell.00224.2020</pub-id><pub-id pub-id-type="pmcid">PMC7381712</pub-id></element-citation></ref><ref id="bib61"><label>61</label><element-citation publication-type="journal" id="sref61"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>D.-K.</given-names></name><name name-style="western"><surname>Knapp</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Kuang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Chawla</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cassonnet</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H.</given-names></name><name name-style="western"><surname>Sheykhkarimli</surname><given-names>D.</given-names></name><name name-style="western"><surname>Samavarchi-Tehrani</surname><given-names>P.</given-names></name><name name-style="western"><surname>Abdouni</surname><given-names>H.</given-names></name><name name-style="western"><surname>Rayhan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Li</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pogoutse</surname><given-names>O.</given-names></name><name name-style="western"><surname>Coyaud</surname><given-names>&#201;.</given-names></name><name name-style="western"><surname>van der Werf</surname><given-names>S.</given-names></name><name name-style="western"><surname>Demeret</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gingras</surname><given-names>A.-C.</given-names></name><name name-style="western"><surname>Taipale</surname><given-names>M.</given-names></name><name name-style="western"><surname>Raught</surname><given-names>B.</given-names></name><name name-style="western"><surname>Jacob</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Roth</surname><given-names>F.P.</given-names></name></person-group><article-title>A&#160;comprehensive, flexible collection of SARS-CoV-2 coding regions</article-title><source>G3: Genes, Genomes, Genetics</source><volume>10</volume><year>2020</year><fpage>3399</fpage><lpage>3402</lpage><pub-id pub-id-type="pmid">32763951</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1534/g3.120.401554</pub-id><pub-id pub-id-type="pmcid">PMC7467003</pub-id></element-citation></ref><ref id="bib62"><label>62</label><element-citation publication-type="journal" id="sref62"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>H.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>J.</given-names></name><name name-style="western"><surname>Khubaib</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jamal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sheikh</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Kohli</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hasnain</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>S.A.</given-names></name></person-group><article-title>Mapping the genomic landscape &amp; diversity of COVID-19 based on &gt;3950 clinical isolates of SARS-CoV-2: likely origin &amp; transmission dynamics of isolates sequenced in India</article-title><source>Indian J. Med. Res.</source><volume>151</volume><year>2020</year><fpage>474</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">32474554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/ijmr.IJMR_1253_20</pub-id><pub-id pub-id-type="pmcid">PMC7530457</pub-id></element-citation></ref><ref id="bib63"><label>63</label><element-citation publication-type="journal" id="sref63"><person-group person-group-type="author"><name name-style="western"><surname>Koyama</surname><given-names>T.</given-names></name><name name-style="western"><surname>Platt</surname><given-names>D.</given-names></name><name name-style="western"><surname>Parida</surname><given-names>L.</given-names></name></person-group><article-title>Variant analysis of SARS-CoV-2 genomes</article-title><source>Bull. World Health Organ.</source><volume>98</volume><year>2020</year><fpage>495</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">32742035</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2471/BLT.20.253591</pub-id><pub-id pub-id-type="pmcid">PMC7375210</pub-id></element-citation></ref><ref id="bib64"><label>64</label><element-citation publication-type="journal" id="sref64"><person-group person-group-type="author"><name name-style="western"><surname>Phan</surname><given-names>T.</given-names></name></person-group><article-title>Genetic diversity and evolution of SARS-CoV-2</article-title><source>Infect. Genet. Evol.</source><volume>81</volume><year>2020</year><fpage>104260</fpage><pub-id pub-id-type="pmid">32092483</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.meegid.2020.104260</pub-id><pub-id pub-id-type="pmcid">PMC7106203</pub-id></element-citation></ref><ref id="bib65"><label>65</label><element-citation publication-type="journal" id="sref65"><person-group person-group-type="author"><name name-style="western"><surname>Sakamoto</surname><given-names>S.</given-names></name><name name-style="western"><surname>Putalun</surname><given-names>W.</given-names></name><name name-style="western"><surname>Vimolmangkang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Phoolcharoen</surname><given-names>W.</given-names></name><name name-style="western"><surname>Shoyama</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>H.</given-names></name><name name-style="western"><surname>Morimoto</surname><given-names>S.</given-names></name></person-group><article-title>Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites</article-title><source>J.&#160;Nat. Med.</source><volume>72</volume><year>2018</year><fpage>32</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">29164507</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11418-017-1144-z</pub-id><pub-id pub-id-type="pmcid">PMC5775980</pub-id></element-citation></ref><ref id="bib66"><label>66</label><element-citation publication-type="journal" id="sref66"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nie</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nie</surname><given-names>L.</given-names></name><name name-style="western"><surname>Qin</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity</article-title><source>Cell</source><volume>182</volume><year>2020</year><fpage>1284</fpage><lpage>1294.e9</lpage><pub-id pub-id-type="pmid">32730807</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2020.07.012</pub-id><pub-id pub-id-type="pmcid">PMC7366990</pub-id></element-citation></ref><ref id="bib67"><label>67</label><element-citation publication-type="journal" id="sref67"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J.-S.</given-names></name><name name-style="western"><surname>Jang</surname><given-names>J.-H.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J.-M.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>Y.-S.</given-names></name><name name-style="western"><surname>Yoo</surname><given-names>C.-K.</given-names></name><name name-style="western"><surname>Han</surname><given-names>M.-G.</given-names></name></person-group><article-title>Genome-wide identification and characterization of point mutations in the SARS-CoV-2 genome</article-title><source>Osong Publ. Health Res. Perspect.</source><volume>11</volume><year>2020</year><fpage>101</fpage><lpage>111</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.24171/j.phrp.2020.11.3.05</pub-id><pub-id pub-id-type="pmcid">PMC7282418</pub-id><pub-id pub-id-type="pmid">32528815</pub-id></element-citation></ref><ref id="bib68"><label>68</label><element-citation publication-type="journal" id="sref68"><person-group person-group-type="author"><name name-style="western"><surname>Dutta</surname><given-names>N.K.</given-names></name><name name-style="western"><surname>Mazumdar</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gordy</surname><given-names>J.T.</given-names></name></person-group><article-title>The nucleocapsid protein of SARS-CoV-2: a target for vaccine development</article-title><source>J.&#160;Virol.</source><volume>94</volume><year>2020</year><fpage>e00647-20</fpage><pub-id pub-id-type="pmid">32546606</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JVI.00647-20</pub-id><pub-id pub-id-type="pmcid">PMC7307180</pub-id></element-citation></ref><ref id="bib69"><label>69</label><element-citation publication-type="journal" id="sref69"><person-group person-group-type="author"><name name-style="western"><surname>Maitra</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sarkar</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Raheja</surname><given-names>H.</given-names></name><name name-style="western"><surname>Biswas</surname><given-names>N.K.</given-names></name><name name-style="western"><surname>Chakraborti</surname><given-names>S.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sarkar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Patra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mondal</surname><given-names>R.K.</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chatterjee</surname><given-names>A.</given-names></name><name name-style="western"><surname>Banu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Majumdar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chinnaswamy</surname><given-names>S.</given-names></name><name name-style="western"><surname>Srinivasan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Dutta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Das</surname><given-names>S.</given-names></name></person-group><article-title>Mutations in SARS-CoV-2 viral RNA identified in Eastern India: possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility</article-title><source>J.&#160;Biosci.</source><volume>45</volume><year>2020</year><fpage>76</fpage><pub-id pub-id-type="pmid">32515358</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12038-020-00046-1</pub-id><pub-id pub-id-type="pmcid">PMC7269891</pub-id></element-citation></ref><ref id="bib70"><label>70</label><element-citation publication-type="journal" id="sref70"><person-group person-group-type="author"><name name-style="western"><surname>Castillo</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Parra</surname><given-names>B.</given-names></name><name name-style="western"><surname>Tapia</surname><given-names>P.</given-names></name><name name-style="western"><surname>Acevedo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lagos</surname><given-names>J.</given-names></name><name name-style="western"><surname>Andrade</surname><given-names>W.</given-names></name><name name-style="western"><surname>Arata</surname><given-names>L.</given-names></name><name name-style="western"><surname>Leal</surname><given-names>G.</given-names></name><name name-style="western"><surname>Barra</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tambley</surname><given-names>C.</given-names></name><name name-style="western"><surname>Tognarelli</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bustos</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ulloa</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fasce</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fern&#225;ndez</surname><given-names>J.</given-names></name></person-group><article-title>Phylogenetic analysis of the first four SARS-CoV-2 cases in Chile</article-title><source>J.&#160;Med. Virol.</source><volume>92</volume><year>2020</year><fpage>1562</fpage><lpage>1566</lpage><pub-id pub-id-type="pmid">32222995</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmv.25797</pub-id><pub-id pub-id-type="pmcid">PMC7228331</pub-id></element-citation></ref><ref id="bib71"><label>71</label><element-citation publication-type="journal" id="sref71"><person-group person-group-type="author"><name name-style="western"><surname>Copp&#233;e</surname><given-names>F.</given-names></name><name name-style="western"><surname>Lechien</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Decl&#232;ves</surname><given-names>A.-E.</given-names></name><name name-style="western"><surname>Tafforeau</surname><given-names>L.</given-names></name><name name-style="western"><surname>Saussez</surname><given-names>S.</given-names></name></person-group><article-title>Severe acute respiratory syndrome coronavirus 2: virus mutations in specific European populations</article-title><source>New Microb. New Infect.</source><volume>36</volume><year>2020</year><fpage>100696</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nmni.2020.100696</pub-id><pub-id pub-id-type="pmcid">PMC7238997</pub-id><pub-id pub-id-type="pmid">32509310</pub-id></element-citation></ref><ref id="bib72"><label>72</label><element-citation publication-type="journal" id="sref72"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hozumi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>G.-W.</given-names></name></person-group><article-title>Decoding SARS-CoV-2 transmission and evolution and ramifications for COVID-19 diagnosis, vaccine, and medicine</article-title><source>J.&#160;Chem. Inf. Model.</source><year>2020</year><comment>acs.jcim.0c00501</comment><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.jcim.0c00501</pub-id><pub-id pub-id-type="pmcid">PMC7318555</pub-id><pub-id pub-id-type="pmid">32530284</pub-id></element-citation></ref><ref id="bib73"><label>73</label><element-citation publication-type="journal" id="sref73"><person-group person-group-type="author"><name name-style="western"><surname>Barretto</surname><given-names>N.</given-names></name><name name-style="western"><surname>Jukneliene</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ratia</surname><given-names>K.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Mesecar</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Baker</surname><given-names>S.C.</given-names></name></person-group><article-title>The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity</article-title><source>J.&#160;Virol.</source><volume>79</volume><year>2005</year><fpage>15189</fpage><lpage>15198</lpage><pub-id pub-id-type="pmid">16306590</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JVI.79.24.15189-15198.2005</pub-id><pub-id pub-id-type="pmcid">PMC1316023</pub-id></element-citation></ref><ref id="bib74"><label>74</label><element-citation publication-type="journal" id="sref74"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Mu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Han</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.-Y.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>W.</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name></person-group><article-title>The ORF3a protein of SARS-CoV-2 induces apoptosis in cells</article-title><source>Cell. Mol. Immunol.</source><volume>17</volume><year>2020</year><fpage>881</fpage><lpage>883</lpage><pub-id pub-id-type="pmid">32555321</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41423-020-0485-9</pub-id><pub-id pub-id-type="pmcid">PMC7301057</pub-id></element-citation></ref><ref id="bib75"><label>75</label><element-citation publication-type="journal" id="sref75"><person-group person-group-type="author"><name name-style="western"><surname>Kandeil</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mostafa</surname><given-names>A.</given-names></name><name name-style="western"><surname>El-Shesheny</surname><given-names>R.</given-names></name><name name-style="western"><surname>Shehata</surname><given-names>M.</given-names></name><name name-style="western"><surname>Roshdy</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Gomaa</surname><given-names>M.</given-names></name><name name-style="western"><surname>El Taweel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kayed</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Mahmoud</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Moatasim</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kutkat</surname><given-names>O.</given-names></name><name name-style="western"><surname>Kamel</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>Mahrous</surname><given-names>N.</given-names></name><name name-style="western"><surname>El Sayes</surname><given-names>M.</given-names></name><name name-style="western"><surname>El Guindy</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Naguib</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>M.A.</given-names></name></person-group><article-title>Coding-complete genome sequences of two SARS-CoV-2 isolates from Egypt</article-title><source>Microbiol Resour. Announc.</source><volume>9</volume><year>2020</year><fpage>e00489-20</fpage><pub-id pub-id-type="pmid">32467284</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/MRA.00489-20</pub-id><pub-id pub-id-type="pmcid">PMC7256271</pub-id></element-citation></ref><ref id="bib76"><label>76</label><element-citation publication-type="journal" id="sref76"><person-group person-group-type="author"><name name-style="western"><surname>Saha</surname><given-names>P.</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Tripathi</surname><given-names>P.P.</given-names></name><name name-style="western"><surname>Srivastava</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Ray</surname><given-names>U.</given-names></name></person-group><article-title>A&#160;virus that has gone viral: amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity</article-title><source>Biosci. Rep.</source><volume>40</volume><year>2020</year><comment>BSR20201312</comment><pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/BSR20201312</pub-id><pub-id pub-id-type="pmcid">PMC7225408</pub-id><pub-id pub-id-type="pmid">32378705</pub-id></element-citation></ref><ref id="bib77"><label>77</label><element-citation publication-type="journal" id="sref77"><person-group person-group-type="author"><name name-style="western"><surname>Jakhmola</surname><given-names>S.</given-names></name><name name-style="western"><surname>Indari</surname><given-names>O.</given-names></name><name name-style="western"><surname>Baral</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kashyap</surname><given-names>D.</given-names></name><name name-style="western"><surname>Varshney</surname><given-names>N.</given-names></name><name name-style="western"><surname>Das</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chatterjee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jha</surname><given-names>H.C.</given-names></name></person-group><article-title>Comorbidity assessment is essential during COVID-19 treatment</article-title><source>Front. Physiol.</source><volume>11</volume><year>2020</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphys.2020.00984</pub-id><pub-id pub-id-type="pmcid">PMC7438844</pub-id><pub-id pub-id-type="pmid">32903640</pub-id></element-citation></ref><ref id="bib78"><label>78</label><element-citation publication-type="other" id="sref78"><article-title>Hypertension</article-title><comment>available online:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/hypertension" id="intref0035">https://www.who.int/news-room/fact-sheets/detail/hypertension</ext-link></element-citation></ref><ref id="bib79"><label>79</label><element-citation publication-type="other" id="sref79"><article-title>Diabetes</article-title><comment>available online:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/diabetes" id="intref0040">https://www.who.int/news-room/fact-sheets/detail/diabetes</ext-link></element-citation></ref><ref id="bib80"><label>80</label><element-citation publication-type="journal" id="sref80"><person-group person-group-type="author"><name name-style="western"><surname>Maddaloni</surname><given-names>E.</given-names></name><name name-style="western"><surname>Buzzetti</surname><given-names>R.</given-names></name></person-group><article-title>Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics</article-title><source>Diabetes Metab. Res. Rev.</source><year>2020</year><object-id pub-id-type="publisher-id">e33213321</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/dmrr.3321</pub-id><pub-id pub-id-type="pmcid">PMC7228318</pub-id><pub-id pub-id-type="pmid">32233018</pub-id></element-citation></ref><ref id="bib81"><label>81</label><element-citation publication-type="journal" id="sref81"><person-group person-group-type="author"><name name-style="western"><surname>Mills</surname><given-names>K.T.</given-names></name><name name-style="western"><surname>Bundy</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>T.N.</given-names></name><name name-style="western"><surname>Reed</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Kearney</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Reynolds</surname><given-names>K.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><name name-style="western"><surname>He</surname><given-names>J.</given-names></name></person-group><article-title>Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries</article-title><source>Circulation</source><volume>134</volume><year>2016</year><fpage>441</fpage><lpage>450</lpage><pub-id pub-id-type="pmid">27502908</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.115.018912</pub-id><pub-id pub-id-type="pmcid">PMC4979614</pub-id></element-citation></ref><ref id="bib82"><label>82</label><element-citation publication-type="journal" id="sref82"><person-group person-group-type="author"><name name-style="western"><surname>Schiffrin</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Flack</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Ito</surname><given-names>S.</given-names></name><name name-style="western"><surname>Muntner</surname><given-names>P.</given-names></name><name name-style="western"><surname>Webb</surname><given-names>R.C.</given-names></name></person-group><article-title>Hypertension and COVID-19</article-title><source>Am. J. Hypertens.</source><volume>33</volume><year>2020</year><fpage>373</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">32251498</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ajh/hpaa057</pub-id><pub-id pub-id-type="pmcid">PMC7184512</pub-id></element-citation></ref><ref id="bib83"><label>83</label><element-citation publication-type="journal" id="sref83"><person-group person-group-type="author"><name name-style="western"><surname>You</surname><given-names>W.-P.</given-names></name><name name-style="western"><surname>Henneberg</surname><given-names>M.</given-names></name></person-group><article-title>Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth</article-title><source>BMJ Open Diabetes Res Care</source><volume>4</volume><year>2016</year><object-id pub-id-type="publisher-id">e000161</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjdrc-2015-000161</pub-id><pub-id pub-id-type="pmcid">PMC4780042</pub-id><pub-id pub-id-type="pmid">26977306</pub-id></element-citation></ref><ref id="bib84"><label>84</label><element-citation publication-type="journal" id="sref84"><person-group person-group-type="author"><name name-style="western"><surname>Govindarajan</surname><given-names>G.</given-names></name><name name-style="western"><surname>Sowers</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Stump</surname><given-names>C.S.</given-names></name></person-group><article-title>Hypertension and diabetes mellitus</article-title><source>Radcliffe Cardiol.</source><volume>2</volume><year>2006</year><fpage>1</fpage><lpage>7</lpage></element-citation></ref><ref id="bib85"><label>85</label><element-citation publication-type="journal" id="sref85"><person-group person-group-type="author"><name name-style="western"><surname>Petrie</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Guzik</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Touyz</surname><given-names>R.M.</given-names></name></person-group><article-title>Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms</article-title><source>Can. J. Cardiol.</source><volume>34</volume><year>2018</year><fpage>575</fpage><lpage>584</lpage><pub-id pub-id-type="pmid">29459239</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cjca.2017.12.005</pub-id><pub-id pub-id-type="pmcid">PMC5953551</pub-id></element-citation></ref><ref id="bib86"><label>86</label><element-citation publication-type="journal" id="sref86"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Li</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name></person-group><article-title>Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis</article-title><source>Aging</source><volume>12</volume><year>2020</year><fpage>6049</fpage><lpage>6057</lpage><pub-id pub-id-type="pmid">32267833</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/aging.103000</pub-id><pub-id pub-id-type="pmcid">PMC7185114</pub-id></element-citation></ref><ref id="bib87"><label>87</label><element-citation publication-type="journal" id="sref87"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gou</surname><given-names>X.</given-names></name><name name-style="western"><surname>Pu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name></person-group><article-title>Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis</article-title><source>Int. J. Infect. Dis.</source><volume>94</volume><year>2020</year><fpage>91</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">32173574</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijid.2020.03.017</pub-id><pub-id pub-id-type="pmcid">PMC7194638</pub-id></element-citation></ref><ref id="bib88"><label>88</label><element-citation publication-type="journal" id="sref88"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>R.</given-names></name><name name-style="western"><surname>Misra</surname><given-names>A.</given-names></name></person-group><article-title>Comorbidities in COVID-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers</article-title><source>Diabetes Metab. Syndr.</source><volume>14</volume><year>2020</year><fpage>283</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">32283499</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.dsx.2020.03.016</pub-id><pub-id pub-id-type="pmcid">PMC7144598</pub-id></element-citation></ref><ref id="bib89"><label>89</label><element-citation publication-type="journal" id="sref89"><person-group person-group-type="author"><name name-style="western"><surname>Guan</surname><given-names>W.-J.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>W.-H.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>H.-R.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.-S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.-M.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.-Q.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>R.-C.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>C.-L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ou</surname><given-names>C.-Q.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P.-Y.</given-names></name><name name-style="western"><surname>Sang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.-F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.-C.</given-names></name><name name-style="western"><surname>Ou</surname><given-names>L.-M.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>B.</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ni</surname><given-names>Z.-Y.</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Shan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lei</surname><given-names>C.-L.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>Y.-X.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.-H.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.-M.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.-Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>G.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Z.-J.</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>S.-Q.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>C.-J.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>S.-Y.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>L.-L.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>F.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.-Y.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>J.-P.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>N.-F.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>N.-S.</given-names></name><name name-style="western"><surname>He</surname><given-names>J.-X.</given-names></name></person-group><article-title>China medical treatment expert group for COVID-19, comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis</article-title><source>Eur. Respir. J.</source><volume>55</volume><year>2020</year><fpage>200547</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/13993003.00547-2020</pub-id><pub-id pub-id-type="pmcid">PMC7098485</pub-id><pub-id pub-id-type="pmid">32217650</pub-id></element-citation></ref><ref id="bib90"><label>90</label><element-citation publication-type="journal" id="sref90"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J.-J.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>X.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y.-Y.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Y.-D.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.-B.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>Y.-Q.</given-names></name><name name-style="western"><surname>Akdis</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y.-D.</given-names></name></person-group><article-title>Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China</article-title><source>Allergy</source><volume>75</volume><year>2020</year><fpage>1730</fpage><lpage>1741</lpage><pub-id pub-id-type="pmid">32077115</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/all.14238</pub-id></element-citation></ref><ref id="bib91"><label>91</label><element-citation publication-type="journal" id="sref91"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>&#8217;an Xia</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name><name name-style="western"><surname>Du</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Song</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>W.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>F.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bai</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y.</given-names></name></person-group><article-title>Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, China</article-title><source>JAMA Intern. Med.</source><volume>180</volume><year>2020</year><fpage>934</fpage><lpage>943</lpage><pub-id pub-id-type="pmid">32167524</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamainternmed.2020.0994</pub-id><pub-id pub-id-type="pmcid">PMC7070509</pub-id></element-citation></ref><ref id="bib92"><label>92</label><element-citation publication-type="journal" id="sref92"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>K.</given-names></name></person-group><article-title>Clinical characteristics and outcomes of patients with severe covid-19 with diabetes</article-title><source>BMJ Open Diab. Res. Care</source><volume>8</volume><year>2020</year><object-id pub-id-type="publisher-id">e001343</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjdrc-2020-001343</pub-id><pub-id pub-id-type="pmcid">PMC7222577</pub-id><pub-id pub-id-type="pmid">32345579</pub-id></element-citation></ref><ref id="bib93"><label>93</label><element-citation publication-type="journal" id="sref93"><person-group person-group-type="author"><name name-style="western"><surname>Apicella</surname><given-names>M.</given-names></name><name name-style="western"><surname>Campopiano</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Mantuano</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mazoni</surname><given-names>L.</given-names></name><name name-style="western"><surname>Coppelli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Del Prato</surname><given-names>S.</given-names></name></person-group><article-title>COVID-19 in people with diabetes: understanding the reasons for worse outcomes</article-title><source>Lancet Diab.Endocrinol.</source><volume>8</volume><year>2020</year><fpage>782</fpage><lpage>792</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2213-8587(20)30238-2</pub-id><pub-id pub-id-type="pmcid">PMC7367664</pub-id><pub-id pub-id-type="pmid">32687793</pub-id></element-citation></ref><ref id="bib94"><label>94</label><element-citation publication-type="journal" id="sref94"><person-group person-group-type="author"><name name-style="western"><surname>Rubino</surname><given-names>F.</given-names></name><name name-style="western"><surname>Amiel</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Zimmet</surname><given-names>P.</given-names></name><name name-style="western"><surname>Alberti</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bornstein</surname><given-names>S.</given-names></name><name name-style="western"><surname>Eckel</surname><given-names>R.H.</given-names></name><name name-style="western"><surname>Mingrone</surname><given-names>G.</given-names></name><name name-style="western"><surname>Boehm</surname><given-names>B.</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Chai</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Del Prato</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hopkins</surname><given-names>D.</given-names></name><name name-style="western"><surname>Herman</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Khunti</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mbanya</surname><given-names>J.-C.</given-names></name><name name-style="western"><surname>Renard</surname><given-names>E.</given-names></name></person-group><article-title>New-onset diabetes in covid-19</article-title><source>N.&#160;Engl. J. Med.</source><volume>383</volume><year>2020</year><fpage>789</fpage><lpage>790</lpage><pub-id pub-id-type="pmid">32530585</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMc2018688</pub-id><pub-id pub-id-type="pmcid">PMC7304415</pub-id></element-citation></ref><ref id="bib95"><label>95</label><element-citation publication-type="journal" id="sref95"><person-group person-group-type="author"><name name-style="western"><surname>Ormazabal</surname><given-names>V.</given-names></name><name name-style="western"><surname>Nair</surname><given-names>S.</given-names></name><name name-style="western"><surname>Elfeky</surname><given-names>O.</given-names></name><name name-style="western"><surname>Aguayo</surname><given-names>C.</given-names></name><name name-style="western"><surname>Salomon</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zu&#241;iga</surname><given-names>F.A.</given-names></name></person-group><article-title>Association between insulin resistance and the development of cardiovascular disease</article-title><source>Cardiovasc. Diabetol.</source><volume>17</volume><year>2018</year><fpage>122</fpage><pub-id pub-id-type="pmid">30170598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12933-018-0762-4</pub-id><pub-id pub-id-type="pmcid">PMC6119242</pub-id></element-citation></ref><ref id="bib96"><label>96</label><element-citation publication-type="journal" id="sref96"><person-group person-group-type="author"><name name-style="western"><surname>Burrell</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Johnston</surname><given-names>C.I.</given-names></name><name name-style="western"><surname>Tikellis</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>M.E.</given-names></name></person-group><article-title>ACE2, a new regulator of the renin-angiotensin system</article-title><source>Trends Endocrinol. Metab.</source><volume>15</volume><year>2004</year><fpage>166</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">15109615</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tem.2004.03.001</pub-id><pub-id pub-id-type="pmcid">PMC7128798</pub-id></element-citation></ref><ref id="bib97"><label>97</label><element-citation publication-type="journal" id="sref97"><person-group person-group-type="author"><name name-style="western"><surname>Yagil</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yagil</surname><given-names>C.</given-names></name></person-group><article-title>Hypothesis: ACE2 modulates blood pressure in the mammalian organism</article-title><source>Hypertension</source><volume>41</volume><year>2003</year><fpage>871</fpage><lpage>873</lpage><pub-id pub-id-type="pmid">12654716</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.HYP.0000063886.71596.C8</pub-id></element-citation></ref><ref id="bib98"><label>98</label><element-citation publication-type="journal" id="sref98"><person-group person-group-type="author"><name name-style="western"><surname>Gurley</surname><given-names>S.B.</given-names></name><name name-style="western"><surname>Allred</surname><given-names>A.</given-names></name><name name-style="western"><surname>Le</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Griffiths</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>L.</given-names></name><name name-style="western"><surname>Philip</surname><given-names>N.</given-names></name><name name-style="western"><surname>Haystead</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Donoghue</surname><given-names>M.</given-names></name><name name-style="western"><surname>Breitbart</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Acton</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Rockman</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>Coffman</surname><given-names>T.M.</given-names></name></person-group><article-title>Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice</article-title><source>J.&#160;Clin. Invest.</source><volume>116</volume><year>2006</year><fpage>2218</fpage><lpage>2225</lpage><pub-id pub-id-type="pmid">16878172</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI16980</pub-id><pub-id pub-id-type="pmcid">PMC1518789</pub-id></element-citation></ref><ref id="bib99"><label>99</label><element-citation publication-type="journal" id="sref99"><person-group person-group-type="author"><name name-style="western"><surname>Tikellis</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pickering</surname><given-names>R.</given-names></name><name name-style="western"><surname>Tsorotes</surname><given-names>D.</given-names></name><name name-style="western"><surname>Du</surname><given-names>X.-J.</given-names></name><name name-style="western"><surname>Kiriazis</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nguyen-Huu</surname><given-names>T.-P.</given-names></name><name name-style="western"><surname>Head</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>M.C.</given-names></name></person-group><article-title>Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes</article-title><source>Clin. Sci. .</source><volume>123</volume><year>2012</year><fpage>519</fpage><lpage>529</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/CS20110668</pub-id><pub-id pub-id-type="pmid">22616805</pub-id></element-citation></ref><ref id="bib100"><label>100</label><element-citation publication-type="journal" id="sref100"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Karakiulakis</surname><given-names>G.</given-names></name><name name-style="western"><surname>Roth</surname><given-names>M.</given-names></name></person-group><article-title>Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?</article-title><source>Lancet Respir. Med.</source><volume>8</volume><year>2020</year><fpage>e21</fpage><pub-id pub-id-type="pmid">32171062</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2213-2600(20)30116-8</pub-id><pub-id pub-id-type="pmcid">PMC7118626</pub-id></element-citation></ref><ref id="bib101"><label>101</label><element-citation publication-type="journal" id="sref101"><person-group person-group-type="author"><name name-style="western"><surname>Furuhashi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Moniwa</surname><given-names>N.</given-names></name><name name-style="western"><surname>Mita</surname><given-names>T.</given-names></name><name name-style="western"><surname>Fuseya</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ishimura</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ohno</surname><given-names>K.</given-names></name><name name-style="western"><surname>Shibata</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>M.</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Akasaka</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ohnishi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>H.</given-names></name><name name-style="western"><surname>Takizawa</surname><given-names>H.</given-names></name><name name-style="western"><surname>Saitoh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ura</surname><given-names>N.</given-names></name><name name-style="western"><surname>Shimamoto</surname><given-names>K.</given-names></name><name name-style="western"><surname>Miura</surname><given-names>T.</given-names></name></person-group><article-title>Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker</article-title><source>Am. J. Hypertens.</source><volume>28</volume><year>2015</year><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">24842388</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ajh/hpu086</pub-id></element-citation></ref><ref id="bib102"><label>102</label><element-citation publication-type="journal" id="sref102"><person-group person-group-type="author"><name name-style="western"><surname>Ferrario</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Jessup</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chappell</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Averill</surname><given-names>D.B.</given-names></name><name name-style="western"><surname>Brosnihan</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Tallant</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Diz</surname><given-names>D.I.</given-names></name><name name-style="western"><surname>Gallagher</surname><given-names>P.E.</given-names></name></person-group><article-title>Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2</article-title><source>Circulation</source><volume>111</volume><year>2005</year><fpage>2605</fpage><lpage>2610</lpage><pub-id pub-id-type="pmid">15897343</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.104.510461</pub-id></element-citation></ref><ref id="bib103"><label>103</label><element-citation publication-type="journal" id="sref103"><person-group person-group-type="author"><name name-style="western"><surname>Hoffmann</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kleine-Weber</surname><given-names>H.</given-names></name><name name-style="western"><surname>Schroeder</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kr&#252;ger</surname><given-names>N.</given-names></name><name name-style="western"><surname>Herrler</surname><given-names>T.</given-names></name><name name-style="western"><surname>Erichsen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schiergens</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Herrler</surname><given-names>G.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>N.-H.</given-names></name><name name-style="western"><surname>Nitsche</surname><given-names>A.</given-names></name><name name-style="western"><surname>M&#252;ller</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Drosten</surname><given-names>C.</given-names></name><name name-style="western"><surname>P&#246;hlmann</surname><given-names>S.</given-names></name></person-group><article-title>SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor</article-title><source>Cell</source><volume>181</volume><year>2020</year><fpage>271</fpage><lpage>280.e8</lpage><pub-id pub-id-type="pmid">32142651</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2020.02.052</pub-id><pub-id pub-id-type="pmcid">PMC7102627</pub-id></element-citation></ref><ref id="bib104"><label>104</label><element-citation publication-type="journal" id="sref104"><person-group person-group-type="author"><name name-style="western"><surname>Babapoor-Farrokhran</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gill</surname><given-names>D.</given-names></name><name name-style="western"><surname>Walker</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rasekhi</surname><given-names>R.T.</given-names></name><name name-style="western"><surname>Bozorgnia</surname><given-names>B.</given-names></name><name name-style="western"><surname>Amanullah</surname><given-names>A.</given-names></name></person-group><article-title>Myocardial injury and COVID-19: possible mechanisms</article-title><source>Life Sci.</source><volume>253</volume><year>2020</year><fpage>117723</fpage><pub-id pub-id-type="pmid">32360126</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lfs.2020.117723</pub-id><pub-id pub-id-type="pmcid">PMC7194533</pub-id></element-citation></ref><ref id="bib105"><label>105</label><element-citation publication-type="journal" id="sref105"><person-group person-group-type="author"><name name-style="western"><surname>Turner</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Hiscox</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Hooper</surname><given-names>N.M.</given-names></name></person-group><article-title>ACE2: from vasopeptidase to SARS virus receptor</article-title><source>Trends Pharmacol. Sci.</source><volume>25</volume><year>2004</year><fpage>291</fpage><lpage>294</lpage><pub-id pub-id-type="pmid">15165741</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tips.2004.04.001</pub-id><pub-id pub-id-type="pmcid">PMC7119032</pub-id></element-citation></ref><ref id="bib106"><label>106</label><element-citation publication-type="journal" id="sref106"><person-group person-group-type="author"><name name-style="western"><surname>Oudit</surname><given-names>G.Y.</given-names></name><name name-style="western"><surname>Kassiri</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>P.P.</given-names></name><name name-style="western"><surname>Poutanen</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Penninger</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Butany</surname><given-names>J.</given-names></name></person-group><article-title>SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS</article-title><source>Eur. J. Clin. Invest.</source><volume>39</volume><year>2009</year><fpage>618</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">19453650</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2362.2009.02153.x</pub-id><pub-id pub-id-type="pmcid">PMC7163766</pub-id></element-citation></ref><ref id="bib107"><label>107</label><element-citation publication-type="journal" id="sref107"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>N.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhan</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>F.</given-names></name></person-group><article-title>Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis</article-title><source>J.&#160;Med. Virol.</source><year>2020</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmv.25727</pub-id><pub-id pub-id-type="pmcid">PMC7228300</pub-id><pub-id pub-id-type="pmid">32104917</pub-id></element-citation></ref><ref id="bib108"><label>108</label><element-citation publication-type="journal" id="sref108"><person-group person-group-type="author"><name name-style="western"><surname>Alhogbani</surname><given-names>T.</given-names></name></person-group><article-title>Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus</article-title><source>Ann. Saudi Med.</source><volume>36</volume><year>2016</year><fpage>78</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">26922692</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5144/0256-4947.2016.78</pub-id><pub-id pub-id-type="pmcid">PMC6074274</pub-id></element-citation></ref><ref id="bib109"><label>109</label><element-citation publication-type="journal" id="sref109"><person-group person-group-type="author"><name name-style="western"><surname>Thygesen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Alpert</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Jaffe</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Chaitman</surname><given-names>B.R.</given-names></name><name name-style="western"><surname>Bax</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Morrow</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>White</surname><given-names>H.D.</given-names></name></person-group><article-title>The executive group on behalf of the joint European society of cardiology (ESC)/American college of cardiology (ACC)/American heart association (AHA)/World heart federation (WHF) task force for the universal definition of myocardial infarction, fourth universal definition of myocardial infarction (2018)</article-title><source>Circulation</source><volume>138</volume><year>2018</year><fpage>305</fpage><lpage>338</lpage></element-citation></ref><ref id="bib110"><label>110</label><element-citation publication-type="journal" id="sref110"><person-group person-group-type="author"><name name-style="western"><surname>Buja</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Zehr</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lelenwa</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ogechukwu</surname><given-names>E.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>B.</given-names></name><name name-style="western"><surname>Dasgupta</surname><given-names>A.</given-names></name><name name-style="western"><surname>Barth</surname><given-names>R.F.</given-names></name></person-group><article-title>Clinicopathological complexity in the application of the universal definition of myocardial infarction</article-title><source>Cardiovasc. Pathol.</source><volume>44</volume><year>2020</year><fpage>107153</fpage><pub-id pub-id-type="pmid">31760238</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.carpath.2019.107153</pub-id></element-citation></ref><ref id="bib111"><label>111</label><element-citation publication-type="journal" id="sref111"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>T.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>He</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Z.</given-names></name></person-group><article-title>Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)</article-title><source>JAMA Cardiol.</source><volume>5</volume><year>2020</year><fpage>811</fpage><lpage>818</lpage><pub-id pub-id-type="pmid">32219356</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamacardio.2020.1017</pub-id><pub-id pub-id-type="pmcid">PMC7101506</pub-id></element-citation></ref><ref id="bib112"><label>112</label><element-citation publication-type="journal" id="sref112"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>Y.-Y.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y.-T.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.-Y.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>X.</given-names></name></person-group><article-title>COVID-19 and the cardiovascular system</article-title><source>Nat. Rev. Cardiol.</source><volume>17</volume><year>2020</year><fpage>259</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">32139904</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41569-020-0360-5</pub-id><pub-id pub-id-type="pmcid">PMC7095524</pub-id></element-citation></ref><ref id="bib113"><label>113</label><element-citation publication-type="journal" id="sref113"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Rhee</surname><given-names>J.-W.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>P.</given-names></name><name name-style="western"><surname>Waliany</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>A.</given-names></name><name name-style="western"><surname>Witteles</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Maecker</surname><given-names>H.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>P.K.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>S.M.</given-names></name></person-group><article-title>Cardiovascular complications in patients with COVID-19: consequences of viral toxicities and host immune response</article-title><source>Curr. Cardiol. Rep.</source><volume>22</volume><year>2020</year><fpage>32</fpage><pub-id pub-id-type="pmid">32318865</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11886-020-01292-3</pub-id><pub-id pub-id-type="pmcid">PMC7171437</pub-id></element-citation></ref><ref id="bib114"><label>114</label><element-citation publication-type="journal" id="sref114"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ren</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name></person-group><article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">31986264</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(20)30183-5</pub-id><pub-id pub-id-type="pmcid">PMC7159299</pub-id></element-citation></ref><ref id="bib115"><label>115</label><element-citation publication-type="journal" id="sref115"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lv</surname><given-names>J.</given-names></name></person-group><article-title>Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection</article-title><source>J.&#160;Am. Heart Assoc.</source><volume>9</volume><year>2020</year><object-id pub-id-type="publisher-id">e016219</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/JAHA.120.016219</pub-id><pub-id pub-id-type="pmcid">PMC7428639</pub-id><pub-id pub-id-type="pmid">32233755</pub-id></element-citation></ref><ref id="bib116"><label>116</label><element-citation publication-type="journal" id="sref116"><person-group person-group-type="author"><name name-style="western"><surname>Ogimi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Englund</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Bradford</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Qin</surname><given-names>X.</given-names></name><name name-style="western"><surname>Boeckh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Waghmare</surname><given-names>A.</given-names></name></person-group><article-title>Characteristics and outcomes of coronavirus infection in children: the role of viral factors and an immunocompromised state</article-title><source>J.&#160;Pediatric Infect. Dis. Soc.</source><volume>8</volume><year>2019</year><fpage>21</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">29447395</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jpids/pix093</pub-id><pub-id pub-id-type="pmcid">PMC6437838</pub-id></element-citation></ref><ref id="bib117"><label>117</label><element-citation publication-type="journal" id="sref117"><person-group person-group-type="author"><name name-style="western"><surname>Russell</surname><given-names>B.</given-names></name><name name-style="western"><surname>Moss</surname><given-names>C.</given-names></name><name name-style="western"><surname>George</surname><given-names>G.</given-names></name><name name-style="western"><surname>Santaolalla</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cope</surname><given-names>A.</given-names></name><name name-style="western"><surname>Papa</surname><given-names>S.</given-names></name><name name-style="western"><surname>Van Hemelrijck</surname><given-names>M.</given-names></name></person-group><article-title>Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence</article-title><source>Ecancermedical. Sci.</source><volume>14</volume><year>2020</year><fpage>1022</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3332/ecancer.2020.1022</pub-id><pub-id pub-id-type="pmcid">PMC7105343</pub-id><pub-id pub-id-type="pmid">32256705</pub-id></element-citation></ref><ref id="bib118"><label>118</label><element-citation publication-type="journal" id="sref118"><person-group person-group-type="author"><name name-style="western"><surname>Gerna</surname><given-names>G.</given-names></name><name name-style="western"><surname>Campanini</surname><given-names>G.</given-names></name><name name-style="western"><surname>Rovida</surname><given-names>F.</given-names></name><name name-style="western"><surname>Percivalle</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sarasini</surname><given-names>A.</given-names></name><name name-style="western"><surname>Marchi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Baldanti</surname><given-names>F.</given-names></name></person-group><article-title>Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients</article-title><source>J.&#160;Med. Virol.</source><volume>78</volume><year>2006</year><fpage>938</fpage><lpage>949</lpage><pub-id pub-id-type="pmid">16721849</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmv.20645</pub-id><pub-id pub-id-type="pmcid">PMC7167039</pub-id></element-citation></ref><ref id="bib119"><label>119</label><element-citation publication-type="journal" id="sref119"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>A.T.Y.</given-names></name><name name-style="western"><surname>Tsang</surname><given-names>O.T.Y.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>M.Y.F.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>W.L.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>S.T.</given-names></name><name name-style="western"><surname>Yuen</surname><given-names>K.Y.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>K.W.</given-names></name><name name-style="western"><surname>Tso</surname><given-names>E.Y.K.</given-names></name><name name-style="western"><surname>Chau</surname><given-names>T.N.</given-names></name><name name-style="western"><surname>Tong</surname><given-names>W.L.</given-names></name><name name-style="western"><surname>Chiu</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>W.C.</given-names></name><collab>PMH SARS Study Group</collab></person-group><article-title>Coronavirus infection in an AIDS patient</article-title><source>AIDS</source><volume>18</volume><year>2004</year><fpage>829</fpage><lpage>830</lpage><pub-id pub-id-type="pmid">15075525</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00002030-200403260-00021</pub-id></element-citation></ref><ref id="bib120"><label>120</label><element-citation publication-type="journal" id="sref120"><person-group person-group-type="author"><name name-style="western"><surname>Schaecher</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Stabenow</surname><given-names>J.</given-names></name><name name-style="western"><surname>Oberle</surname><given-names>C.</given-names></name><name name-style="western"><surname>Schriewer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Buller</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Sagartz</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Pekosz</surname><given-names>A.</given-names></name></person-group><article-title>An immunosuppressed Syrian golden hamster model for SARS-CoV infection</article-title><source>Virology</source><volume>380</volume><year>2008</year><fpage>312</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">18760437</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.virol.2008.07.026</pub-id><pub-id pub-id-type="pmcid">PMC3722600</pub-id></element-citation></ref><ref id="bib121"><label>121</label><element-citation publication-type="journal" id="sref121"><person-group person-group-type="author"><name name-style="western"><surname>Monti</surname><given-names>S.</given-names></name><name name-style="western"><surname>Balduzzi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Delvino</surname><given-names>P.</given-names></name><name name-style="western"><surname>Bellis</surname><given-names>E.</given-names></name><name name-style="western"><surname>Quadrelli</surname><given-names>V.S.</given-names></name><name name-style="western"><surname>Montecucco</surname><given-names>C.</given-names></name></person-group><article-title>Clinical&#160;course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies</article-title><source>Ann. Rheum. Dis.</source><volume>79</volume><year>2020</year><fpage>667</fpage><lpage>668</lpage><pub-id pub-id-type="pmid">32241793</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/annrheumdis-2020-217424</pub-id><pub-id pub-id-type="pmcid">PMC7211079</pub-id></element-citation></ref><ref id="bib122"><label>122</label><element-citation publication-type="journal" id="sref122"><person-group person-group-type="author"><name name-style="western"><surname>Sarzi-Puttini</surname><given-names>P.</given-names></name><name name-style="western"><surname>Giorgi</surname><given-names>V.</given-names></name><name name-style="western"><surname>Sirotti</surname><given-names>S.</given-names></name><name name-style="western"><surname>Marotto</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ardizzone</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rizzardini</surname><given-names>G.</given-names></name><name name-style="western"><surname>Antinori</surname><given-names>S.</given-names></name><name name-style="western"><surname>Galli</surname><given-names>M.</given-names></name></person-group><article-title>COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?</article-title><source>Clin. Exp. Rheumatol.</source><volume>38</volume><year>2020</year><fpage>337</fpage><lpage>342</lpage><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/32202240" id="intref0045">https://www.ncbi.nlm.nih.gov/pubmed/32202240</ext-link><pub-id pub-id-type="pmid">32202240</pub-id></element-citation></ref><ref id="bib123"><label>123</label><element-citation publication-type="journal" id="sref123"><person-group person-group-type="author"><name name-style="western"><surname>Duncan</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Wilkes</surname><given-names>D.S.</given-names></name></person-group><article-title>Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections</article-title><source>Proc. Am. Thorac. Soc.</source><volume>2</volume><year>2005</year><fpage>449</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">16322599</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1513/pats.200507-073JS</pub-id><pub-id pub-id-type="pmcid">PMC2713333</pub-id></element-citation></ref><ref id="bib124"><label>124</label><element-citation publication-type="journal" id="sref124"><person-group person-group-type="author"><name name-style="western"><surname>L&#243;pez</surname><given-names>V.</given-names></name><name name-style="western"><surname>V&#225;zquez</surname><given-names>T.</given-names></name><name name-style="western"><surname>Alonso-Titos</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cabello</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alonso</surname><given-names>A.</given-names></name><name name-style="western"><surname>Beneyto</surname><given-names>I.</given-names></name><name name-style="western"><surname>Crespo</surname><given-names>M.</given-names></name><name name-style="western"><surname>D&#237;az-Corte</surname><given-names>C.</given-names></name><name name-style="western"><surname>Franco</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gonz&#225;lez-Roncero</surname><given-names>F.</given-names></name><name name-style="western"><surname>Guti&#233;rrez</surname><given-names>E.</given-names></name><name name-style="western"><surname>Guirado</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jim&#233;nez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jironda</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lauzurica</surname><given-names>R.</given-names></name><name name-style="western"><surname>Llorente</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mazuecos</surname><given-names>A.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rodr&#237;guez-Benot</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ruiz</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>S&#225;nchez-Fructuoso</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sola</surname><given-names>E.</given-names></name><name name-style="western"><surname>Torregrosa</surname><given-names>V.</given-names></name><name name-style="western"><surname>Z&#225;rraga</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hern&#225;ndez</surname><given-names>D.</given-names></name></person-group><article-title>Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients</article-title><source>Nefrolog&#237;a (English Edition)</source><volume>40</volume><year>2020</year><fpage>265</fpage><lpage>271</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nefro.2020.03.002</pub-id><pub-id pub-id-type="pmcid">PMC7129342</pub-id><pub-id pub-id-type="pmid">32278616</pub-id></element-citation></ref><ref id="bib125"><label>125</label><element-citation publication-type="journal" id="sref125"><person-group person-group-type="author"><name name-style="western"><surname>D&#8217;Antiga</surname><given-names>L.</given-names></name></person-group><article-title>Coronaviruses and immunosuppressed patients: the facts during the third epidemic</article-title><source>Liver Transplant.</source><volume>26</volume><year>2020</year><fpage>832</fpage><lpage>834</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/lt.25756</pub-id><pub-id pub-id-type="pmid">32196933</pub-id></element-citation></ref><ref id="bib126"><label>126</label><element-citation publication-type="journal" id="sref126"><person-group person-group-type="author"><name name-style="western"><surname>Guillen</surname><given-names>E.</given-names></name><name name-style="western"><surname>Pineiro</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Revuelta</surname><given-names>I.</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bodro</surname><given-names>M.</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>A.</given-names></name><name name-style="western"><surname>Campistol</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Diekmann</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ventura-Aguiar</surname><given-names>P.</given-names></name></person-group><article-title>Case report of COVID-19 in a kidney transplant recipient: does immunosuppression alter the clinical presentation?</article-title><source>Am. J. Transplant.</source><volume>20</volume><year>2020</year><fpage>1875</fpage><lpage>1878</lpage><pub-id pub-id-type="pmid">32198834</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ajt.15874</pub-id><pub-id pub-id-type="pmcid">PMC7228209</pub-id></element-citation></ref><ref id="bib127"><label>127</label><element-citation publication-type="journal" id="sref127"><person-group person-group-type="author"><name name-style="western"><surname>Clerkin</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Fried</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Raikhelkar</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sayer</surname><given-names>G.</given-names></name><name name-style="western"><surname>Griffin</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Masoumi</surname><given-names>A.</given-names></name></person-group><article-title>Coronavirus disease 2019 (COVID-19) and cardiovascular disease</article-title><source>Circulation</source><volume>141</volume><year>2020</year><fpage>1648</fpage><lpage>1655</lpage><pub-id pub-id-type="pmid">32200663</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.120.046941</pub-id></element-citation></ref><ref id="bib128"><label>128</label><element-citation publication-type="journal" id="sref128"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Guan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>G.</given-names></name></person-group><article-title>Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression</article-title><source>Am. J. Transplant.</source><volume>20</volume><year>2020</year><fpage>1859</fpage><lpage>1863</lpage><pub-id pub-id-type="pmid">32181990</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ajt.15869</pub-id><pub-id pub-id-type="pmcid">PMC7228349</pub-id></element-citation></ref><ref id="bib129"><label>129</label><element-citation publication-type="journal" id="sref129"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Han</surname><given-names>X.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Alwalid</surname><given-names>O.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>C.</given-names></name></person-group><article-title>Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study</article-title><source>Lancet Infect. Dis.</source><volume>20</volume><year>2020</year><fpage>425</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">32105637</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1473-3099(20)30086-4</pub-id><pub-id pub-id-type="pmcid">PMC7159053</pub-id></element-citation></ref><ref id="bib130"><label>130</label><element-citation publication-type="other" id="sref130"><article-title>Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations</article-title><comment>Available online:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendation" id="intref0050">https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendation</ext-link><comment>(accessed May 11, 2020)</comment></element-citation></ref><ref id="bib131"><label>131</label><element-citation publication-type="book" id="sref131"><source>Standard Precautions</source><year>2020</year><comment>Available online:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cdc.gov/oralhealth/infectioncontrol/summary-infection-prevention-practices/standard-precautions.html" id="intref0055">https://www.cdc.gov/oralhealth/infectioncontrol/summary-infection-prevention-practices/standard-precautions.html</ext-link><comment>(accessed May 11, 2020)</comment></element-citation></ref><ref id="bib132"><label>132</label><element-citation publication-type="journal" id="sref132"><person-group person-group-type="author"><name name-style="western"><surname>Kutter</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Spronken</surname><given-names>M.I.</given-names></name><name name-style="western"><surname>Fraaij</surname><given-names>P.L.</given-names></name><name name-style="western"><surname>Fouchier</surname><given-names>R.A.M.</given-names></name><name name-style="western"><surname>Herfst</surname><given-names>S.</given-names></name></person-group><article-title>Transmission routes of respiratory viruses among humans</article-title><source>Curr. Opin. Virol.</source><volume>28</volume><year>2018</year><fpage>142</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">29452994</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.coviro.2018.01.001</pub-id><pub-id pub-id-type="pmcid">PMC7102683</pub-id></element-citation></ref><ref id="bib133"><label>133</label><element-citation publication-type="other" id="sref133"><article-title>Transmission of SARS-CoV-2: implications for infection prevention precautions</article-title><comment>Available online:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions" id="intref0060">https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions</ext-link><year>2020</year></element-citation></ref><ref id="bib134"><label>134</label><element-citation publication-type="journal" id="sref134"><person-group person-group-type="author"><name name-style="western"><surname>Ong</surname><given-names>S.W.X.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>Y.K.</given-names></name><name name-style="western"><surname>Chia</surname><given-names>P.Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Ng</surname><given-names>O.T.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>M.S.Y.</given-names></name><name name-style="western"><surname>Marimuthu</surname><given-names>K.</given-names></name></person-group><article-title>Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient</article-title><source>JAMA</source><volume>323</volume><year>2020</year><fpage>1610</fpage><lpage>1612</lpage><pub-id pub-id-type="pmid">32129805</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2020.3227</pub-id><pub-id pub-id-type="pmcid">PMC7057172</pub-id></element-citation></ref><ref id="bib135"><label>135</label><element-citation publication-type="journal" id="sref135"><person-group person-group-type="author"><name name-style="western"><surname>Deshmukh</surname><given-names>V.</given-names></name><name name-style="western"><surname>Motwani</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kumari</surname><given-names>C.</given-names></name><name name-style="western"><surname>Raza</surname><given-names>K.</given-names></name></person-group><article-title>Histopathological observations in COVID-19: a systematic review</article-title><source>J.&#160;Clin. Pathol.</source><year>2020</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jclinpath-2020-206995</pub-id><pub-id pub-id-type="pmid">32817204</pub-id></element-citation></ref><ref id="bib136"><label>136</label><element-citation publication-type="journal" id="sref136"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yue</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>G.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lei</surname><given-names>M.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.-Y.</given-names></name><name name-style="western"><surname>Du</surname><given-names>R.</given-names></name></person-group><article-title>Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19</article-title><source>Ann. Intern. Med.</source><volume>172</volume><year>2020</year><fpage>629</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">32163542</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/M20-0533</pub-id><pub-id pub-id-type="pmcid">PMC7081173</pub-id></element-citation></ref><ref id="bib137"><label>137</label><element-citation publication-type="journal" id="sref137"><person-group person-group-type="author"><name name-style="western"><surname>Bernheim</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mei</surname><given-names>X.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fayad</surname><given-names>Z.A.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Diao</surname><given-names>K.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>K.</given-names></name></person-group><article-title>Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection</article-title><source>Radiology</source><volume>295</volume><year>2020</year><fpage>200463</fpage><pub-id pub-id-type="pmid">32077789</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1148/radiol.2020200463</pub-id><pub-id pub-id-type="pmcid">PMC7233369</pub-id></element-citation></ref><ref id="bib138"><label>138</label><element-citation publication-type="journal" id="sref138"><person-group person-group-type="author"><name name-style="western"><surname>Das</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>E.Y.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>R.</given-names></name><name name-style="western"><surname>Enani</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Al Dossari</surname><given-names>K.</given-names></name><name name-style="western"><surname>Van Gorkom</surname><given-names>K.</given-names></name><name name-style="western"><surname>Larsson</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Langer</surname><given-names>R.D.</given-names></name></person-group><article-title>Follow-up chest radiographic findings in patients with MERS-CoV after recovery</article-title><source>Indian J. Radiol. Imag.</source><volume>27</volume><year>2017</year><fpage>342</fpage><lpage>349</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/ijri.IJRI_469_16</pub-id><pub-id pub-id-type="pmcid">PMC5644332</pub-id><pub-id pub-id-type="pmid">29089687</pub-id></element-citation></ref><ref id="bib139"><label>139</label><element-citation publication-type="journal" id="sref139"><person-group person-group-type="author"><name name-style="western"><surname>Tse</surname><given-names>G.M.-K.</given-names></name><name name-style="western"><surname>To</surname><given-names>K.-F.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>P.K.-S.</given-names></name><name name-style="western"><surname>Lo</surname><given-names>A.W.I.</given-names></name><name name-style="western"><surname>Ng</surname><given-names>K.-C.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>H.-C.</given-names></name><name name-style="western"><surname>Mak</surname><given-names>S.-M.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>K.-F.</given-names></name><name name-style="western"><surname>Hui</surname><given-names>D.S.C.</given-names></name><name name-style="western"><surname>Sung</surname><given-names>J.J.-Y.</given-names></name><name name-style="western"><surname>Ng</surname><given-names>H.-K.</given-names></name></person-group><article-title>Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)</article-title><source>J.&#160;Clin. Pathol.</source><volume>57</volume><year>2004</year><fpage>260</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">14990596</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jcp.2003.013276</pub-id><pub-id pub-id-type="pmcid">PMC1770245</pub-id></element-citation></ref><ref id="bib140"><label>140</label><element-citation publication-type="journal" id="sref140"><person-group person-group-type="author"><name name-style="western"><surname>Cheung</surname><given-names>O.Y.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>J.W.M.</given-names></name><name name-style="western"><surname>Ng</surname><given-names>C.K.</given-names></name><name name-style="western"><surname>Koo</surname><given-names>C.K.</given-names></name></person-group><article-title>The spectrum of pathological changes in severe acute respiratory syndrome (SARS)</article-title><source>Histopathology</source><volume>45</volume><year>2004</year><fpage>119</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">15279629</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2559.2004.01926.x</pub-id><pub-id pub-id-type="pmcid">PMC7194176</pub-id></element-citation></ref><ref id="bib141"><label>141</label><element-citation publication-type="journal" id="sref141"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Mao</surname><given-names>J.</given-names></name></person-group><article-title>The pathogenesis and treatment of the `Cytokine Storm&#8217; in COVID-19</article-title><source>J.&#160;Infect.</source><volume>80</volume><year>2020</year><fpage>607</fpage><lpage>613</lpage><pub-id pub-id-type="pmid">32283152</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jinf.2020.03.037</pub-id><pub-id pub-id-type="pmcid">PMC7194613</pub-id></element-citation></ref><ref id="bib142"><label>142</label><element-citation publication-type="journal" id="sref142"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>X.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>T.</given-names></name><name name-style="western"><surname>Cheung</surname><given-names>E.</given-names></name><name name-style="western"><surname>Iu</surname><given-names>T.N.-T.</given-names></name><name name-style="western"><surname>Tam</surname><given-names>V.W.-H.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>I.M.-T.</given-names></name><name name-style="western"><surname>Tsang</surname><given-names>M.S.-M.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>P.K.-S.</given-names></name><name name-style="western"><surname>Lam</surname><given-names>C.W.-K.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>C.-K.</given-names></name></person-group><article-title>Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma</article-title><source>Cell. Mol. Immunol.</source><volume>17</volume><year>2019</year><fpage>631</fpage><lpage>646</lpage><pub-id pub-id-type="pmid">31645649</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41423-019-0300-7</pub-id><pub-id pub-id-type="pmcid">PMC7264207</pub-id></element-citation></ref><ref id="bib143"><label>143</label><element-citation publication-type="journal" id="sref143"><person-group person-group-type="author"><name name-style="western"><surname>Mahallawi</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Khabour</surname><given-names>O.F.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Makhdoum</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Suliman</surname><given-names>B.A.</given-names></name></person-group><article-title>MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile</article-title><source>Cytokine</source><volume>104</volume><year>2018</year><fpage>8</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">29414327</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cyto.2018.01.025</pub-id><pub-id pub-id-type="pmcid">PMC7129230</pub-id></element-citation></ref><ref id="bib144"><label>144</label><element-citation publication-type="journal" id="sref144"><person-group person-group-type="author"><name name-style="western"><surname>Gilles</surname><given-names>S.</given-names></name><name name-style="western"><surname>Blume</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wimmer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Damialis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Meulenbroek</surname><given-names>L.</given-names></name><name name-style="western"><surname>G&#246;kkaya</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bergougnan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Eisenbart</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sundell</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lindh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Andersson</surname><given-names>L.-M.</given-names></name><name name-style="western"><surname>Dahl</surname><given-names>&#197;.</given-names></name><name name-style="western"><surname>Chaker</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kolek</surname><given-names>F.</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>S.</given-names></name><name name-style="western"><surname>Neumann</surname><given-names>A.U.</given-names></name><name name-style="western"><surname>Akdis</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Garssen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Westin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Van&#8217;t Land</surname><given-names>B.</given-names></name><name name-style="western"><surname>Davies</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Traidl-Hoffmann</surname><given-names>C.</given-names></name></person-group><article-title>Pollen exposure weakens innate defense against respiratory viruses</article-title><source>Allergy</source><volume>75</volume><year>2020</year><fpage>576</fpage><lpage>587</lpage><pub-id pub-id-type="pmid">31512243</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/all.14047</pub-id></element-citation></ref><ref id="bib145"><label>145</label><element-citation publication-type="journal" id="sref145"><person-group person-group-type="author"><name name-style="western"><surname>McErlean</surname><given-names>P.</given-names></name><name name-style="western"><surname>Greiman</surname><given-names>A.</given-names></name><name name-style="western"><surname>Favoreto</surname><given-names>S.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Avila</surname><given-names>P.C.</given-names></name></person-group><article-title>Viral diversity in asthma</article-title><source>Immunol. Allergy Clin.</source><volume>30</volume><year>2010</year><fpage>481</fpage><lpage>495</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.iac.2010.08.001</pub-id><pub-id pub-id-type="pmcid">PMC2967440</pub-id><pub-id pub-id-type="pmid">21029933</pub-id></element-citation></ref><ref id="bib146"><label>146</label><element-citation publication-type="journal" id="sref146"><person-group person-group-type="author"><name name-style="western"><surname>Brake</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Barnsley</surname><given-names>K.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>W.</given-names></name><name name-style="western"><surname>McAlinden</surname><given-names>K.D.</given-names></name><name name-style="western"><surname>Eapen</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Sohal</surname><given-names>S.S.</given-names></name></person-group><article-title>Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)</article-title><source>J.&#160;Clin. Med. Res.</source><volume>9</volume><year>2020</year><fpage>841</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jcm9030841</pub-id><pub-id pub-id-type="pmcid">PMC7141517</pub-id><pub-id pub-id-type="pmid">32244852</pub-id></element-citation></ref><ref id="bib147"><label>147</label><element-citation publication-type="journal" id="sref147"><person-group person-group-type="author"><name name-style="western"><surname>Seys</surname><given-names>L.J.M.</given-names></name><name name-style="western"><surname>Widagdo</surname><given-names>W.</given-names></name><name name-style="western"><surname>Verhamme</surname><given-names>F.M.</given-names></name><name name-style="western"><surname>Kleinjan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Janssens</surname><given-names>W.</given-names></name><name name-style="western"><surname>Joos</surname><given-names>G.F.</given-names></name><name name-style="western"><surname>Bracke</surname><given-names>K.R.</given-names></name><name name-style="western"><surname>Haagmans</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>Brusselle</surname><given-names>G.G.</given-names></name></person-group><article-title>DPP4, the Middle East respiratory syndrome coronavirus receptor, is upregulated in lungs of smokers and chronic obstructive pulmonary disease patients</article-title><source>Clin. Infect. Dis.</source><volume>66</volume><year>2018</year><fpage>45</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">29020176</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/cix741</pub-id><pub-id pub-id-type="pmcid">PMC7108100</pub-id></element-citation></ref><ref id="bib148"><label>148</label><element-citation publication-type="journal" id="sref148"><person-group person-group-type="author"><name name-style="western"><surname>Birrell</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>S.</given-names></name><name name-style="western"><surname>Catley</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Belvisi</surname><given-names>M.G.</given-names></name></person-group><article-title>Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages</article-title><source>J.&#160;Cell. Physiol.</source><volume>214</volume><year>2008</year><fpage>27</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">17541958</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcp.21158</pub-id></element-citation></ref><ref id="bib149"><label>149</label><element-citation publication-type="journal" id="sref149"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>X.-Z.J.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>P.G.</given-names></name></person-group><article-title>New fronts emerge in the influenza cytokine storm</article-title><source>Semin. Immunopathol.</source><volume>39</volume><year>2017</year><fpage>541</fpage><lpage>550</lpage><pub-id pub-id-type="pmid">28555383</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00281-017-0636-y</pub-id><pub-id pub-id-type="pmcid">PMC5580809</pub-id></element-citation></ref><ref id="bib150"><label>150</label><element-citation publication-type="journal" id="sref150"><person-group person-group-type="author"><name name-style="western"><surname>Mogensen</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Paludan</surname><given-names>S.R.</given-names></name></person-group><article-title>Molecular pathways in virus-induced cytokine production</article-title><source>Microbiol. Mol. Biol. Rev.</source><volume>65</volume><year>2001</year><fpage>131</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">11238989</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/MMBR.65.1.131-150.2001</pub-id><pub-id pub-id-type="pmcid">PMC99022</pub-id></element-citation></ref><ref id="bib151"><label>151</label><element-citation publication-type="journal" id="sref151"><person-group person-group-type="author"><name name-style="western"><surname>Walls</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Park</surname><given-names>Y.-J.</given-names></name><name name-style="western"><surname>Tortorici</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Wall</surname><given-names>A.</given-names></name><name name-style="western"><surname>McGuire</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>Veesler</surname><given-names>D.</given-names></name></person-group><article-title>Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein</article-title><source>Cell</source><volume>181</volume><year>2020</year><fpage>281</fpage><lpage>292.e6</lpage><pub-id pub-id-type="pmid">32155444</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2020.02.058</pub-id><pub-id pub-id-type="pmcid">PMC7102599</pub-id></element-citation></ref><ref id="bib152"><label>152</label><element-citation publication-type="journal" id="sref152"><person-group person-group-type="author"><name name-style="western"><surname>Andersen</surname><given-names>K.G.</given-names></name><name name-style="western"><surname>Rambaut</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lipkin</surname><given-names>W.I.</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Garry</surname><given-names>R.F.</given-names></name></person-group><article-title>The proximal origin of SARS-CoV-2</article-title><source>Nat. Med.</source><volume>26</volume><year>2020</year><fpage>450</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">32284615</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-020-0820-9</pub-id><pub-id pub-id-type="pmcid">PMC7095063</pub-id></element-citation></ref><ref id="bib153"><label>153</label><element-citation publication-type="journal" id="sref153"><person-group person-group-type="author"><name name-style="western"><surname>Shang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yount</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gully</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Auerbach</surname><given-names>A.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>G.</given-names></name><name name-style="western"><surname>Baric</surname><given-names>R.</given-names></name><name name-style="western"><surname>Li</surname><given-names>F.</given-names></name></person-group><article-title>Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry</article-title><source>PLoS Pathog.</source><volume>16</volume><year>2020</year><object-id pub-id-type="publisher-id">e1008392</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.ppat.1008392</pub-id><pub-id pub-id-type="pmcid">PMC7082060</pub-id><pub-id pub-id-type="pmid">32150576</pub-id></element-citation></ref><ref id="bib154"><label>154</label><element-citation publication-type="journal" id="sref154"><person-group person-group-type="author"><name name-style="western"><surname>Tortorici</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Walls</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Lang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Koerhuis</surname><given-names>D.</given-names></name><name name-style="western"><surname>Boons</surname><given-names>G.-J.</given-names></name><name name-style="western"><surname>Bosch</surname><given-names>B.-J.</given-names></name><name name-style="western"><surname>Rey</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>de Groot</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Veesler</surname><given-names>D.</given-names></name></person-group><article-title>Structural basis for human coronavirus attachment to sialic acid receptors</article-title><source>Nat. Struct. Mol. Biol.</source><volume>26</volume><year>2019</year><fpage>481</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">31160783</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41594-019-0233-y</pub-id><pub-id pub-id-type="pmcid">PMC6554059</pub-id></element-citation></ref><ref id="bib155"><label>155</label><element-citation publication-type="journal" id="sref155"><person-group person-group-type="author"><name name-style="western"><surname>Schmitz</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Kracht</surname><given-names>M.</given-names></name><name name-style="western"><surname>Saul</surname><given-names>V.V.</given-names></name></person-group><article-title>The intricate interplay between RNA viruses and NF-&#954;B</article-title><source>Biochim. Biophys. Acta</source><volume>1843</volume><year>2014</year><fpage>2754</fpage><lpage>2764</lpage><pub-id pub-id-type="pmid">25116307</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbamcr.2014.08.004</pub-id><pub-id pub-id-type="pmcid">PMC7114235</pub-id></element-citation></ref><ref id="bib156"><label>156</label><element-citation publication-type="journal" id="sref156"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>B.H.-Y.</given-names></name><name name-style="western"><surname>Chiu</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Poon</surname><given-names>V.K.-M.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>J.F.-W.</given-names></name><name name-style="western"><surname>To</surname><given-names>K.K.-W.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yuen</surname><given-names>K.-Y.</given-names></name></person-group><article-title>Activation of C-type lectin receptor and (RIG)-I-like receptors contributes to proinflammatory response in Middle East respiratory syndrome coronavirus-infected macrophages</article-title><source>J.&#160;Infect. Dis.</source><volume>221</volume><year>2020</year><fpage>647</fpage><lpage>659</lpage><pub-id pub-id-type="pmid">31562757</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jiz483</pub-id><pub-id pub-id-type="pmcid">PMC7107474</pub-id></element-citation></ref><ref id="bib157"><label>157</label><element-citation publication-type="journal" id="sref157"><person-group person-group-type="author"><name name-style="western"><surname>Barrat</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Crow</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Ivashkiv</surname><given-names>L.B.</given-names></name></person-group><article-title>Interferon target-gene expression and epigenomic signatures in health and disease</article-title><source>Nat. Immunol.</source><volume>20</volume><year>2019</year><fpage>1574</fpage><lpage>1583</lpage><pub-id pub-id-type="pmid">31745335</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-019-0466-2</pub-id><pub-id pub-id-type="pmcid">PMC7024546</pub-id></element-citation></ref><ref id="bib158"><label>158</label><element-citation publication-type="journal" id="sref158"><person-group person-group-type="author"><name name-style="western"><surname>Ivashkiv</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Donlin</surname><given-names>L.T.</given-names></name></person-group><article-title>Regulation of type I interferon responses</article-title><source>Nat. Rev. Immunol.</source><volume>14</volume><year>2014</year><fpage>36</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">24362405</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri3581</pub-id><pub-id pub-id-type="pmcid">PMC4084561</pub-id></element-citation></ref><ref id="bib159"><label>159</label><element-citation publication-type="journal" id="sref159"><person-group person-group-type="author"><name name-style="western"><surname>Di Paolo</surname><given-names>N.C.</given-names></name></person-group><article-title>Recognition of human oncogenic viruses by host pattern-recognition receptors</article-title><source>Front. Immunol.</source><volume>5</volume><year>2014</year><fpage>353</fpage><pub-id pub-id-type="pmid">25101093</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2014.00353</pub-id><pub-id pub-id-type="pmcid">PMC4105630</pub-id></element-citation></ref><ref id="bib160"><label>160</label><element-citation publication-type="journal" id="sref160"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Ni</surname><given-names>G.</given-names></name><name name-style="western"><surname>Damania</surname><given-names>B.</given-names></name></person-group><article-title>Innate sensing of DNA virus genomes</article-title><source>Annu. Rev. Virol.</source><volume>5</volume><year>2018</year><fpage>341</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">30265633</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-virology-092917-043244</pub-id><pub-id pub-id-type="pmcid">PMC6443256</pub-id></element-citation></ref><ref id="bib161"><label>161</label><element-citation publication-type="journal" id="sref161"><person-group person-group-type="author"><name name-style="western"><surname>Massa</surname><given-names>D.</given-names></name><name name-style="western"><surname>Baran</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bengoechea</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Bowie</surname><given-names>A.G.</given-names></name></person-group><article-title>PYHIN1 regulates pro-inflammatory cytokine induction rather than innate immune DNA sensing in airway epithelial cells</article-title><source>J.&#160;Biol. Chem.</source><volume>295</volume><year>2020</year><fpage>4438</fpage><lpage>4450</lpage><pub-id pub-id-type="pmid">32102850</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.RA119.011400</pub-id><pub-id pub-id-type="pmcid">PMC7135979</pub-id></element-citation></ref><ref id="bib162"><label>162</label><element-citation publication-type="journal" id="sref162"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tin</surname><given-names>M.Q.</given-names></name><name name-style="western"><surname>Tong</surname><given-names>L.</given-names></name></person-group><article-title>Toll-like receptor 2-mediated NF-kappa B pathway activation in ocular surface epithelial cells</article-title><source>Eye Vis. (Lond).</source><volume>4</volume><year>2017</year><fpage>17</fpage><pub-id pub-id-type="pmid">28706958</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40662-017-0082-x</pub-id><pub-id pub-id-type="pmcid">PMC5506675</pub-id></element-citation></ref><ref id="bib163"><label>163</label><element-citation publication-type="journal" id="sref163"><person-group person-group-type="author"><name name-style="western"><surname>Coon</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>McKelvey</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Lear</surname><given-names>T.</given-names></name><name name-style="western"><surname>Rajbhandari</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Connelly</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Han</surname><given-names>S.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Weathington</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>McVerry</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>B.B.</given-names></name></person-group><article-title>The proinflammatory role of HECTD2 in innate immunity and experimental lung injury</article-title><source>Sci. Transl. Med.</source><volume>7</volume><year>2015</year><comment>295ra109&#8211;295ra109</comment><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.aab3881</pub-id><pub-id pub-id-type="pmcid">PMC4706383</pub-id><pub-id pub-id-type="pmid">26157031</pub-id></element-citation></ref><ref id="bib164"><label>164</label><element-citation publication-type="journal" id="sref164"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>G&#246;tz</surname><given-names>F.</given-names></name></person-group><article-title>Lipoproteins of gram-positive bacteria: key players in the immune response and virulence</article-title><source>Microbiol. Mol. Biol. Rev.</source><volume>80</volume><year>2016</year><fpage>891</fpage><lpage>903</lpage><pub-id pub-id-type="pmid">27512100</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/MMBR.00028-16</pub-id><pub-id pub-id-type="pmcid">PMC4981669</pub-id></element-citation></ref><ref id="bib165"><label>165</label><element-citation publication-type="journal" id="sref165"><person-group person-group-type="author"><name name-style="western"><surname>Corman</surname><given-names>V.M.</given-names></name><name name-style="western"><surname>Landt</surname><given-names>O.</given-names></name><name name-style="western"><surname>Kaiser</surname><given-names>M.</given-names></name><name name-style="western"><surname>Molenkamp</surname><given-names>R.</given-names></name><name name-style="western"><surname>Meijer</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chu</surname><given-names>D.K.</given-names></name><name name-style="western"><surname>Bleicker</surname><given-names>T.</given-names></name><name name-style="western"><surname>Br&#252;nink</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>J.</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Mulders</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Haagmans</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>van der Veer</surname><given-names>B.</given-names></name><name name-style="western"><surname>van den Brink</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wijsman</surname><given-names>L.</given-names></name><name name-style="western"><surname>Goderski</surname><given-names>G.</given-names></name><name name-style="western"><surname>Romette</surname><given-names>J.-L.</given-names></name><name name-style="western"><surname>Ellis</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zambon</surname><given-names>M.</given-names></name><name name-style="western"><surname>Peiris</surname><given-names>M.</given-names></name><name name-style="western"><surname>Goossens</surname><given-names>H.</given-names></name><name name-style="western"><surname>Reusken</surname><given-names>C.</given-names></name><name name-style="western"><surname>Koopmans</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Drosten</surname><given-names>C.</given-names></name></person-group><article-title>Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR</article-title><source>Euro Surveill.</source><volume>25</volume><year>2020</year><fpage>2000045</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.2807/1560-7917.ES.2020.25.3.2000045</pub-id><pub-id pub-id-type="pmcid">PMC6988269</pub-id><pub-id pub-id-type="pmid">31992387</pub-id></element-citation></ref><ref id="bib166"><label>166</label><element-citation publication-type="journal" id="sref166"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>N.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>G.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>C.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F.</given-names></name></person-group><article-title>Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients</article-title><source>Clin. Infect. Dis.</source><volume>71</volume><year>2020</year><fpage>793</fpage><lpage>798</lpage><pub-id pub-id-type="pmid">32221523</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciaa345</pub-id><pub-id pub-id-type="pmcid">PMC7184442</pub-id></element-citation></ref><ref id="bib167"><label>167</label><element-citation publication-type="journal" id="sref167"><person-group person-group-type="author"><name name-style="western"><surname>Broughton</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Fasching</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Servellita</surname><given-names>V.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>J.</given-names></name><name name-style="western"><surname>Miao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Streithorst</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Granados</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sotomayor-Gonzalez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zorn</surname><given-names>K.</given-names></name><name name-style="western"><surname>Gopez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>E.</given-names></name><name name-style="western"><surname>Gu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>C.-Y.</given-names></name><name name-style="western"><surname>Guevara</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wadford</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Chiu</surname><given-names>C.Y.</given-names></name></person-group><article-title>CRISPR-Cas12-based detection of SARS-CoV-2</article-title><source>Nat. Biotechnol.</source><volume>38</volume><year>2020</year><fpage>870</fpage><lpage>874</lpage><pub-id pub-id-type="pmid">32300245</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41587-020-0513-4</pub-id><pub-id pub-id-type="pmcid">PMC9107629</pub-id></element-citation></ref><ref id="bib168"><label>168</label><element-citation publication-type="journal" id="sref168"><person-group person-group-type="author"><name name-style="western"><surname>Kellner</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Koob</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Gootenberg</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Abudayyeh</surname><given-names>O.O.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F.</given-names></name></person-group><article-title>SHERLOCK: nucleic acid detection with CRISPR nucleases</article-title><source>Nat. Protoc.</source><volume>14</volume><year>2019</year><fpage>2986</fpage><lpage>3012</lpage><pub-id pub-id-type="pmid">31548639</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41596-019-0210-2</pub-id><pub-id pub-id-type="pmcid">PMC6956564</pub-id></element-citation></ref><ref id="bib169"><label>169</label><element-citation publication-type="journal" id="sref169"><person-group person-group-type="author"><name name-style="western"><surname>Myhrvold</surname><given-names>C.</given-names></name><name name-style="western"><surname>Freije</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Gootenberg</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Abudayyeh</surname><given-names>O.O.</given-names></name><name name-style="western"><surname>Metsky</surname><given-names>H.C.</given-names></name><name name-style="western"><surname>Durbin</surname><given-names>A.F.</given-names></name><name name-style="western"><surname>Kellner</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Parham</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>K.F.</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>K.G.</given-names></name><name name-style="western"><surname>Chak</surname><given-names>B.</given-names></name><name name-style="western"><surname>Mondini</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nogueira</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Isern</surname><given-names>S.</given-names></name><name name-style="western"><surname>Michael</surname><given-names>S.F.</given-names></name><name name-style="western"><surname>Lorenzana</surname><given-names>I.</given-names></name><name name-style="western"><surname>Yozwiak</surname><given-names>N.L.</given-names></name><name name-style="western"><surname>MacInnis</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>Bosch</surname><given-names>I.</given-names></name><name name-style="western"><surname>Gehrke</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Sabeti</surname><given-names>P.C.</given-names></name></person-group><article-title>Field-deployable viral diagnostics using CRISPR-Cas13</article-title><source>Science</source><volume>360</volume><year>2018</year><fpage>444</fpage><lpage>448</lpage><pub-id pub-id-type="pmid">29700266</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aas8836</pub-id><pub-id pub-id-type="pmcid">PMC6197056</pub-id></element-citation></ref><ref id="bib170"><label>170</label><element-citation publication-type="journal" id="sref170"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name></person-group><article-title>Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): current status, challenges, and countermeasures</article-title><source>Rev. Med. Virol.</source><volume>30</volume><year>2020</year><object-id pub-id-type="publisher-id">e2106</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/rmv.2106</pub-id><pub-id pub-id-type="pmcid">PMC7235496</pub-id><pub-id pub-id-type="pmid">32302058</pub-id></element-citation></ref><ref id="bib171"><label>171</label><element-citation publication-type="journal" id="sref171"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>K.-H.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Luk</surname><given-names>H.K.H.</given-names></name><name name-style="western"><surname>Poon</surname><given-names>R.W.S.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>J.F.W.</given-names></name><name name-style="western"><surname>Yuen</surname><given-names>K.-Y.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lau</surname><given-names>S.K.P.</given-names></name><name name-style="western"><surname>Woo</surname><given-names>P.C.Y.</given-names></name></person-group><article-title>A&#160;sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus</article-title><source>Emerg. Microb. Infect.</source><volume>4</volume><year>2015</year><fpage>e26</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/emi.2015.26</pub-id><pub-id pub-id-type="pmcid">PMC4575394</pub-id><pub-id pub-id-type="pmid">26421268</pub-id></element-citation></ref><ref id="bib172"><label>172</label><element-citation publication-type="journal" id="sref172"><person-group person-group-type="author"><name name-style="western"><surname>Lau</surname><given-names>S.K.P.</given-names></name><name name-style="western"><surname>Woo</surname><given-names>P.C.Y.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>B.H.L.</given-names></name><name name-style="western"><surname>Tsoi</surname><given-names>H.-W.</given-names></name><name name-style="western"><surname>Woo</surname><given-names>G.K.S.</given-names></name><name name-style="western"><surname>Poon</surname><given-names>R.W.S.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>K.-H.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>W.I.</given-names></name><name name-style="western"><surname>Peiris</surname><given-names>J.S.M.</given-names></name><name name-style="western"><surname>Yuen</surname><given-names>K.-Y.</given-names></name></person-group><article-title>Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzyme-linked immunosorbent assay</article-title><source>J.&#160;Clin. Microbiol.</source><volume>42</volume><year>2004</year><fpage>2884</fpage><lpage>2889</lpage><pub-id pub-id-type="pmid">15243033</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JCM.42.7.2884-2889.2004</pub-id><pub-id pub-id-type="pmcid">PMC446266</pub-id></element-citation></ref><ref id="bib173"><label>173</label><element-citation publication-type="journal" id="sref173"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ying</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>W.</given-names></name></person-group><article-title>Sensitivity of chest CT for COVID-19: comparison to RT-PCR</article-title><source>Radiology</source><volume>296</volume><year>2020</year><fpage>E115</fpage><lpage>E117</lpage><pub-id pub-id-type="pmid">32073353</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1148/radiol.2020200432</pub-id><pub-id pub-id-type="pmcid">PMC7233365</pub-id></element-citation></ref><ref id="bib174"><label>174</label><element-citation publication-type="journal" id="sref174"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Su</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gou</surname><given-names>J.</given-names></name><name name-style="western"><surname>Qu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>He</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L.</given-names></name></person-group><article-title>Characteristics of liver tests in COVID-19 patients</article-title><source>J.&#160;Hepatol.</source><year>2020</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhep.2020.04.006</pub-id><pub-id pub-id-type="pmcid">PMC7194951</pub-id><pub-id pub-id-type="pmid">32298767</pub-id></element-citation></ref><ref id="bib175"><label>175</label><element-citation publication-type="journal" id="sref175"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>J.</given-names></name></person-group><article-title>Clinical features of COVID-19-related liver functional abnormality</article-title><source>Clin. Gastroenterol. Hepatol.</source><volume>18</volume><year>2020</year><fpage>1561</fpage><lpage>1566</lpage><pub-id pub-id-type="pmid">32283325</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cgh.2020.04.002</pub-id><pub-id pub-id-type="pmcid">PMC7194865</pub-id></element-citation></ref><ref id="bib176"><label>176</label><element-citation publication-type="journal" id="sref176"><person-group person-group-type="author"><name name-style="western"><surname>Bangash</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>J.</given-names></name><name name-style="western"><surname>Parekh</surname><given-names>D.</given-names></name></person-group><article-title>COVID-19 and the liver: little cause for concern</article-title><source>Lancet Gastroenterol. Hepatol.</source><volume>5</volume><year>2020</year><fpage>529</fpage><lpage>530</lpage><pub-id pub-id-type="pmid">32203680</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2468-1253(20)30084-4</pub-id><pub-id pub-id-type="pmcid">PMC7270582</pub-id></element-citation></ref><ref id="bib177"><label>177</label><element-citation publication-type="journal" id="sref177"><person-group person-group-type="author"><name name-style="western"><surname>Pfefferle</surname><given-names>S.</given-names></name><name name-style="western"><surname>Reucher</surname><given-names>S.</given-names></name><name name-style="western"><surname>N&#246;rz</surname><given-names>D.</given-names></name><name name-style="western"><surname>L&#252;tgehetmann</surname><given-names>M.</given-names></name></person-group><article-title>Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system</article-title><source>Euro Surveill.</source><volume>25</volume><year>2020</year><fpage>2000152</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.2807/1560-7917.ES.2020.25.9.2000152</pub-id><pub-id pub-id-type="pmcid">PMC7068162</pub-id><pub-id pub-id-type="pmid">32156329</pub-id></element-citation></ref><ref id="bib178"><label>178</label><element-citation publication-type="journal" id="sref178"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kou</surname><given-names>G.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Ni</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Tan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>S.</given-names></name></person-group><article-title>Evaluation of nucleocapsid and spike protein-based enzyme-linked immunosorbent assays for detecting antibodies against SARS-CoV-2</article-title><source>J.&#160;Clin. Microbiol.</source><volume>58</volume><year>2020</year><fpage>e00461-20</fpage><pub-id pub-id-type="pmid">32229605</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JCM.00461-20</pub-id><pub-id pub-id-type="pmcid">PMC7269413</pub-id></element-citation></ref><ref id="bib179"><label>179</label><element-citation publication-type="journal" id="sref179"><person-group person-group-type="author"><name name-style="western"><surname>Pan</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>P.</given-names></name><name name-style="western"><surname>Gui</surname><given-names>S.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>D.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hesketh</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>C.</given-names></name></person-group><article-title>Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19)</article-title><source>Radiology</source><volume>295</volume><year>2020</year><fpage>715</fpage><lpage>721</lpage><pub-id pub-id-type="pmid">32053470</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1148/radiol.2020200370</pub-id><pub-id pub-id-type="pmcid">PMC7233367</pub-id></element-citation></ref><ref id="bib180"><label>180</label><element-citation publication-type="journal" id="sref180"><person-group person-group-type="author"><name name-style="western"><surname>Franquet</surname><given-names>T.</given-names></name></person-group><article-title>Imaging of pulmonary viral pneumonia</article-title><source>Radiology</source><volume>260</volume><year>2011</year><fpage>18</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">21697307</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1148/radiol.11092149</pub-id></element-citation></ref><ref id="bib181"><label>181</label><element-citation publication-type="book" id="sref181"><source>Office of the Commissioner, Coronavirus (COVID-19) Update: FDA Issues New Policy to Help Expedite Availability of Diagnostics</source><year>2020</year><comment>Available online:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-new-policy-help-expedite-availability-diagnostics" id="intref0065">https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-new-policy-help-expedite-availability-diagnostics</ext-link><comment>(accessed September 24, 2020)</comment></element-citation></ref><ref id="bib182"><label>182</label><element-citation publication-type="other" id="sref182"><article-title>&#8220;Solidarity&#8221; clinical trial for COVID-19 treatments</article-title><comment>Available online:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments" id="intref0070">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments</ext-link><comment>(accessed September 24, 2020)</comment></element-citation></ref><ref id="bib183"><label>183</label><element-citation publication-type="journal" id="sref183"><person-group person-group-type="author"><name name-style="western"><surname>D&#8217;Alessandro</surname><given-names>S.</given-names></name><name name-style="western"><surname>Scaccabarozzi</surname><given-names>D.</given-names></name><name name-style="western"><surname>Signorini</surname><given-names>L.</given-names></name><name name-style="western"><surname>Perego</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ilboudo</surname><given-names>D.P.</given-names></name><name name-style="western"><surname>Ferrante</surname><given-names>P.</given-names></name><name name-style="western"><surname>Delbue</surname><given-names>S.</given-names></name></person-group><article-title>The use of antimalarial drugs against viral infection</article-title><source>Microorganisms</source><volume>8</volume><year>2020</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/microorganisms8010085</pub-id><pub-id pub-id-type="pmcid">PMC7022795</pub-id><pub-id pub-id-type="pmid">31936284</pub-id></element-citation></ref><ref id="bib184"><label>184</label><element-citation publication-type="journal" id="sref184"><person-group person-group-type="author"><name name-style="western"><surname>Al-Salama</surname><given-names>Z.T.</given-names></name><name name-style="western"><surname>Scott</surname><given-names>L.J.</given-names></name></person-group><article-title>Baricitinib: a review in rheumatoid arthritis</article-title><source>Drugs</source><volume>78</volume><year>2018</year><fpage>761</fpage><lpage>772</lpage><pub-id pub-id-type="pmid">29687421</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40265-018-0908-4</pub-id></element-citation></ref><ref id="bib185"><label>185</label><element-citation publication-type="journal" id="sref185"><person-group person-group-type="author"><name name-style="western"><surname>Bugert</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Hucke</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zanetta</surname><given-names>P.</given-names></name><name name-style="western"><surname>Bassetto</surname><given-names>M.</given-names></name><name name-style="western"><surname>Brancale</surname><given-names>A.</given-names></name></person-group><article-title>Antivirals in medical biodefense</article-title><source>Virus Genes</source><volume>56</volume><year>2020</year><fpage>150</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">32076918</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11262-020-01737-5</pub-id><pub-id pub-id-type="pmcid">PMC7089181</pub-id></element-citation></ref><ref id="bib186"><label>186</label><element-citation publication-type="journal" id="sref186"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kotian</surname><given-names>P.</given-names></name><name name-style="western"><surname>Warren</surname><given-names>T.</given-names></name><name name-style="western"><surname>Panchal</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bavari</surname><given-names>S.</given-names></name><name name-style="western"><surname>Julander</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dobo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rose</surname><given-names>A.</given-names></name><name name-style="western"><surname>El-Kattan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Taubenheim</surname><given-names>B.</given-names></name><name name-style="western"><surname>Babu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sheridan</surname><given-names>W.P.</given-names></name></person-group><article-title>BCX4430 - a broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease</article-title><source>J.&#160;Infect. Public Health</source><volume>9</volume><year>2016</year><fpage>220</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">27095300</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jiph.2016.04.002</pub-id><pub-id pub-id-type="pmcid">PMC4937725</pub-id></element-citation></ref><ref id="bib187"><label>187</label><element-citation publication-type="journal" id="sref187"><person-group person-group-type="author"><name name-style="western"><surname>Turner</surname><given-names>T.L.</given-names></name><name name-style="western"><surname>Kopp</surname><given-names>B.T.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>G.</given-names></name><name name-style="western"><surname>Landgrave</surname><given-names>L.C.</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>D.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Thompson</surname><given-names>R.</given-names></name></person-group><article-title>Respiratory syncytial virus: current and emerging treatment options</article-title><source>Clinicoecon. Outcomes Res.</source><volume>6</volume><year>2014</year><fpage>217</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">24812523</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/CEOR.S60710</pub-id><pub-id pub-id-type="pmcid">PMC4008286</pub-id></element-citation></ref><ref id="bib188"><label>188</label><element-citation publication-type="journal" id="sref188"><person-group person-group-type="author"><name name-style="western"><surname>Marcelin</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Razonable</surname><given-names>R.R.</given-names></name></person-group><article-title>Mayo Clinic Hematology/Oncology and Transplant Infectious Diseases Services, Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients</article-title><source>Transpl. Infect. Dis.</source><volume>16</volume><year>2014</year><fpage>242</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">24621016</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/tid.12194</pub-id></element-citation></ref><ref id="bib189"><label>189</label><element-citation publication-type="journal" id="sref189"><person-group person-group-type="author"><name name-style="western"><surname>Kelleni</surname><given-names>M.T.</given-names></name></person-group><article-title>Nitazoxanide/azithromycin combination for COVID-19: a suggested new protocol for early management</article-title><source>Pharmacol. Res.</source><volume>157</volume><year>2020</year><fpage>104874</fpage><pub-id pub-id-type="pmid">32360581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phrs.2020.104874</pub-id><pub-id pub-id-type="pmcid">PMC7192107</pub-id></element-citation></ref><ref id="bib190"><label>190</label><element-citation publication-type="other" id="sref190"><article-title>Draft landscape of COVID-19 candidate vaccines</article-title><comment>Available online:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines" id="intref0075">https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines</ext-link></element-citation></ref><ref id="bib191"><label>191</label><element-citation publication-type="journal" id="sref191"><person-group person-group-type="author"><name name-style="western"><surname>Speers</surname><given-names>D.J.</given-names></name></person-group><article-title>Clinical applications of molecular biology for infectious diseases</article-title><source>Clin. Biochem. Rev.</source><volume>27</volume><year>2006</year><fpage>39</fpage><lpage>51</lpage><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/16886046" id="intref0080">https://www.ncbi.nlm.nih.gov/pubmed/16886046</ext-link><pub-id pub-id-type="pmid">16886046</pub-id><pub-id pub-id-type="pmcid">PMC1390794</pub-id></element-citation></ref><ref id="bib192"><label>192</label><element-citation publication-type="journal" id="sref192"><person-group person-group-type="author"><name name-style="western"><surname>Teixeira</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Martinelli Filho</surname><given-names>M.</given-names></name><name name-style="western"><surname>Benvenuti</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Costa</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pedrosa</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Nishi&#243;ka</surname><given-names>S.A.D.</given-names></name></person-group><article-title>Cardiac damage from chronic use of chloroquine: a case report and review of the literature</article-title><source>Arq. Bras. Cardiol.</source><volume>79</volume><year>2002</year><fpage>85</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">12163948</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/s0066-782x2002001000009</pub-id></element-citation></ref><ref id="bib193"><label>193</label><element-citation publication-type="book" id="sref193"><person-group person-group-type="author"><collab>CDC</collab></person-group><chapter-title>Coronavirus Disease 2019 (COVID-19)</chapter-title><year>2020</year><publisher-name>Centers for Disease Control and Prevention</publisher-name><comment>Available online:</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/groups-at-higher-risk.html" id="intref0085">https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/groups-at-higher-risk.html</ext-link><comment>(accessed May 11, 2020)</comment></element-citation></ref><ref id="bib194"><label>194</label><element-citation publication-type="journal" id="sref194"><person-group person-group-type="author"><name name-style="western"><surname>Duan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Qu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Meng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>B.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W.</given-names></name><name name-style="western"><surname>Peng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>K.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Gong</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>D.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>J.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name></person-group><article-title>Effectiveness of convalescent plasma therapy in severe COVID-19 patients</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>117</volume><year>2020</year><fpage>9490</fpage><lpage>9496</lpage><pub-id pub-id-type="pmid">32253318</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2004168117</pub-id><pub-id pub-id-type="pmcid">PMC7196837</pub-id></element-citation></ref><ref id="bib195"><label>195</label><element-citation publication-type="journal" id="sref195"><person-group person-group-type="author"><name name-style="western"><surname>Keyaerts</surname><given-names>E.</given-names></name><name name-style="western"><surname>Vijgen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pannecouque</surname><given-names>C.</given-names></name><name name-style="western"><surname>Van Damme</surname><given-names>E.</given-names></name><name name-style="western"><surname>Peumans</surname><given-names>W.</given-names></name><name name-style="western"><surname>Egberink</surname><given-names>H.</given-names></name><name name-style="western"><surname>Balzarini</surname><given-names>J.</given-names></name><name name-style="western"><surname>Van Ranst</surname><given-names>M.</given-names></name></person-group><article-title>Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle</article-title><source>Antivir. Res.</source><volume>75</volume><year>2007</year><fpage>179</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">17428553</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.antiviral.2007.03.003</pub-id><pub-id pub-id-type="pmcid">PMC7114093</pub-id></element-citation></ref><ref id="bib196"><label>196</label><element-citation publication-type="journal" id="sref196"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>V.</given-names></name><name name-style="western"><surname>Dhanjal</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Kaul</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Wadhwa</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sundar</surname><given-names>D.</given-names></name></person-group><article-title>Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (M) of SARS-CoV-2 and inhibit its activity</article-title><source>J.&#160;Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/07391102.2020.1772108</pub-id><pub-id pub-id-type="pmcid">PMC7284143</pub-id><pub-id pub-id-type="pmid">32431217</pub-id></element-citation></ref><ref id="bib197"><label>197</label><element-citation publication-type="journal" id="sref197"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>V.</given-names></name><name name-style="western"><surname>Dhanjal</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Bhargava</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kaul</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kaul</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Wadhwa</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sundar</surname><given-names>D.</given-names></name></person-group><article-title>Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells</article-title><source>J.&#160;Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/07391102.2020.1775704</pub-id><pub-id pub-id-type="pmcid">PMC7309304</pub-id><pub-id pub-id-type="pmid">32469279</pub-id></element-citation></ref><ref id="bib198"><label>198</label><element-citation publication-type="book" id="sref198"><source>Previfenon&#174; as Chemoprophylaxis of COVID-19 in Health Workers - Full Text View - ClinicalTrials.Gov</source><year>2020</year><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04446065" id="intref0090">https://clinicaltrials.gov/ct2/show/NCT04446065</ext-link></element-citation></ref></ref-list><ack id="ack0010"><title>Acknowledgements</title><p id="p0245">We appreciate our lab colleagues for insightful discussions and advice. We gratefully acknowledge the Indian Institute of Technology Indore for providing facilities and support.</p></ack></back></article></pmc-articleset>